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Introduction 
 
Please start here! 
These guidelines are meant to be accessible to a broad spectrum of readers (see Scope, below). So, 
as far as possible, we have written them in non-technical language; but in some places, technical 
language and concepts have been unavoidable. We have differentiated between non-technical and 
technical sections by using the following symbols:  
 
   = Non-technical  = Technical 
 
 
 
Preamble  
An estimated 50–80% of people with shoulder pain don’t seek medical attention for it. Despite this, 
shoulder pain is the third most common musculoskeletal reason for people to visit their GPs, and 
around 15% of these people are referred for physiotherapy in the three years following their initial 
consultations (reviewed by Linsell et al 2006). Others will consult a physiotherapist in the first 
instance. For physiotherapists, therefore, as well as sufferers and GPs among others, shoulder pain 
is a significant problem. 
Contracted (frozen) shoulder is an important type of shoulder pain. More specifically, it is a 
combination of shoulder pain and stiffness that causes sleep disturbance and marked disability, 
and which runs a prolonged course. In some cases, it does not resolve completely (Bunker 2009). 
Its prevalence appears to vary by setting. For example, Walker-Bone et al (2004) conducted a large, 
UK-based primary care1 study, comprising a questionnaire survey and subsequent physical 
examination of respondents who reported shoulder pain, and found that contracted (frozen) 
shoulder affected 8.2% of men and 10.1% of women of working age. In contrast, based on his 
extensive tertiary care1 experience as a specialist shoulder surgeon, Bunker (2009) estimates that 
contracted (frozen) shoulder affects only 0.75% of the population. A plausible explanation for this 
discrepancy is that, by definition, only the most resistant cases are seen in the tertiary (and to a 
lesser extent, the secondary1) care settings. Since physiotherapy spans all three care settings, 
individual physiotherapists might encounter contracted (frozen) shoulder often; this, added to the 
unpleasant nature of the condition, makes it important to identify the most effective ways for 
physiotherapists to diagnose it, evaluate it and manage it. But no detailed physiotherapy guidelines 
for contracted (frozen) shoulder have hitherto been published either in the UK or abroad.  
                                                          
1
 Primary care refers to community-based healthcare. Secondary care is hospital-based, whereas tertiary care—also 
hospital-based—is specialised consultative care.   
  
 
2 
In the UK in particular, this leaves a vacuum of accessible information at a critical time. Widespread 
freezing of physiotherapist posts in the NHS has had profound implications for physiotherapy 
graduate employment, student recruitment and academic staff retention, and thus for patient 
care. Looking to the coming decade, the Chief Executive of the Chartered Society of Physiotherapy 
(CSP), summarising the implications of the Darzi report (Department of Health 2008), has observed 
that ‘CSP members will have to … make both the business case and the clinical case for 
physiotherapy at a local level’ (Gray 2008). Meeting these unprecedented challenges requires 
physiotherapists to be effective, to evidence their effectiveness, and to make healthcare 
commissioners aware of this evidence. Unfortunately, despite dramatic increases in the quality and 
quantity of physiotherapy research over recent decades, implementation of the findings by clinical 
physiotherapists and commissioners has been scant. 
‘Priorities for physiotherapy research in the UK’ reports six consistent barriers to evidence-based 
practice (Chartered Society of Physiotherapy 2002). Four of these: 
 shortage of time; 
 the need to develop skills in critical appraisal and the understanding of statistics; 
 difficulty translating findings into local clinical practice; and 
 problems accessing the evidence 
 
may potentially be addressed or circumvented by guidelines. Furthermore, by highlighting areas 
where future research is required, guidelines may indirectly address the fifth consistent barrier, 
 a lack of high quality research. 
 
Guidelines can also make a case for the provision of specific treatments, as well as influencing 
commissioning. Both factors may help physiotherapists better to meet their patients’ identified 
needs. 
The development of these evidence-based clinical guidelines on the physiotherapy diagnosis, 
assessment and physiotherapy management of contracted (frozen) shoulder is therefore timely.   
Scope  
These guidelines are about contracted (frozen) shoulder in people aged 18 and over. Based on the 
best available research evidence, they focus on physiotherapy but set it in context, giving an 
overview of the diagnosis and management possibilities for this condition, from initial consultation 
(e.g. by a GP) to, if necessary, operative care. The guidelines target professionals who are directly 
or indirectly involved in caring for people with contracted (frozen) shoulder—physiotherapy 
teachers and practitioners foremost, but also commissioners/providers of healthcare, GPs, 
orthopaedic surgeons, radiologists (doctors who specialise in X-rays and other types of medical 
imaging) and rheumatologists (doctors whose specialty includes the non-operative management of 
joint problems) and others. Not least, they were written in plain English, because we intended 
them to be accessible to patients and their representative organisations. To help us in achieving 
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this aim, we involved a Delphi expert panel, which included patients and patient representatives 
among others (see footnote2).  
Exclusions  
We specifically do not intend the guidelines to apply to: 
 pain from causes other than contracted (frozen) shoulder; or shoulder pain or stiffness 
secondary to: 
  
o stroke;  
o significant trauma (e.g. fracture or dislocation);  
o surgery (except in relation to operations undertaken to treat contracted (frozen) 
shoulder, such as manipulation under anaesthetic); or  
o systemic inflammatory conditions (e.g. rheumatoid arthritis). 
 
Aims and objectives  
Through the development of the guidelines we have aimed to improve patient care by: 
 addressing the clinical question, ‘what is best practice in the diagnosis, assessment and 
physiotherapy management of contracted (frozen) shoulder?’; and 
 facilitating best practice in physiotherapists’ diagnosis, assessment and physiotherapy 
management of contracted (frozen) shoulder. 
 
These aims have taken account of pain, movement and patient-reported outcome measures 
(PROMs). 
  
Our objectives have been to: 
 identify and critically appraise the best available evidence relating to the diagnosis and 
assessment of contracted (frozen) shoulder; 
 systematically review the best available evidence relating to the physiotherapy management 
of contracted (frozen) shoulder; 
 make general recommendations, derived by transparent processes from the best available 
evidence, for the diagnosis and assessment of contracted (frozen) shoulder; 
 make graded recommendations, again derived by transparent processes from the best 
available evidence, for the physiotherapy management of contracted (frozen) shoulder;  
 highlight areas where further research is required; 
 help implement evidence, as a basis both for optimising practice and influencing healthcare 
commissioning; 
 enable people to take a more active role in their treatment if they wish to do so; and 
 develop guidelines that are user-friendly and practical. 
                                                          
2
 We intended the guidelines as a resource for patients as well as healthcare professionals. However we were 
advised by our Delphi panellists to produce a separate patient information leaflet.    
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Protocol  
As a measure against introducing bias into the guidelines, we developed a protocol in advance, and 
adhered to this throughout the development process. Any deviations from the protocol have been 
explicitly justified. 
Key research concepts and methods in brief  
This section introduces some key concepts and briefly explains how we developed the guidelines. 
For the full methods, see APPENDICES A and A2. We aimed for accessibility, such that a clinician 
with only a limited grounding in research should be able to understand the judgements made. 
 
Clinical trials 
The guidelines’ recommendations for management are based on evidence from clinical trials. There 
are several types of clinical trials. All investigate a study ‘sample’: a group of patients meant to be 
representative of the population of people with the same condition. Randomised controlled trials 
(RCTs) are considered the best clinical trials because they are least prone to bias. In RCTs, each 
patient in the sample is randomly allocated to either a treatment group or a ‘control’ group, 
resulting in a fair distribution of condition severity and other key characteristics across the groups. 
The groups are tested on a chosen measure (called an ‘outcome measure’) at the start and at the 
end of the trial. If the randomisation was effective, one would expect the outcomes to be 
comparable at the start of the trial. Furthermore, if the treatment made a difference, one would 
expect the outcomes to be different at the end of the trial. Based on the results in their study 
sample, researchers use statistical tests to make inferences about how the population would 
respond to the same treatment. Valid inferences depend on the sample really being representative 
of the population, a property called ‘external validity’. Quasi-RCTs differ from RCTs in that people 
are not allotted to groups in a truly random fashion, but by some other means e.g. according to 
whether their birth date is odd or even. Quasi-RCTs are considered inferior to RCTs because they 
are more prone to bias, but better than non-randomised controlled trials, in which patients are 
allocated to groups without any randomisation.  
Systematic reviews and meta-analyses 
Individual controlled trials may not include enough patients to detect moderate to small 
differences between the treatment and control groups, even though the differences may be 
clinically important. A solution to this would be to have much larger trials, but these are often 
prevented by practical constraints. An alternative is to find, collate and evaluate all the trials that 
have investigated the condition of interest, ideally using a transparent, systematic process (a 
‘systematic review’); then, if a number of the trials are sufficiently similar, to perform a special 
statistical test called a meta-analysis. Meta-analyses combine the results of two or more similar 
studies and increase our ability to detect differences between groups. Systematic reviews that 
include a meta-analysis (if this is appropriate) are now regarded as the highest level of research 
evidence where trials are concerned; but, in fact, not all such reviews are good. Inappropriate 
meta-analyses, for example, may give meaningless or misleading results.  
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Cochrane Collaboration and Cochrane reviews 
The Cochrane Collaboration (http://cochrane.co.uk/en/collaboration.html) is an international, not-
for-profit and independent organisation dedicated to producing systematic reviews (including 
meta-analyses, as appropriate) of high methodological quality: Cochrane reviews are generally 
regarded as the ‘gold standard’ of systematic reviews.  
Search for Cochrane reviews 
We searched in the on-line Cochrane Library (http://www.cochrane.org/) for Cochrane reviews on 
treatments that physiotherapists might use for shoulder pain. We found four, respectively covering 
‘standard physiotherapy’ (Green, Buchbinder & Hetrick 2003), acupuncture (Green, Buchbinder & 
Hetrick 2005), corticosteroid injections (Buchbinder, Green & Youd 2003) and distension therapy, 
which involves injecting a large volume of fluid to stretch out the joint (Buchbinder et al 2008). For 
this version of the guidelines (version 1.X) our focus was ‘standard physiotherapy’ treatments, 
corresponding to those modalities which a newly graduated physiotherapist in the UK would have 
at his or her disposal, although this has involved comparison with other interventions. The relevant 
Cochrane review (Green, Buchbinder & Hetrick 2003) had considered for inclusion RCTs and quasi-
RCTs up to June 2002.  
Systematic review 
We noted the trials included in the above Cochrane reviews, obtained the trials’ original reports 
and filtered out those that were not applicable to the present guidelines. We then derived our 
search strategy from the Cochrane reviews, increasing its specificity to contracted (frozen) shoulder 
and limiting it to reports in the English language, and ran searches on the Ovid MEDLINE, AMED, 
CINAHL and EMBASE databases from 2001 to 09 July 2008, using the OvidSP platform. Thus our 
search period overlapped with that of the earliest of the four Cochrane reviews (Green, Buchbinder 
& Hetrick 2003), whose cut-off for inclusion of trials was June 2002. Using methodology based on 
Verhagen et al (1998) and the Cochrane Handbook (2009) we then evaluated the trials and, with 
special focus on results’ clinical importance, conducted analyses or, if appropriate, meta-analyses.    
Questionnaire survey of CSP members 
We conducted a survey of Chartered Society of Physiotherapy (CSP) members in order to: 
 obtain a snapshot of physiotherapists’ approaches to diagnosing and treating contracted 
(frozen) shoulder at the present time, enabling us to:  
o identify the treatments currently in use and focus on these in our overview of 
interventions (section 1.6);  
o set the overview of interventions in context; 
o establish a baseline against which the guidelines’ impact might be evaluated; and 
 identify discrepancies between practice and research. 
We posted notices on eight special interest networks of the interactive CSP (iCSP) website, to 
whose subscribers contracted (frozen) shoulder might be of interest. The notices invited 
subscribers to follow a link to a self-administered, on-line questionnaire. The questionnaire 
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required respondents to state whether or not they had a ‘special interest’ in contracted (frozen) 
shoulder, because we were interested to see whether this distinction affected the diagnostic and 
management strategies they used; and to differentiate according to whether pain or stiffness was 
the primary problem. A full version of the survey report is available in full elsewhere (Hanchard et 
al 2011).  
GRADE system 
Finally, we graded the quality of the evidence and derived our recommendations using the GRADE 
system, which is recommended by the Cochrane Collaboration, transparent, and increasingly in 
standard use. Specifically, we graded the quality of the evidence using GRADEprofiler version 3.2.2 
software, which was developed by the GRADE Working Group. Aspects of quality include: 
 design and limitations (risk of bias); 
 inconsistency (which occurs when trials’ results do not agree); 
 indirectness (which occurs when the trials’ results are inapplicable to the population of 
interest);  
 imprecision (which occurs when the estimates of effect are wide); and  
 publication bias (underestimation or overestimation of effects due to selective publication 
of trials). 
 The resulting tables—GRADE evidence profile tables—are in APPENDIX E.  
Our recommendations for management have taken the quality of the evidence into account. 
When evidence is graded ‘high’, it means that further research is unlikely to change our confidence 
in the estimated effect; when it is ‘moderate’, further research is likely to influence our confidence 
in the estimated effect, and may change the estimate; when it is ‘low’, further research is very 
likely to seriously influence our confidence in the estimated effect, and is likely to change the 
estimate; and when it is ‘very low’, any estimate of effect is very uncertain. With the quality of the 
evidence taken into account, potential benefits were weighed against potential harms and, if 
feasible, a recommendation for management made. As recommended by the GRADE Working 
Group, we used four classifications of recommendation: ‘do it’, ‘probably do it’, ’probably don’t do 
it’ and ‘don’t do it’. ‘Do it’ or ‘don’t do it’ indicate a judgement that most well informed people (i.e. 
patients) would make. ‘“Probably do it” or “probably don’t do it” indicate a judgement that a 
majority of well informed people would make but a substantial minority would not’ (GRADE 
Working Group 2004).  
 
‘A recommendation to use or withhold an intervention does not mean that all patients 
should be treated identically. Nor does it mean that clinicians should not involve patients in 
the decision, or explain the merits of the alternatives. However, because most well informed 
patients will make the same choice, the explanation of the merits of the alternatives may be 
relatively brief. A recommendation is intended to facilitate an appropriate decision for an 
individual patient or a population. It should therefore reflect what people would likely 
choose, based on the evidence and their own values or preferences in relation to the 
expected outcomes. A recommendation to “probably do something” indicates a need for 
clinicians to more fully and carefully consider patients’ values and preferences when offering 
them the intervention.’ (GRADE Working Group 2004)  
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In instances where the evidence was insufficient to make a recommendation for practice, we 
reserved judgement.  
We have not considered economic data in this iteration of the guidelines. 
Feedback from target audience 
We engaged representative members of our diverse target audience (a Delphi expert panel) to feed 
back to us during the development process, thus ensuring the guidelines’ ‘fitness for purpose’ 
(APPENDICES F, G).  
Endorsement 
On the guidelines’ completion, CSP endorsement was contingent upon a successful twofold peer-
review process, by the GPP and five anonymous, independent expert reviewers using the AGREE 
instrument.  
Future versions 
Future versions of these guidelines will incorporate acupuncture, corticosteroid injections and 
capsular distension, thus encompassing other interventions that might be used by physiotherapists. 
The guidelines’ electronic format will facilitate this staged process.  
 
Structure  
The guidelines are presented in three parts, as follows. 
Part 1: Background, diagnosis, assessment and overview of strategies for 
managing contracted (frozen) shoulder  
Part 2: Systematic review and meta-analysis of treatment interventions  
This is a systematic review of treatment interventions which, in this first version (version 1.X), is 
restricted to ‘standard physiotherapy’. We have defined ‘standard physiotherapy’ as any 
intervention(s) that might be undertaken by a graduate physiotherapist without additional training, 
namely: advice; exercise therapy; manual therapy; electrotherapy; heat or cold treatments; 
ultrasound; or any combination of these. 
Part 3: Recommendations for management of contracted (frozen) shoulder 
Recommendations for management are derived from the systematic review using the GRADE 
system. 
  
Part 4: Recommendations for research 
Part 5: APPENDICES 
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1. Background, diagnosis, assessment and overview of 
strategies for managing contracted (frozen) shoulder  
1.1. Anatomy of the shoulder  
 
The shoulder joint is a ball and socket joint between between the head of humerus (the upper arm 
bone) and the scapula (shoulder blade). A membrane (synovial membrane) lining the non-
articulating surfaces constantly secretes and reabsorb a slippery lubricant, synovial fluid; the 
articulating surfaces are covered with smooth cartilage; and the whole is enclosed in a flexible 
fibrous capsule, which is attached to bone at the margins of the articulating surfaces, but not to the 
articulating surfaces themselves. In some other joints, the capsule has an important stabilising 
function—for example at the knee, where, at the sides, the capsule is condensed into the tough 
collateral ligaments that prevent side-to-side movement. But this is less so at the shoulder, where 
the capsule must be relatively lax to allow for mobility in all directions. This laxity, which gives the 
joint a surprisingly large capacity—a normal shoulder joint holds 10–30 ml of fluid (Lee et al 
2002)—is greatest underneath the joint in the axilla (armpit), where it forms the redundant axillary 
fold. The other aspects of the joint capsule blend with the tendons of the rotator cuff, the 
shoulder’s deep stabilising and controlling muscles. Specifically, the tendons of teres minor and 
infraspinatus lie behind (posteriorly) and merge with the rear of the capsule; the tendon of 
supraspinatus lies above (superiorly) and merges with the top of the capsule; and the tendon of 
subscapularis lies in front (anteriorly) and merges with the front of the capsule. There is no clear 
demarcation between the tendons, which merge with each other as well as the capsule, except 
anteriorly, between supraspinatus and subscapularis, where there is a deficiency in the rotator cuff 
called the rotator interval. At the shoulder joint, stability is a dynamic affair, brought about by 
interplay between the rotator cuff components and other muscles.  
The rotator cuff is separated from the bone, ligament and muscle overlying it by a bursa (a sac lined 
with synovial membrane which, like synovial membrane inside the joint, secretes slippery synovial 
fluid). This bursa which, at about the size of the palm of the hand, is the largest in the body, 
prevents friction between the rotator cuff and its adjacent structures. In some circumstances 
(discussed by Hanchard, Cummins & Jeffries 2004) the bursa is unable to fulfil this role, and allows 
painful pinching of the soft tissues between bony protuberances on the humerus (the humeral 
tuberosities) and the arch of bone and ligament above them (the acromion process and the coraco-
acromial ligament) which extends from the scapula. This is subacromial or outlet impingement, 
which can lead to erosion of the rotator cuff. Other types of impingements can occur inside the 
shoulder joint, especially in sportspeople who forcibly move their shoulders to the extremes of 
range, menacing the deep surface of the rotator cuff tendons among other structures (Edelson & 
Teitz 2000, Gold et al 2003, Halbrecht, Tirman & Atkin 1999, Jobe 1996, 1997, Pappas et al 2006, 
Valadie et al 2000). The various impingements are the main intrinsic causes of shoulder pain, and 
therefore important differential diagnoses from contracted (frozen) shoulder. Neck problems are a 
common extrinsic cause of shoulder pain, which is why neck movements should be screened as 
part of a shoulder assessment.  
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Movements at the shoulder joint are defined in standard anatomical terms (FIGURES 1.1a–h). All of 
the movements, especially elevation, are augmented by movements of the scapula relative to the 
chest wall.  
 
                   
                      
Anterior Anterior 
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aa bb dd uu cc tt iiioo nn ’’’    oo rr    ‘‘‘aa bb dd uu cc tt iiioo nn ’’’    FF IIIGURR EE    11 ...11 dd ...    Add dd uu cc tt iiioo nn    
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1.2. From ‘50s shoulder’ to ‘contracted (frozen) shoulder’:  
a tour of terminology and pathology 
 
The terminology surrounding contracted (frozen) shoulder has been reviewed extensively by 
Nobuhara (2003). In Japan, the condition has long been known as 50s shoulder. Nobuhara reports a 
reference to this term in an eighteenth-century source, Rigenshuran, which offers, as an alternative 
FF IIIGURR EE    11 ...11 ee ...    EE xx tt ee rr nn aa lll    (( oo rr    lllaa tt ee rr aa lll ))    
rr oo tt aa tt iiioo nn    wiii tt hh    ee lllbb oo w   aa tt    ss iiidd ee    
FF IIIGURR EE    11 ...11 ff ...    EE xx tt ee rr nn aa lll    (( oo rr    lllaa tt ee rr aa lll ))    rr oo tt aa tt iiioo nn    
iiinn    aa pp pp rr oo xx iiimaa tt ee lllyy    33 00 °°    aa bb dd uu cc tt iiioo nn    
FF IIIGURR EE    11 ...11 gg ...    IIInn tt ee rr nn aa lll    (( oo rr    mee dd iiiaa lll ))    
rr oo tt aa tt iiioo nn    wiii tt hh    ee lllbb oo w   aa tt    ss iiidd ee    FF IIIGURR EE    11 ...11 hh ...    Hoo rr iiizz oo nn tt aa lll    aa dd dd uu cc tt iiioo nn    
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descriptor, ‘long-life disease’. It seems that to survive beyond 50 was noteworthy, then. Perhaps a 
painful shoulder was a small price to pay. According to Nobuhara (2003), Rigenshuran defines 50s 
shoulder as ‘pain in the arm and joints which develops at about age 50 at times, but improves after 
a while without the administration of drugs’. This catches some of the essence of contracted 
(frozen) shoulder, although it omits to mention stiffness, which is a key feature. Recognition of the 
condition took rather longer in the West. It was not until 1867 that the French surgeon E.S. Duplay 
reported the results of his surgical explorations, initially of post-traumatic stiff shoulders, and 
dignified these with the name ‘periarthritis scapulohumerale’. Later, he realised that this condition 
also occurred in the absence of trauma. He achieved the double distinction of having the condition 
named both by him (‘periarthritis scapulohumerale’) and for him (maladie de Duplay).  
Mistakenly, Duplay and most of his contemporaries believed that the condition was primarily due 
to pathology in the subacromial–subdeltoid bursa (Lee et al 1973, Nobuhara 2003). Considering 
this, periarthritis (peri = around; arthr = joint; itis = inflammation) seems rather a vague term, since 
it could legitimately refer to inflammation of any tissue around a joint; but it may be this very 
vagueness that has accounted for its lasting appeal. In fact, ‘periarthritis’, and its variant 
‘periarticular shoulder pain’, have remained in use to the present day (Lee et al 1973, Shehab & 
Adnam 2000, Nobuhara 2003). No more precise anatomically, and less so pathologically, is ‘frozen 
shoulder’, a label originated by the American surgeon E.A. Codman in his seminal book (1934). But 
this term has also stuck: so much so that we felt obliged to keep it in the title of these guidelines, 
albeit in brackets. Codman admitted that he was perplexed by the pathology of frozen shoulder. At 
first he, like Duplay, believed that the bursa played the primary role. Later, he implicated the 
tendons. This too was a false scent. However, his clinical description of patients with contracted 
(frozen) shoulder has hardly been bettered.  
It comes on ‘slowly; [with] pain usually felt near the insertion of the deltoid3; inability 
to sleep on the affected side; painful and incomplete elevation and external rotation; 
restriction of both spasmodic and mildly adherent type; atrophy of the spinati4; little 
local tenderness; [and] X-rays negative except for bone atrophy’ (Codman 1934).    
Attention turned to the shoulder joint capsule as the source of problems with a series of surgical 
explorations in 10 patients by J.S. Neviaser, which he reported in 1945. Neviaser found that the 
capsules were thicker than normal and contracted: they gaped apart when he incised them with his 
scalpel. Additionally, he reported that in each case the capsule was abnormally adherent to the 
humerus, in the same way that sticky plasters are adherent to skin, but could be peeled off by 
repetitive rotational movements of the joint. In nine of the cases, he said, the capsule was also 
adherent to itself in the redundant axillary fold. Neviaser asserted that the primary pathology was 
not a periarthritis, and proposed the term ‘“adhesive capsulitis” … as descriptive of the pathology 
of “frozen shoulder”’ (Neviaser 1945). The term is widely used, especially in the USA. Meanwhile, 
the orthopaedic physician J.H. Cyriax had incriminated the joint capsule by deduction, and 
considered that Neviaser’s findings bore out his views (Cyriax 1982). The significance—indeed the 
                                                          
3
 The deltoid is the muscle that gives the shoulder its rounded contour. Its ‘insertion’ is where it attaches to the humerus, 
about half way down the bone. 
4
 i.e. wasting of the supraspinatus and infraspinatus muscles. 
  
 
13 
existence—of adhesions has since been challenged (Bunker 1997, Bunker 2009, Omari & Bunker 
2001), but Neviaser and Cyriax were right to incriminate the joint capsule. 
Since Neviaser’s study, the advent of arthroscopic (keyhole) techniques has made surgical 
exploration of shoulder joints commonplace. As reviewed by Bunker (2009), one of the most 
striking features on arthroscoping a contracted (frozen) shoulder is capsular contracture: the 
capsule becomes tough and thickened, and its volume may shrink to as little as 3–4 ml. (This loss of 
capacity is also obvious when attempting to inject moderate volumes of fluid into affected 
shoulders.) Another striking feature is the formation of new blood vessels in the synovial 
membrane, especially in the rotator interval area, but also in the superior capsule, the posterior 
capsule and the redundant axillary fold. In cases where the pain is giving way to stiffness, these 
new blood vessels become embedded in thick scar (Bunker 2009, Omari and Bunker 2001). 
But the underlying pathology has been elusive. Some have argued that the fundamental process is 
inflammation; others that it is scarring; yet others that it is scarring produced in reaction to 
inflammation (Hand et al 2007). The last of these is logically appealing for a number of reasons: 
because frozen shoulder causes both pain and stiffness, but the stiffness outlasts the pain; because 
of the changes seen in relation to blood circulation; and also because painful contracted (frozen) 
shoulder may respond to injections of corticosteroid (Buchbinder, Green & Youd 2003), a potent 
suppressor of inflammation. Hand et al (2007) microscopically examined tissues from the rotator 
interval of 22 patients with frozen shoulder. This examination, combined with novel staining 
techniques, revealed large numbers of fibroblasts (cells that, among other things, produce scar); 
cells associated with chronic inflammation (Hand et al 2007); and an increase in blood vessels. On 
this basis, Hand et al (2007) have proposed that frozen shoulder does indeed represent a process in 
which inflammation leads to scarring. They have tentatively implicated mast cells in this link. Mast 
cells, which are among the inflammation-related cells they found, are known to control the 
proliferation of fibroblasts. Myofibroblasts, another cell type—a cross between fibroblasts and 
muscle cells, which cause scar to contract—may also be implicated in the pathology of frozen 
shoulder. Bunker (1997) and Omari and Bunker (2001) resorted to open surgery in patients with 
frozen shoulder that had responded to neither conservative measures nor manipulation under 
anaesthesia, and found abundant myofibroblasts in tissue taken from the rotator interval. Clearly, 
on a large scale, myofibroblasts could contribute to capsular contracture; and that Hand et al 
(2007) did not find significant numbers of these cells may reflect the fact that their patient 
population was less chronic. Another finding in capsular tissue from patients with frozen shoulder 
is the absence of certain enzymes that would normally be involved in the remodelling of scar tissue 
(Bunker 2009).   
Regardless of the mechanism by which it comes about, contracture is such a striking feature of 
frozen shoulder that Bunker (2009) has suggested a further redesignation, ‘contracted (frozen) 
shoulder’, which we have adopted.  
 
The subtypes of contracted (frozen) shoulder have also been inconsistently classified. Codman 
(1934)—and indeed Duplay—noted that the condition could be insidious or secondary to trauma. 
Cyriax called the former monarticular infective [sic] arthritis (Cyriax & Troisier 1953, Cyriax 1954) 
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then monarticular rheumatoid arthritis (Cyriax 1957), subsequently changing this, in deference to 
objections from the rheumatology community, to ‘steroid-sensitive arthritis’. (He found it 
responsive to intra-articular injections of the corticosteroid hydrocortisone.) He called the latter 
traumatic arthritis (Cyriax & Troisier 1953, Cyriax 1954, 1957), though he later reported that these 
cases, too, were responsive to intra-articular injection of corticosteroid: not hydrocortisone, but 
triamcinilone, which became available to him in 1970 (Cyriax 1982). Lundberg’s 1969 classification 
was into primary (of unknown cause) and secondary (to trauma). Others have since expanded 
Lundberg’s secondary category to include any association with another event or condition 
(reviewed by Kelley, McClure & Leggin 2009). In this connection, ‘another event’ would include 
trauma or cardiac- or neuro-surgery; while ‘another condition’ would include diabetes5, 
Dupuytren’s disease6, thyroid disease, Parkinson’s disease, osteoporosis, cardiorespiratory disease, 
stroke, high cholesterol or adrenocorticotrophic hormone (ACTH) deficiency (reviewed by Hand et 
al 2008, Kelley, McClure & Leggin 2009). This expanded classification is helpful, and will be adhered 
to here, but it is not universally recognised. For example, some writers, following Lundberg’s 
original classification system, would categorise contracted (frozen) shoulder in a person with 
diabetes as primary, providing it was non-traumatic in origin. 
1.3. Diagnosing contracted (frozen) shoulder  
Formal diagnostic test accuracy studies (of sensitivity and specificity) for contracted (frozen) 
shoulder are impracticable because there is no agreed diagnostic reference standard (Harryman & 
Lazarus 2004). However, this section describes the options for clinically diagnosing contracted 
(frozen) shoulder (establishing that the condition is present); presents the evidence there is6; 
examines some of the strategies in use, based on the questionnaire survey of CSP members 
(Hanchard et al 2011); and offers suggestions. 
Trials of treatments for shoulder pain vary in their inclusivity. Some evaluate treatments in samples 
incorporating different types of shoulder pain. Others represent an attempt to target specific types 
of shoulder pain. Green, Hetrick and Buchbinder (2003) note that trials of the second type are 
appealing to clinicians because they reflect the way in which clinicians work: clinicians treat 
different types of shoulder pain in different ways. As might be expected, contracted (frozen) 
shoulder and its subtypes go by many names in such trials. Also, the precise diagnostic criteria 
vary—often reflecting imprecise reporting—but, typically, they remain compatible with the clinical 
features described by Codman (1934).  
There is a gradual onset of arm pain; the patient is unable to lie on the affected side; there is 
restriction of movements notably including elevation and external rotation; and all this in the face 
of negative X-rays. The condition runs a distinct course, divided into different phases by different 
authorities, though we recommend a simple ‘pain-predominant’ or ‘stiffness-predominant’ 
classification, which respondents to our survey (Hanchard et al 2011) found clinically meaningful. 
                                                          
5
 Among people with diabetes or severe Dupuytren’s disease, contracted (frozen) shoulder is not only prevalent, but also 
potentially slower to resolve and more resistant to treatment (Bunker 2009). 
6
 For search strategy and results see APPENDIX A2. 
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Over 90% of patients notice pain before stiffness (Boyle-Walker et al 1997). There is then a phase 
of increasing pain and increasing stiffness, during which pain is the predominant complaint: at its 
height, pain is present even at rest, may extend down the arm past the elbow, disturbs sleep and 
prevents lying on the affected side (Cyriax 1982). Sleep disturbance, often the patient’s main 
reason for seeking help, is not especially helpful diagnostically, because the same symptom occurs 
with rotator cuff tears (reviewed by Hanchard, Cummins & Jeffries 2004). The pain abates leaving 
stiffness as the predominant complaint; then the condition ends—more or less—in resolution. 
Codman (1934) wrote that resolution was the rule within about two years, an assertion echoed by 
other authorities (e.g. Cyriax 1982); but a recent study of 223 patients referred to tertiary care with 
contracted (frozen) shoulder revealed that 38% had persistent mild symptoms at a mean follow-up 
time of 4.4 years from onset of symptoms (range 2–20 years), mostly pain; and that 3% had 
persistent severe symptoms with pain and loss of function. Those with the worst symptoms at the 
outset had the worst prognosis (Hand et al 2008).  
Cyriax (1982) established that restriction of passive movement7 was necessary to make the 
diagnosis of contracted (frozen) shoulder, and this is now a generally accepted principle. He also 
introduced the concept of the capsular pattern, a pattern of limitation of passive movements which 
is unique to each joint and which, theoretically, always denotes ‘capsulitis’ (literally capsule 
inflammation). Cyriax defined the capsular pattern of the shoulder as the ratio between three 
passive movements, whereby external rotation is most restricted, abduction less, and internal 
rotation less still, with the rotations being tested in the elbow-at-side position (Cyriax 1982). In 
theory, a capsular pattern would be expected in contracted (frozen) shoulder, since some degree of 
capsulitis is likely to be present. Rundquist et al (2003) tested this hypothesis in 10 patients with 
stiffness predominant primary contracted (frozen) shoulder, using electromagnetic sensors to track 
the 3-dimensional positions of the trunk, scapula and humerus during external rotation, abduction 
and internal rotation—although these movements were active, not passive—and found a classical 
capsular pattern in seven. External rotation was the most restricted movement in eight, and the 
most or second most restricted in nine. In a subsequent study of 23 patients, Rundquist and 
Ludewig (2004) found that external rotation was most restricted, jointly most restricted, or second 
most restricted in 92%. The other prospective studies with a primary focus on range of motion in 
contracted (frozen) shoulder have also reported proportionately predominant involvement of 
passive external rotation, with the arm in 0° abduction (Kerimoglu et al 2007), 45° abduction 
(Mitsch et al 2004) and 90° abduction (Binder et al 1984, Bulgen et al 1984). Furthermore in a study 
by Wolf and Cox (2010), pain on passive external rotation at 0° abduction—irrespective of 
restriction—was found to be indicative of glenohumeral osteoarthritis (identifiable on subsequent 
X-ray, n = 23/379) or, by exclusion, contracted (frozen) shoulder (n = 68/379 of whom 58 were 
available for follow-up). In the latter subgroup, treated by corticosteroid injection(s) and, in five 
cases, manipulation, satisfaction was high (85%) and of the nine who were dissatisfied, six had 
been improved and reported insufficient symptoms to warrant further intervention. Based on 
these results, Wolf and Cox (2010) argue that, in the absence of glenohumeral arthritis or a history 
                                                          
7
 Passive movements are those which are performed for the patient, while his or her muscles are relaxed. These are 
distinct from active movements, which the patient produces of his or her own volition.   
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of trauma, pain on passive external rotation should be considered sufficient to diagnose contracted 
(frozen) shoulder, even if range of movement is not (yet) restricted.          
Setting the details of the capsular pattern aside, this involvement of external rotation is not 
surprising. Contracted (frozen) shoulder is known to centre on the rotator interval (Bunker 1997, 
2009), and in experiments on eight cadaveric shoulders, Harryman et al (1992) found that 
shortening the rotator interval capsule by approximately 1 cm reduced external rotation by a mean 
value of 37.7º (± standard deviation 20.8º). In contrast, abduction and internal rotation were hardly 
affected. At 60º of flexion, the reduction in external rotation dwindled to a relatively modest 17.8º 
(± 6.3º): a persuasive argument, too, for testing external rotation in the elbow-at-side position.  
In our survey of UK physiotherapists, we found the capsular pattern concept popular, but often 
misinterpreted. Many other respondents—more among those with a special interest—placed more 
emphasis on restriction of passive external rotation than its place in a multi-component pattern in 
diagnosing contracted (frozen) shoulder (Hanchard et al 2011). This approach contrasts with the 
consensus of 70 healthcare professionals from Australia and New Zealand, who favoured global 
loss of active and passive range of movement as a diagnostic criterion (Walmsely, Rivett and 
Osmotherly 2009); but focus on passive external rotation is better evidenced, simple, memorable, 
and unlikely to lead to confusion.  
Differential diagnosis between contracted (frozen) shoulder and the impingement-type disorders 
does cause some confusion in practice, however. Specifically, standard tests for impingement are 
positive in the pain-predominant phase of contracted (frozen) shoulder, because they involve 
stretching the joint capsule. This applies to Neer’s sign (Neer & Welsh 1977, Neer 1983), among 
others. Neer recognised this problem, and it was for this reason that he described Neer’s test, 
which involves injecting local anaesthetic under the acromial arch. Neer argued that in subacromial 
impingement, this would render his sign negative (Neer & Welsh 1977, Neer 1983). A simpler 
approach is to regard signs of contracted (frozen) shoulder as taking primacy over signs of 
impingement.  
Whether palpation has a place in the diagnosis of contracted (frozen) shoulder is unclear. One 
study (Carbone et al 2010) evaluated digital pressure over the coracoid process against an unclearly 
defined, composite ‘reference’ standard. Although the authors reported high accuracy, this must 
be considered in the light of the biases to which the study is prone (test review bias, differential 
verification bias, and possibly—though the reporting is too imprecise to be sure—diagnostic review 
bias) as well as technical uncertainties. By contrast, Bulgen et al (1984) reported tenderness, mainly 
over the humeral tuberosities, in only 21% (9/42) of their cohort.     
Finally, Codman’s (1934) observation, since amplified by Bunker (1997, 2009) and the findings of 
Wolf and Cox (2010), that a normal X-ray is prerequisite to a definitive diagnosis of contracted 
(frozen) shoulder, warrants restating. Restricted passive external rotation and the capsular pattern 
are not unique to contracted (frozen) shoulder: locked dislocations restrict passive external 
rotation; arthritis may cause painful passive external rotation, presumably with or without 
restriction (Wolf & Cox 2010); and arthritis and joint fractures would each theoretically cause a 
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capsular pattern (Cyriax 1982). All are visible on X-ray, though orthogonal views8 (views taken at 
right angles) are recommended in order that abnormalities are not overlooked. It is perhaps 
unrealistic to expect that all patients presenting with the clinical features of contracted (frozen) 
shoulder will routinely be referred for X-ray, but it should be remembered that in the absence of 
this procedure the diagnosis is tentative. Care should therefore be taken during the history to rule 
out substantial trauma, systemic (body-wide) disease and general ill-health; specific examination 
should be made for crepitus (gross creaking or grating) on passive movement; and a poor response 
to treatment should promptly trigger further investigation.    
1.4. Reproducibility of physical tests for contracted (frozen)  
shoulder, and general guidance on applying the physical tests 
Is the capsular pattern a reproducible finding? One aspect of reproducibility concerns whether 
different testers agree on whether a capsular pattern is present. Nominal agreement of this type is 
necessary for the diagnosis is to be reproducible. Hanchard, Howe and Gilbert (2004), conducted a 
standardised history and physical examination of 53 patients with different types of shoulder pain. 
Patients were typically examined in standing, and universal goniometers (protractors for measuring 
joint angles) were made available to testers, although their use was optional. Agreements between 
testers (one expert and three non-expert) on diagnoses of contracted (frozen) shoulder were found 
to be respectively ‘good’, ‘very good’ and ‘very good’ (for those with a statistical turn of mind,  = 
0.63, 0.81 and 0.82). 
Another aspect of reproducibility goes beyond agreement on whether passive movements are 
‘positive’ or ‘negative’ and concerns the extent to which there is agreement on the amount of 
available movement,  measured in degrees. Quantitative agreement of this type is necessary for 
estimations of the condition’s severity to be reproducible. There are within-tester and between-
testers elements. Specifically, the extent to which a single tester obtains similar values (in degrees) 
on successive measurements or estimates is termed within-tester agreement. The extent to which 
different testers obtain similar values is termed between-testers agreement. If its quantitative 
within-tester agreement is good (and it is otherwise valid), a test is useful for assessing a 
condition’s severity (and its progress and outcome), providing the same person takes the 
measurements. If its between-tester reliability is good (and it is otherwise valid), a test is useful for 
such assessment even if different people take the measurements.  
With respect to within-tester agreement, Tveita et al (2008a) took measurements a week apart in 
32 patients with contracted (frozen) shoulder of three months’ to two years’ duration, using a 
digital, gravity-dependent measuring device (digital inclinometer). For measurements of rotation, 
their patients lay supine with 45º of shoulder abduction. Based on their results, they estimated 
that, 95 times out of 100, a change in passive external rotation of > 13º would reflect real change; 
but that any smaller change would be indistinguishable from measurement error.  
                                                          
8
 A-P and axillary lateral views are normally taken 
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Regarding between-testers agreement, de Winter et al (2004) conducted a study in which two 
physiotherapists, again using a digital inclinometer, independently measured passive external 
rotation in 155 patients with different types of shoulder pain. Rotation was measured with patients 
lying supine, and their elbows at their sides. In this sample, > 23º change in passive external 
rotation was necessary to reflect real change 95 times out of 100. Terwee et al (2005) evaluated 
the agreement between two independent physiotherapists’ visual estimates of joint angles in a 
sample of 201 patients with different types of shoulder pain. Patients were seated for the test 
movements, passive external rotation being tested with the elbow at the side. Visual estimation is 
standard practice for many—probably most—clinicians, who work within tight time constraints, 
and testing is very often done in an upright (sitting or standing) position, making the study 
particularly apposite. In their sample, changes in passive external rotation had to equal or exceed 
35º in order to reflect true change 95 times out of 100, and Terwee et al observed that agreement 
was particularly low for patients in severe pain and with major disability. Furthermore, Croft et al 
(1994), who evaluated agreement on visual estimated ranges of shoulder movement between 
primary care physicians, concluded ‘external rotation is poorly reproducible because of systematic 
variation in examination technique and random variation in visual assessment’. 
Included for completeness is Mullaney et al (2010), who compared agreement between 
goniometric and digital inclinometric measurements of active-assisted external rotation, within- 
and between-testers, in a sample with different types of shoulder pain. But because the 
measurements were conducted at 90° of shoulder abduction—and availability of this range was 
prerequisite to recruitment—the results have little relevance to contracted (frozen) shoulder 
populations.   
In individual clinical instances, agreement may be better or worse that demonstrated in the 
foregoing studies’ samples. The key messages here are that passive external rotation is 
fundamental to the diagnosis of contracted (frozen) shoulder, but an inexact tool for assessing the 
condition’s severity, progress and outcome; and that, in so far as it is used in these capacities, 
repeated measurements are more meaningful when taken by one tester than by several. Also, it 
would be expected that standardised technique would probably enhance both within-tester and 
between-testers reproducibility. Prerequisite to standardised technique are clear operational 
definitions, such as whether the end point of movement is considered to be the maximum 
attainable range or (more likely) the point at which pain occurs, increases or becomes intolerable; 
and these definitions should be made explicit on patients’ records. Stabilisation of the scapula or 
trunk is another important consideration and, especially if the test is performed in standing, great 
care should be taken to prevent trunk rotation. We suggest that external rotation be tested with 
the patient’s elbow at his or her side for optimal ‘sensitivity’ to contracted (frozen) shoulder 
(Harryman et al 1992, Kerimoglu et al 2007, Rundquist et al 2003, Rundquist & Ludewig 2004, Wolf 
& Cox 2010). In this position (FIGURE 1.2a), the tester can limit trunk rotation and, with his or her 
shoulder behind the patient’s scapula, is well placed to detect scapular retraction. Even so, the 
tester should be realistic about the likely reproducibility of his or her estimations of range, perhaps 
thinking in terms of 30º increments rather than discrete degrees (FIGURE 1.2b). Where an estimate 
falls between two increments, the smaller (i.e. the more conservative) could be taken.  
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1.5. Other ‘tools’ for assessment   
It is essential to reliably measure and document the effectiveness of our interventions, and to do 
this in a way that is meaningful for our patients. Both generic and specific outcome measures exist. 
A key advantage of generic measures is that they allow for comparison of people with different 
conditions, or for comparison against normative values. Their main disadvantages are that, 
compared to specific outcome measures, they may be insensitive; that they may be prone to ‘floor’ 
or ‘ceiling’ effects; and that they may lack face validity. Region/joint-specific outcome measures are 
of restricted use for comparisons, but on the other hand, they tend to be sensitive and to have face 
validity (Finch et al 2002).  
 
Some region/joint-specific outcome measures are for completion by the patient, and the additional 
advantage of these is that they cost the clinician no time. There are numerous outcome measures 
of this type which have been validated, usually in samples incorporating different types of shoulder 
pain. An indicative (by no means comprehensive) selection is shown in TABLE 1.1. An obvious 
question when using an outcome measure in practice is, ‘how much change must there be before I 
know my patient’s status has altered?’ The statistic of interest here is the Minimum Clinically 
Important Difference (MCID). MCIDs have been reported for a number of outcome measures. 
Some are duplicated here (TABLE 1.1), but note that these values are specific to the populations, 
conditions and settings in relation to which they have been obtained.  
FIGURE 1.2a. A method for estimating passive 
external rotation (the key physical diagnostic 
test) in standing. The tester’s trunk hand 
stabilises the patient’s trunk; his trunk blocks 
scapular retraction and stabilises the patient’s 
elbow.  
 
FIGURE 1.2b. Estimation of external rotation 
in 30° increments. Where an estimate falls 
between two values, the smaller can be 
taken. 
 
0º 
30º 
60º 
90º 
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Combined pain‒function outcome measures Abbrev. MCID Reference for 
MCID 
Flexi-level Scale of Shoulder Function FLEX-SF 3.02/50  Cook et al 20031 
Shoulder Disability Questionnaire - Netherlands  SDQ – NL 2‒3/16 (14.0%)  Paul et al 20042 
Shoulder Disability Questionnaire – UK SDQ-UK 1‒2/23 (4‒8.0%)  Paul et al 20042 
Shoulder Pain and Disability Index  SPADI 8.0%3 Paul et al 20042 
Shoulder Rating Questionnaire SRQ 13.0% Paul et al 20042 
American Shoulder and Elbow Surgeons’ patient self-evaluation form ASES 6.4% Michener, McClure and 
Sennett 20024 
Pain outcome measures    
100 mm Visual Analogue Scale 100 mm VAS 1.4 cm Tashjian et al 20095 
11-point Numeric pain rating Scale 11-point NPRS 2.0 (or 33%) Salaffi et al 20046 
 
TABLE 1.1. Examples of combined pain‒function and pain outcome measures, with Minimum 
Clinically Important Differences (MCIDs) and references. 1Patients with different types of shoulder 
pain (the care setting was unclear); 2Patients with first episode of shoulder pain in UK primary care; 
3But Tveita et al (2008b) reported a Smallest Detectable Difference (SDD) of 17% in individual 
patients with contracted (frozen) shoulder in Norwegian secondary care; 4Patients with different 
types of shoulder pain at various outpatient clinics 5Patients undergoing non-operative treatment 
in secondary care for rotator cuff disease; 6Chronic musculoskeletal pain in secondary care.  
 
 
 
1.6.  Summary of key points in diagnosis and assessment  
 The principal diagnostic test is passive external rotation, which is restricted in contracted 
(frozen) shoulder (but also in other conditions). 
 A finding of restricted passive external rotation should be corroborated by history 
(screening for substantial trauma/serious disease), X-ray examination (which can exclude 
the other causes of restriction) and palpation (screening for gross crepitus). 
 Measuring the range of passive external rotation reliably is difficult, and this should be 
recognised. We suggest a method in standing which involves estimating range to the 
nearest 30°. (Where an estimate falls between two values, the smaller can be taken.) We 
also suggest that operational definitions are made explicit. 
 We recommend the terminology ‘pain-predominant’ and ‘stiffness-predominant’ to classify 
the stage of the condition. Where there is doubt, pain should take precedence. 
 A validated region/joint-specific measure should be used to evaluate patients’ status, 
progress and outcome.  
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An overview of treatment options  
 
This section gives an overview of treatment options, from advice and education to operative 
intervention, briefly discussing those options’ intended effects and the means by which they are 
supposed to achieve their effects. Emphasis is placed on the more common interventions as 
determined by a questionnaire survey of CSP members with 289 valid respondents (Hanchard et al 
2011) and the focus of recent trials. We have organised the treatment options from more to less 
conservative, but the order is not meant to be prescriptive. It should not be supposed that any 
individual would, or should, receive all of the treatments listed. Nor are the treatments necessarily 
mutually exclusive.  
The information for each option is arranged under Background and, to provide clinical context, 
Results of CSP survey (Hanchard et al 2011). The popularity or otherwise of an intervention should 
not be taken as evidence of efficacy.   
1.7.1. Conservative management 
Advice and education 
Background: Advice and education from physiotherapists may be tailored to individuals or given in 
more generic form, possibly as a patient information leaflet.  
Patients may be frightened by the severity of their symptoms, and may compare their experience 
unfavourably with that of relatives or friends who have had ‘shoulder pain’, especially if 
improvement seems slow.  Reassurance is therefore a key factor: specifically, reassurance that 
serious causes of shoulder pain are rare; that the patient has been screened for potential red flags; 
and that the condition is usually self-limiting. Simply acknowledging the severity of symptoms may 
help provide peace of mind, as may education on the potential spectrum and variability of 
symptoms in contracted (frozen) shoulder.  
Advice includes activity modification in the home, at work and in sporting and leisure activities. 
Physiotherapists may be able to suggest alternative ways of completing tasks that do not aggravate 
symptoms. For example, patients may find dressing easier if they wear loose and front-fastening 
tops, and if they place the affected arm into the arm-hole first. In bed, and during activities that 
require sustained positions of the affected arm, support is important: this may be achieved by use 
of pillows or towels in bed, or, during activities, by building the elbow’s or forearm’s platform of 
support up to the level required. Advice on pacing activities, avoiding aggravating factors and 
managing symptoms may help to prevent disruption of social activities and/or minimise the 
condition’s potential impact on the patient’s quality of life. 
Self-management may be enhanced by an understanding of pain mechanisms, and face to face 
education or recommendation of textbooks may be used to achieve this.           
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Results of CSP survey: Ninety-six percent of respondents said that they might use or recommend 
advice and education for pain-predominant contracted (frozen) shoulder; 88% said that they might 
use or recommend advice and education in the stiffness-predominant stage.    
Supervised neglect 
Background: Diercks et al (2004) describe supervised neglect as supportive therapy and pendular 
and active exercise within the limits of pain, and the resumption of tolerable activities, with use of 
anti-inflammatory or analgesic medication as required.   
Results of CSP survey: Supervised neglect was not given as an option. 
Superficial heat or cold 
Background: Superficial heat and cold are widely used to promote repair and healing processes. 
Typically, heat therapy involves the application of dry or moist hot pack to the skin through some 
intervening protective layer (to minimise the risk of heat damage or burns). Heat therapy is 
believed to reduce pain by mechanisms involving the release of endorphins. Additionally, the local 
warming effect may reduce stiffness in joints and spasm in muscles; and heat is thought to reduce 
oedema (swelling) by increasing fluid absorption from the tissues. The associated increase in blood 
flow is believed to improve transport of oxygen and nutrients to the tissues, while aiding the 
removal of waste products.   
Cold may be applied in many ways and works on the principle of heat exchange. Placing a cold pack 
on warm skin will cause heat to be drawn away from underlying inflamed tissues, while swelling is 
limited by constriction (narrowing) of the capillaries. Other effects are muscle relaxation, local 
anaesthesia, analgesia and increased pain threshold. All these effects are usually achieved within 
20–30 minutes of application, depending on body type. Applying cold packs for longer than 30 
minutes risks damaging the skin or deeper tissues.  
Results of CSP survey: Sixty-nine percent of respondents said that they might use or recommend 
superficial heat or cold for pain-predominant contracted (frozen) shoulder. Over 40% said they 
might use or recommend one or the other of these modalities in the stiffness-predominant stage.  
Exercise therapy 
Background: Exercise therapy is regularly used in the management of shoulder complaints. In the 
context of pain-predominant contracted (frozen) shoulder, gentle rhythmic active exercises (e.g. 
Codman’s pendular exercises) may help to reduce pain (pain modulation) and maintain the health 
of tissues within and around the joint. In the stiffness-predominant stage, function-based exercises 
may be used to maintain/restore the range or quality (co-ordination and/or control) of movement 
or both.  
Results of CSP survey: Seventy-nine percent of respondents said that they might use or 
recommend gentle active exercise in the management of pain-predominant contracted (frozen) 
shoulder. Seventy-five percent said that they might use or recommend function-based exercises for 
stiffness-predominant contracted (frozen) shoulder. 
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Manual mobilisations  
Background: Manual mobilisations (normally abbreviated to ‘mobilisations’) are therapist-applied 
passive movements of joints or other structures performed in such a way that they are always 
within the control of the patient. They may be performed by various techniques and may be 
combined with active movement on the part of the patient. The main aim in pain-predominant 
contracted (frozen) shoulder is pain relief, for which rhythmic mobilisations within comfortable 
range are used. It is speculated that these cause interactions between different types of nerve 
fibres, ‘blocking’ the transmission of pain signals to the brain. The same theory underpins the use 
of several electrotherapies in pain-predominant contracted (frozen) shoulder (see further). In the 
stiffness-predominant stage, the main aim is to restore range of movement, so mobilisations will 
stretch the joint into resistance.  
Results of CSP survey: Thirty-five percent of respondents said they might use or recommend joint 
mobilisations for pain-predominant contracted (frozen) shoulder. Eighty-seven percent said they 
might use or recommend mobilisations in the stiffness-predominant stage.   
Electrotherapy 
General 
Background: Electrotherapy includes trans-cutaneous electrical nerve stimulation (TENS), a low 
cost pain-control device; interferential (IF), a therapist-applied type of nerve stimulation; and 
shortwave diathermy (SWD) and pulsed shortwave diathermy (PSWD), which are both forms of 
radio-frequency electromagnetic field. We have also included therapeutic ultrasound in this 
category. Ultrasound does not involve applying any currents or fields to the patient’s tissues and, in 
that sense, is not, strictly speaking, ‘electrotherapy’. But it is included among electrotherapy 
modalities by popular usage among physiotherapists and in many textbooks. (For an up to date list 
of electrotherapy books, see Professor Tim Watson’s website at 
http://www.electrotherapy.org/index.htm).  
Results of CSP survey: Electrotherapy ranked as only the tenth most preferred treatment for pain-
predominant contracted (frozen) shoulder. Only 30% of all respondents chose this option: see 
under the individual modalities for a further breakdown. An interesting observation was that 
electrotherapy was substantially less popular among physiotherapists with a special interest in 
contracted (frozen) shoulder (22%) than those without (38%).This difference was statistically 
significant (Chi-square 7.780, p = 0.0053) and highly unlikely to be due to chance alone. For 
stiffness-predominant contracted (frozen) shoulder, fewer than 4% of respondents chose 
electrotherapy of any sort as an option.  
Trans-cutaneous electrical nerve stimulation (TENS) 
Background: TENS consists of low frequency electrical pulses (generated by a small, portable unit) 
transmitted to the tissues through electrodes on the skin. The pulses stimulate peripheral nerves in 
such a way as to suppress the perception of pain. Different pulse patterns are believed to achieve 
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analgesia by different mechanisms: by causing interactions between types of nerve fibres, resulting 
in a ‘block’ on the transmission of pain signals to the brain; or by releasing hormones that block 
pain receptors in the central nervous system.  
Results of CSP survey: Sixteen percent of respondents said that they might use or recommend 
TENS at some stage in the management of contracted (frozen) shoulder. 
Interferential 
Background: Low frequency electrical currents are known to have analgesic effects in the tissues 
(see TENS above for postulated mechanisms), but a low frequency current sufficiently strong to 
reach deeper tissues would be painful on the skin. Medium frequency currents are more 
comfortable on the skin, but lack analgesic effects in the deeper tissues. Interferential aims to 
circumvent this problem. In classical (‘four polar’ or ‘quadripolar’) interferential, which uses four 
electrodes, two medium-frequency currents are applied to the skin surface in such a way that they 
interact in the deeper tissues, generating a low-frequency stimulus and the desired therapeutic 
response. Another type of interferential exists, called bipolar interferential. This differs from the 
traditional type in that the medium frequency currents interact within the machine, rather than the 
patient’s tissues. As far as is known, the two types of interferential are interchangeable in terms of 
their physiological effects (reviewed by Watson, 2009).  
Results of CSP survey: Six percent of respondents said that they might use or recommend 
interferential at some stage in the management of contracted (frozen) shoulder.  
Shortwave diathermy (SWD) and pulsed shortwave diathermy (PSWD) 
Background: SWD is radio-frequency energy which generates heat in the tissues. The heating effect 
is thought to be deeper than that obtainable using, for example, hot packs or a heat lamp. 
However, there is still disagreement over which tissues are preferentially heated by SWD. In recent 
years, PSWD has become relatively more prevalent than SWD. In this mode, SWD is applied in 
pulses, between which heat is able to dissipate to a greater or lesser extent (depending on the 
intensity, the length of the pulses, and the interval between them). In general, the therapeutic 
effects of heating include analgesia, reduced muscle spasm, reduced joint stiffness, increased 
metabolism and increased blood flow, all of which could, theoretically, be beneficial at some stage 
or other of contracted (frozen) shoulder.  
Results of CSP survey: Eight percent of respondents said that they might use or recommend SWD 
or PSWD at some stage in the management of contracted (frozen) shoulder. 
Therapeutic ultrasound 
Background: Sound is mechanical vibration and ultrasound is mechanical vibration at very high 
frequencies—well above the audible range. Ultrasound does have a heating effect, although, as 
with PSWD (see above) it may be pulsed to allow heat to dissipate, and it is uncertain whether any 
effects are due to thermal or non-thermal mechanisms. Theoretical benefits include those 
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attributed to SWD and PSWD (see above) as well as increased rate of healing and improved quality 
of tissue repair.    
Results of CSP survey: Six percent of respondents said that they might use or recommend 
therapeutic ultrasound at some stage in the management of contracted (frozen) shoulder.   
Medication 
 
Non-opioid analgesics 
Background: Non-opioid analgesics include aspirin and the other non-steroidal anti-inflammatory 
drugs (NSAIDs) and paracetamol, and are suitable for pain of musculoskeletal origin. Paracetamol 
differs from the NSAIDs in having no anti-inflammatory activity but being less irritating to the 
gastric system.  
Results of survey: Not applicable. 
Opioid analgesics 
Background: The opioid analgesics, e.g. codeine, are one of the main classes of pain relieving 
drugs, and act on the central nervous system to increase tolerance to pain. Semi-synthetic variants 
include Tramadol.  
Results of survey: Not applicable. 
Corticosteroids 
Background: Corticosteroids (for which the generic term ‘steroids’ is usually used) strongly 
suppress all stages of acute and chronic inflammation. In relation to contracted (frozen) shoulder, 
they may be injected intra-articularly (directly into the joint)  or taken orally (in tablet form), 
though the latter is unusual in the UK.   
Results of CSP survey: Twenty-four percent of respondents reported practising injection therapy, 
and the proportion was significantly greater among those with a special interest in shoulders (Chi-
square 33.803, p < 0.0001). Eighty percent of respondents said they would consider using or 
recommending an intra-articular steroid injection in the pain-predominant stage of contracted 
(frozen) shoulder. This fell to approximately 15% in the stiffness-predominant stage.  
1.7.2. Minimally invasive treatments  
Acupuncture 
Background: Acupuncture can be used to treat the pain of contracted (frozen) shoulder. It involves 
inserting needles into the skin at sites which vary from case to case and also depend on the 
practitioners’ school of thought. Typically some needles will be placed near the shoulder and 
others distant from it. Once the patient feels some sensation at the needling sites, the needles may 
simply be left in place for the treatment session; in other circumstances they may be stimulated, 
either by manual manipulation or by small electric pulses. According to traditional theory, 
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acupuncture restores health by removing blockages in energy force. Western explanations lean 
towards nerve interactions and hormonal mechanisms (see TENS and interferential).  
Results of CSP survey: The majority of respondents (61%) reported practising acupuncture, and 
68% of respondents said that they might use or recommend acupuncture for pain-predominant 
contracted (frozen) shoulder. Only 10% said that they might use or recommend acupuncture for 
stiffness-predominant contracted (frozen) shoulder.   
Injections 
Corticosteroids  
See above 
Distension therapy (hydrodilation) 
Background: Distension therapy involves injecting large volumes of fluid (saline or local 
anaesthetic, with or without steroid) into the shoulder joint, with the aim of distending or even 
rupturing the joint capsule.     
Results of CSP survey: Not applicable. 
Sodium hyaluronate 
Background: Sodium hyaluronate (hyaluronic acid) can be injected into the shoulder joint to treat 
the pain of contracted (frozen) shoulder. It has less known potential for adverse effects than 
steroids, and some prefer it on these grounds.   
Results of CSP survey: Not applicable (information on use of sodium hyaluronate was not sought).  
1.7.3. Operative treatments 
Arthroscopic capsular release and manipulation under anaesthetic (MUA) 
Background: Arthroscopic capsular release is usually reserved for patients with contracted (frozen) 
shoulder whose symptoms do not improve with an adequate course of physiotherapy. The 
procedure is normally performed in conjunction with an MUA, and may reduce the potential harms 
of that procedure by allowing it to be done less forcefully. Using a ‘keyhole’ technique, the surgeon 
divides the capsule at the front and lower part of the joint. If the patient continues to lack external 
rotation in abduction, the capsule can also be released at the back of the joint. In addition to a 
general anaesthetic, it is normal for a regional nerve block to be given. This causes post-operative 
numbness and enables the patient to get moving at the earliest possible stage. Intensive 
physiotherapy is regarded as essential to a good outcome.      
Results of CSP survey: Not applicable. 
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2.  Systematic review and meta-analysis of treatment 
interventions (comparisons involving standard 
physiotherapy) 
 
2.1 Results of search and filtering processes  
After de-duplication our search, which addressed both standard and more specialised 
physiotherapy interventions, retrieved 749 citations, most with abstracts. Primary filtering left 84 
citations. The secondary filtering process excluded 66 of these (APPENDIX C: Table of excluded 
studies; APPENDIX D: References to table of excluded studies). Thus 18 trials remained, 14 of which 
included standard physiotherapy, the focus of the first version (version 1.X) of the guidelines. (See  
Table 2.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To the 14 trials including standard physiotherapy, which we had derived from our own search, we 
added five trials on contracted (frozen) shoulder identified in Green, Buchbinder and Hetrick 
Intervention (or comparison)  Number of reports 
Standard physiotherapy 14  
Acupuncture   1      
Steroid injection    5      
Hyaluronate injection   2      
Capsular distension   5      
Manipulation under anaesthetic   2      
Supervised neglect   1      
 
TABLE 2.1. Included trials by intervention (or comparison). Some 
reports are included in more than one category.  
This section gives an overview of the systematic review and meta-analysis of treatment interventions 
(comparisons involving standard physiotherapy) and concludes by enumerating the responses to the 
questionnaire survey. We have kept it as light and readable as possible, but it is unavoidably complex 
because it is derived from methodologically stringent processes which underpin our recommendations 
for management.  
 If you are not at all interested in the methods, you may choose to skip straight to the 
recommendations (starting on page 66 for text, and 78 for summary table). 
 Conversely, if you would like more information on the methods than is given here, you can read 
pages 1 to 6 for a light general background or, for greater depth, APPENDICES A and A2. Also, 
there are signposts throughout this section to detailed supporting information in the 
APPENDICES.  
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(2003), the Cochrane review on standard physiotherapy. This gave a total of 19 trials including 
standard physiotherapy (Table 2.2). These involved various comparisons (34 in all) encompassing 
other standard physiotherapy interventions (home exercises, supervised physiotherapy) and 
pharmacological interventions.   
   
 
 
 
 
 
 
 
 
 
 
 
Detailed descriptions of these trials are given in (APPENDIX B: Table of included trials).  
  
Intervention  Number of reports 
Standard physiotherapy 19  
Acupuncture   1      
Steroid injection    9      
Hyaluronate injection   2      
Capsular distension   5      
Manipulation under anaesthetic   2      
Supervised neglect   1      
 
TABLE 2.2. Included trials by intervention (or comparison). Some 
reports are included in more than one category. This table incorporates 
trials identified in Green, Hetrick and Buchbinder (2003), the Cochrane 
review on standard physiotherapy interventions. 
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2.2. Methodological quality of trials considered for inclusion  
The methodological quality of trials considered for inclusion is summarised in TABLE 2.3. 
Trial E
lig
ib
ili
ty
 c
ri
te
ri
a 
sp
ec
if
ie
d
 
R
an
d
o
m
 a
llo
ca
ti
o
n
 
C
o
n
ce
al
ed
 a
llo
ca
ti
o
n
 
G
ro
u
p
s 
si
m
ila
r 
at
 b
as
e
lin
e
 
B
lin
d
in
g 
o
f 
su
b
je
ct
s 
B
lin
d
in
g 
o
f 
th
er
ap
is
ts
 
B
lin
d
in
g 
o
f 
as
se
ss
o
rs
 
In
te
n
ti
o
n
-t
o
-t
re
at
 
P
o
in
t 
m
ea
su
re
s 
an
d
 
m
ea
su
re
s 
o
f 
va
ri
ab
ili
ty
 
Buchbinder et al (2007)          
Bulgen et al (1984)          
Calis et al (2006)          
Carette et al (2003)    *      
Cheing, So and Chao (2008)          
Dacre, Beeney and Scott (1989)           
Ginn and Cohen (2005)          
Guler-Uysal and Kozanoglu 
(2004) 
         
Johnson et al (2007)          
Khan et al (2005)          
Kivimäki et al (2007)          
Lee et al (1973)          
Leung and Cheing (2008)          
Nicholson (1985)          
Pajareya et al (2004)        †  
Ryans et al (2005)          
Van der Windt et al (1998)          
Vermeulen et al (2006)          
Yang et al (2007)          
 
TABLE 2.3. Methodological quality of trials considered for inclusion. *Analyses were adjusted for 
unequal distribution of gender. †Reportedly yes, but not done in analysis. (Verhagen et al 1998, 
http://www.pedro.fhs.usyd.edu.au/)   
 
The median sample size was 80 (range 18–149; interquartile range 41–104), and about half of the 
trials (9/19) were of good methodological quality (low risk of bias). In the remainder there were 
deficiencies in random allocation (Guler-Uysal & Kosanoglu 2004), allocation concealment (Bulgen 
et al 1984, Calis et al 2006, Cheing, So & Chao 2008, Dacre, Beeney & Scott 1989, Guler-Uysal & 
Kosanoglu 2004, Khan et al 2005, Nicholson 1985); or blinding of assessors (Calis et al 2006, 
Johnson et al 2007, Khan et al 2005). Each of these methodological deficiencies has been 
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empirically linked to overestimation of treatment effects. Trials with inadequate allocation 
concealment have been found to exaggerate treatment effects by around 40% on average (Moher 
et al 1998, Schulz et al 1995). Schulz et al (1995) have additionally shown that trials with unclear 
concealment methods exaggerate treatment effects by an average of 30%. Furthermore, Jüni et al 
(1999) found that trials with non-blinded outcome assessment exaggerate treatment effects by 
35%.  
Nine trials (Bulgen et al 1984, Cheing, So & Chao, 2008, Dacre, Beeney & Scott 1989, Guler-Uysal & 
Kozanoglu 2004, Khan et al 2005, Lee et al 1973, Nicholson 1985, Pajareya et al 2004, Ryans et al 
2005) did not conduct analyses by intention-to-treat. In trials with drop-outs or other exclusions 
after randomisation, absence of intention-to-treat analysis might theoretically bias estimates of 
treatment effects (Cochrane Handbook 2009, Strauss et al 2005). Of the nine trials, Pajareya et al 
(2004) and Ryans et al (2005) were free of the three key methodological deficiencies empirically 
linked to bias (see above) and were included in the review. In Pajareya et al (2004) the drop-outs 
were very few (3%) and unlikely to be influential and there were no other exclusions after 
randomisation. In Ryans et al (2005) drop-outs/exclusions were 10% at 6 weeks and 29% at 16 
weeks. Mindful of possible bias in this latter study, especially at 16 weeks, special note was made 
of drop-outs’/exclusions’ distribution across groups relative to the probable direction and 
magnitude of bias; and of concordance between its results and those of Carette et al (2003), which 
was similar in terms of comparisons and follow-up points. These measures provided reassurance as 
to the results’ validity.   
2.3. Results of analyses  
Our protocol did not anticipate that there would be so many comparisons in so many trials with a 
moderate-to-high risk of bias (TABLE 2.3). Faced with this contingency, we limited further analyses 
to comparisons in those trials with a low risk of bias (TABLE 2.4). These comparisons could be 
grouped under six main headings: 
1. Physiotherapy versus other physiotherapy 
2. Physiotherapy versus other treatments 
3. Physiotherapy versus combinations of physiotherapy and other treatments 
4. Adding physiotherapy to other treatments 
5. Adding physiotherapy elements to combinations of physiotherapy and other treatments 
6. Adding other treatments to physiotherapy 
The trials concerned used a range of outcome measures. For dichotomous outcomes (e.g. 
‘improved’/’not improved’) we calculated the Relative Risk (RR) and its 95% confidence interval 
(95% CI). For outcomes measured on continuous scales we calculated the Mean Difference (MD) 
and its 95% CI. 
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Buchbinder et al (2007)          
Bulgen et al (1984)          
Calis et al (2006)          
Carette et al (2003)    *      
Cheing, So and Chao (2008)          
Dacre, Beeney and Scott (1989)           
Ginn and Cohen (2005)          
Guler-Uysal and Kozanoglu 
(2004) 
         
Johnson et al (2007)          
Khan et al (2005)          
Kivimäki et al (2007)          
Lee et al (1973)          
Leung and Cheing (2008)          
Nicholson (1985)          
Pajareya et al (2004)        †  
Ryans et al (2005)          
Van der Windt et al (1998)          
Vermeulen et al (2006)          
Yang et al (2007)          
 
TABLE 2.3a. Methodological quality trials considered for inclusion: trials with moderate to high 
risk of bias excluded (shaded). *Analyses were adjusted for unequal distribution of gender. 
†Reportedly yes, but not done in analysis. (Verhagen et al 1998, 
http://www.pedro.fhs.usyd.edu.au/)    
 
To pool trials which measured the same outcome but with different tools, e.g. SPADI and SRQ, we 
calculated the Standardised Mean Difference (SMD) and its 95% CI. We then converted the SMD 
and its 95% CIs back into the units of one of the original outcomes, since these are more 
meaningful clinically than the SMD (Cochrane Handbook 2009). To further enhance clinical 
relevance, we reported the Minimal Clinically Important Difference (MCID), if known, for all 
outcomes. We derived within-subject MCIDs from the research literature, but multiplied these by 
0.4. We applied this adjustment because between-groups MCID (i.e. an important difference 
between groups, as in a controlled trial) is thought to approximate to 40% of that within individuals 
(Finch et al 2002). These processes allowed us to see whether the 95% CI for a given outcome (a) 
overlapped zero and (b) overlapped the adjusted threshold for MCID on either side of zero. If the 
95% CI did not overlap zero it could be stated, with 95% confidence, that there would be a 
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directional effect in the population from which the sample was drawn. (Whether this effect 
favoured the intervention or the control would depend upon the direction.) Furthermore, a 95% CI 
that lay entirely beyond the adjusted threshold for a MCID could be said, with 95% confidence, to 
represent a clinically important effect. (Again, whether this effect favoured the intervention or the 
control would depend upon the direction.) We also considered smaller effects with directional 
implications. Specifically, a 95% CI which crossed the adjusted threshold for MCID on only one side 
was interpreted as unidirectional potential for a clinically important effect: in this way, an outcome 
might have unidirectional potential for a clinically important effect even if its 95% CI crossed zero.   
The comparisons are considered below. 
 
2.3.1. Physiotherapy versus other physiotherapy 
 
2.3.1.1. Adding outpatient physiotherapy (with passive mobilisations) to home exercises for both 
stages of contracted (frozen) shoulder   
 
We pooled the results of two trials (Carette et al 2003, Ryans et al 2005), with a combined sample 
size of 86 for the relevant subgroups, which evaluated the addition of outpatient physiotherapy 
(with passive mobilisations) to home exercises for mixed-stage contracted (frozen) shoulder in 
primary and secondary care. The combined pain-function outcome in Carette et al (2003) was the 
Shoulder Pain and Disability Index (SPADI) and that in Ryans et al (2005) was the 22-point Shoulder 
Disability Questionnaire (SDQ). In addition, Carette et al (2003) separately reported the SPADI score 
for pain (a 100 mm VAS), and Ryans et al (2005) scored pain at rest on a 100 mm VAS. Both trials 
evaluated passive external rotation. Neither reported adverse effects/events as an outcome.  
Assessment time points included 6 weeks (short term), 4–6 months (medium term) and, for 
Carette et al (2003) only, 12 months (long term). 
 
 
Combined pain-function outcome, short term (6 weeks) 
Result: P = 0.59, SMD = 0.11 [-0.30, 0.53] and see FIGURE 2.1.  
Result re-expressed as SPADI:  Mean Difference (MD) = 1.85 [-5.03, 8.99]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 3.2.      
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured the addition of outpatient physiotherapy to home exercises in the 
pooled study sample. The pooled 95% CI crossed zero and the adjusted threshold for MCID 
on both sides of zero. Thus it is uncertain in which direction (if any) an effect would occur in 
the population, and whether such an effect would be clinically important.  
Summary: One outcome (pain, short term) had unidirectional potential for a clinically important 
effect in the population, in the direction favouring the addition of outpatient physiotherapy. This 
was corroborated by passive external rotation, short term, for which an effect favouring the 
addition of outpatient physiotherapy could be attributed to the population with 95% confidence; 
though the stand-alone clinical importance of this latter effect (<13°) is uncertain. The trial 
reports did not specify adverse effects/events as an outcome. See below for detailed analysis.   
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 FIGURE 2.1 
 
Combined pain-function outcome, medium term (4–6 months) 
Result: P = 0.80, SMD = 0.06 [-0.39, 0.51] and see FIGURE 2.2.  
Result re-expressed as SPADI:  1.01 [-6.54, 8.56]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004):3.2.      
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured the addition of outpatient physiotherapy to home exercises in the 
pooled study sample. The pooled 95% CI crossed zero and the adjusted threshold for MCID 
on both sides of zero. Thus it is uncertain in which direction (if any) an effect would occur in 
the population, and whether such an effect would be clinically important.  
  
 
 FIGURE 2.2 
 
Combined pain-function outcome (SPADI), long term (12 months) 
Result: P = 0.82, MD = -1.70 [-15.47, 12.07]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 3.2.  
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured the home exercises only group in the study sample. The 95% CI crossed 
zero and the adjusted threshold for MCID on both sides of zero. Thus it is uncertain in which 
direction (if any) an effect would occur in the population, and whether such an effect would 
be clinically important.  
We pooled the short term and medium term results for the SPADI pain score (a 100 mm VAS) in 
Carette et al (2003) with those for the 100 mm VAS for pain at rest in Ryans et al (2005). No long 
term results were reported by Ryans et al (2005).  
Pain (100 mm VAS), short term (6 weeks) 
Result: P =0.26, MD = 7.09 mm [-5.22, 19.40] and see FIGURE 2.3. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm.     
Interpretation: A mean effect which was clinically important but not statistically significant 
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Chi² = 0.01, df = 1 (P = 0.93); I² = 0%
Test for overall effect: Z = 0.54 (P = 0.59)
Mean
-18.9
-3.1
SD
24.46
3.4
Total
23
19
42
Mean
-22.2
-3.5
SD
24.48
4.9
Total
26
20
46
Weight
55.6%
44.4%
100.0%
IV, Fixed, 95% CI
0.13 [-0.43, 0.69]
0.09 [-0.54, 0.72]
0.11 [-0.30, 0.53]
Home exercises Physiotherapy Std. Mean Difference Std. Mean Difference
IV, Fixed, 95% CI
-1 -0.5 0 0.5 1
Favours exs Favours PT + exs
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Chi² = 0.57, df = 1 (P = 0.45); I² = 0%
Test for overall effect: Z = 0.26 (P = 0.80)
Mean
-38.4
-6.6
SD
24.46
5.4
Total
23
12
35
Mean
-43.1
-5.6
SD
24.48
5.8
Total
26
16
42
Weight
64.0%
36.0%
100.0%
IV, Fixed, 95% CI
0.19 [-0.37, 0.75]
-0.17 [-0.92, 0.58]
0.06 [-0.39, 0.51]
Home exercises Physiotherapy Std. Mean Difference Std. Mean Difference
IV, Fixed, 95% CI
-1 -0.5 0 0.5 1
Favours exs Favours PT + exs
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favoured the addition of outpatient physiotherapy to home exercises in the pooled study 
sample. The pooled 95% CI crossed zero, so it is uncertain in which direction (if any) an effect 
would occur in the population, but only the only potential for a clinically important effect 
was in the direction favouring the addition of outpatient physiotherapy. 
 
FIGURE 2.3 
 
Pain (100 mm VAS), medium term (4–6 months) 
Result: P = 0.31, MD = 6.72 mm [-6.27, 19.71] and see FIGURE 2.4. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: A mean effect which was clinically important but not statistically significant 
favoured the addition of outpatient physiotherapy to home exercises in the pooled study 
sample. The pooled 95% CI crossed zero and the adjusted threshold for MCID on both sides 
of zero. Thus it is uncertain in which direction (if any) an effect would occur in the 
population, and whether such an effect would be clinically important.  
 
FIGURE 2.4 
Pain (100 mm VAS), long term (12 months) 
Result: P = 0.99, MD = 0.10 mm [-15.01, 15.21] 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: There was no substantive mean difference between groups in the study 
sample. The 95% CI crossed zero and the adjusted threshold for MCID on both sides of zero. 
Thus it is uncertain in which direction (if any) an effect would occur in the population, and 
whether such an effect would be clinically important.  
We also pooled the short term and medium term results for improvement in passive external 
rotation (degrees) in Carette et al (2003) and Ryans et al (2005). No long term results were 
reported by Ryans et al (2005).  
Passive external rotation (degrees), short term (6 weeks) 
Result: P = 0.03, MD = 6.68° [0.53, 12.82] and see FIGURE 2.5.  
Adjusted threshold for MCID: MCID not known. 
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Chi² = 0.34, df = 1 (P = 0.56); I² = 0%
Test for overall effect: Z = 1.13 (P = 0.26)
Mean
-17.3
-5.4
SD
26.86
27.8
Total
23
19
42
Mean
-21.8
-17.6
SD
27.02
39.1
Total
26
20
46
Weight
66.3%
33.7%
100.0%
IV, Fixed, 95% CI
4.50 [-10.61, 19.61]
12.20 [-9.01, 33.41]
7.09 [-5.22, 19.40]
Home exercises Physiotherapy Mean Difference Mean Difference
IV, Fixed, 95% CI
-20 -10 0 10 20
Favours exs Favours PT + exs
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Chi² = 0.03, df = 1 (P = 0.86); I² = 0%
Test for overall effect: Z = 1.01 (P = 0.31)
Mean
-36.4
-24.5
SD
26.86
34.2
Total
23
12
35
Mean
-43.8
-29.3
SD
27.02
33.7
Total
26
16
42
Weight
73.9%
26.1%
100.0%
IV, Fixed, 95% CI
7.40 [-7.71, 22.51]
4.80 [-20.64, 30.24]
6.72 [-6.27, 19.71]
Home exercises Physiotherapy Mean Difference Mean Difference
IV, Fixed, 95% CI
-20 -10 0 10 20
Favours exs Favours PT + exs
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Interpretation: A mean effect which was statistically significant favoured the addition of 
outpatient physiotherapy to home exercises in the pooled study sample. Based on the 
pooled 95% CI, a similarly directional effect would be anticipated in the population. The 
clinical importance of such an effect (< 13°) is uncertain. 
 
FIGURE 2.5 
Passive external rotation (degrees), medium term (4–6 months)  
Result: P = 0.79, MD = 1.44° [-6.59, 9.48] and see FIGURE 2.6. 
Adjusted threshold for MCID: MCID not known. 
Interpretation: A trivial mean effect which was not statistically significant favoured the 
addition of outpatient physiotherapy to home exercises in the pooled study sample. The 
pooled 95% CI crossed zero. Thus it is uncertain in which direction (if any) an effect would 
occur in the population. The clinical importance of any such effect (< 10°) is also uncertain.  
 
FIGURE 2.6 
Passive external rotation (degrees), long term (12 months) 
Result: P = 0.80, MD = 1.20° [-7.95, 10.35]. 
Adjusted threshold for MCID: MCID not known. 
Interpretation: A trivial mean effect which was not statistically significant favoured the 
addition of outpatient physiotherapy to home exercises in the study sample. The 95% CI 
crossed zero. Thus it is uncertain in which direction (if any) an effect would occur in the 
population. The clinical importance of any such effect (< 11°) is also uncertain.  
2.3.1.2. Home ‘muscle function retraining programme’ versus outpatient physiotherapy (with 
passive mobilisations) and standard home exercises for both stages of contracted (frozen) 
shoulder   
 
In a subgroup of 50 patients with mixed-stage contracted (frozen) shoulder in secondary care, Ginn 
and Cohen (2005) compared an individualised programme of home exercises (a ‘muscle function 
retraining programme’) to a combination of outpatient physiotherapy (with passive mobilisations) 
and standardised home exercises. Outcomes were assessed at 5 weeks (short term) only and 
included patients’ global perceptions of change: ‘improved’, ‘stable’ or ‘deteriorated’. No 
subgroup-specific results were reported for pain, and passive external rotation was not among the 
outcome measures. Adverse effects were reported.  
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Patients’ global perception of change, short term (5 weeks) 
We pooled the ‘stable’ and ‘deteriorated’ categories, and compared these to the ‘improved’ 
category for analysis.  
Result: P = 0.37, RR = 0.87 [0.65, 1.17]). 
Adjusted threshold for MCID: Not applicable (dichotomous outcome). 
Interpretation: A small mean effect, which was not statistically significant, favoured 
outpatient physiotherapy and standard home exercises in the study sample. The 95% CI 
crossed one. Thus it is uncertain in which direction (if any) an effect would occur in the 
population.  
Adverse effects, short term (5 weeks) 
Result: One subject in the muscle function retraining programme group (1/23 = 4.3%) and 
one in the outpatient physiotherapy and standardised home exercise group (1/26 = 3.8%) 
experienced ‘deterioration’ over the 5 week study period. No further details were given. 
 
2.3.1.3. High grade mobilisations versus low grade mobilisations for stiffness-predominant 
contracted (frozen) shoulder 
 
In a trial of 100 patients with stiffness-predominant contracted (frozen) shoulder in 
secondary care, Vermeulen et al (2006) compared a package of physiotherapy including high grade 
mobilisations to a similar package containing low grade mobilisations.  Outcomes were assessed at 
3 months (short term), 6 months (medium term) and 12 months (long term). Outcomes included 
the SRQ; pain during movement, at rest and at night, recorded on a 100 mm VAS; and passive 
external rotation measured using a goniometer. Also recorded was patient-reported, global 
assessment of change relative to baseline (‘much better’, ‘better’, ‘no change’, ‘worse’, ‘much 
worse’). However, the ‘worse’ and ‘much worse’ categories were pooled with ‘no change’, so the 
proportion of adverse effects cannot be ascertained from the trial report.   
 
 
 
  
Summary: For five outcomes the results indicated unidirectional potential for clinically important 
effects in the population. For four of these outcomes (SRQ, medium and long term; 100 VAS for 
night pain, long term; and 100 mm VAS for pain on use, long term) the potential was in the 
direction favouring high grade mobilisations. Also, for passive external rotation (long term), a 
treatment effect favouring high grade mobilisations could be attributed to the population with 
95% confidence, though the stand-alone clinical importance of this (< 13°) is uncertain. For one 
outcome (pain at rest, short term) the potential for a clinically important effect was in the other 
direction, favouring low grade mobilisations. The manner of reporting precludes ascertainment of 
adverse effects. See below for detailed analysis.   
Summary: It is uncertain in which direction (if any) an effect would occur in the population. 
Adverse effects/events were equally distributed across groups. See below for detailed analysis.   
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SRQ, short term (3 months)  
Result: P = 0.75, MD = 2.00 [-10.07, 14.07]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 5.2. 
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured high grade mobilisations in the study sample. The 95% CI crossed zero 
and the adjusted threshold for MCID on both sides of zero. Thus it is uncertain in which 
direction (if any) an effect would occur in the population, and whether such an effect would 
be clinically important.  
SRQ, medium term (6 months) 
Result: P = 0.20, MD = 4.50 [-2.40, 11.40]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 5.2. 
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured high grade mobilisations in the study sample. The 95% CI crossed zero, 
so it is uncertain in which direction (if any) an effect would occur in the population, but the 
only potential for a clinically important effect was in the direction favouring high grade 
mobilisations. 
SRQ, long term (12 months) 
Result: P = 0.07, MD = 6.60 [-0.61, 13.81]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 5.2. 
Interpretation: A mean effect which was clinically important but fell short of statistical 
significance favoured high grade mobilisations in the study sample. The 95% CI crossed zero, 
so it is uncertain in which direction (if any) an effect would occur in the population, but the 
only potential for a clinically important effect was in the direction favouring high grade 
mobilisations.  
Night pain (100 mm VAS), 3 months (short term) 
Result: P =0.58, MD = 3.80 mm [-9.75, 17.35] 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured high grade mobilisations in the study sample. The 95% CI crossed zero 
and the adjusted threshold for MCID on both sides of zero. Thus it is uncertain in which 
direction (if any) an effect would occur in the population, and whether such an effect would 
be clinically important.   
Night pain (100 mm VAS), 6 months (medium term) 
Result: P = 0.58, MD = 7.10 mm [-7.10, 21.30]. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: A mean effect which was clinically important but not statistically significant 
favoured high grade mobilisations in the study sample. The 95% CI crossed zero and the 
adjusted threshold for MCID on both sides of zero. Thus it is uncertain in which direction (if 
any) an effect would occur in the population, and whether such an effect would be clinically 
important. 
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Night pain (100 mm VAS), 12 months (long term) 
Result: P = 0.23, MD = 7.80 mm [-4.91, 20.51]. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: A mean effect which was clinically important but not statistically significant 
favoured high grade mobilisations in the study sample. The 95% CI crossed zero, so it is 
uncertain in which direction (if any) an effect would occur in the population, but the only 
potential for a clinically important effect was in the direction favouring high grade 
mobilisations.  
Pain at rest (100 mm VAS), 3 months (short term) 
Result: P = 0.2, MD = -7.10 mm [-17.90, 3.70].  
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: A mean effect which was clinically important but not statistically significant 
favoured low grade mobilisations in the study sample. The 95% CI crossed zero, so it is 
uncertain in which direction (if any) an effect would occur in the population, but the only 
potential for a clinically important effect was in the direction favouring low grade 
mobilisations.  
Pain at rest (100 mm VAS), 6 months (medium term)  
Result: P = 0.74, MD = -2.00 [-13.74, 9.74] 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured low grade mobilisation in the study sample. The 95% CI crossed zero and 
the adjusted threshold for MCID on both sides of zero. Thus it is uncertain in which direction 
(if any) an effect would occur in the population, and whether such an effect would be 
clinically important.  
Pain at rest (100 mm VAS), 12 months (long term) 
Result: P = 0.87, MD -0.90 mm [-11.68, 9.88]. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured low grade mobilisation in the study sample. The 95% CI crossed zero and 
the adjusted threshold for MCID on both sides of zero. Thus it is uncertain in which direction 
(if any) an effect would occur in the population, and whether such an effect would be 
clinically important. 
Pain on use (100 mm VAS), 3 months (short term) 
Result: P = 0.65, MD = 2.60 mm [-8.46, 13.66] 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured high grade mobilisation in the study sample. The 95% CI crossed zero 
and the adjusted threshold for MCID on both sides of zero. Thus it is uncertain in which 
direction (if any) an effect would occur in the population, and whether such an effect would 
be clinically important.  
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Pain on use (100 mm VAS), 6 months (medium term) 
Result: P = 0.93, MD = 0.50 mm [-10.19, 11.19]. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured high grade mobilisation in the study sample. The 95% CI crossed zero 
and the adjusted threshold for MCID on both sides of zero. Thus it is uncertain in which 
direction (if any) an effect would occur in the population, and whether such an effect would 
be clinically important.  
Pain on use (100 mm VAS), 12 months (long term) 
Result: P = 0.26, MD = 6.60 mm [-4.99, 18.19]. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: A mean effect which was clinically important but not statistically significant 
favoured high grade mobilisations in the study sample. The 95% CI crossed zero, so it is 
uncertain in which direction (if any) an effect would occur in the population, but the only 
potential for a clinically important effect was in the direction favouring high grade 
mobilisations.  
Passive external rotation (degrees), short term (3 months) 
Result: P = 0.58, MD 1.40° [-3.50, 6.30]. 
Adjusted threshold for MCID: MCID not known. 
Interpretation: A trivial mean effect favoured high grade mobilisations in the study sample. 
This effect was not statistically significant. The 95% CI crossed zero. Thus it is uncertain in 
which direction (if any) an effect would occur in the population. The clinical importance of 
any such effect (<7°) is also uncertain.   
Passive external rotation (degrees), medium term (6 months) 
Result: P = 0.12, MD 4.10° [-1.03, 9.23]. 
Adjusted threshold for MCID: MCID not known. 
Interpretation: A trivial mean effect favoured high grade mobilisations in the study sample. 
This effect was not statistically significant. The 95% CI crossed zero. Thus it is uncertain in 
which direction (if any) an effect would occur in the population. The clinical importance of 
any such effect (<10°) is also uncertain.    
Passive external rotation (degrees), long term (12 months) 
Result: P = 0.04, MD 6.50° [0.27, 12.73]. 
Adjusted threshold for MCID: MCID not known. 
Interpretation: A small mean effect favoured high grade mobilisations in the study sample. 
This effect was statistically significant and, based on the 95% CI, a similarly directional effect 
would be anticipated in the population. The clinical importance of such an effect (< 13°) is 
uncertain. 
 
 
  
 
45 
2.3.1.4. MWMs and home exercises versus high grade mobilisations and home exercises for both 
stages of contracted (frozen) shoulder 
In a secondary or tertiary care setting, Yang et al (2007) divided 27 patients with mixed-stage 
contracted (frozen) shoulder between A-B-A-C and A-C-A-B groups, where A was mid-range 
mobilisation, B end-range mobilisation and C mobilisations with movement (MWMs). We 
considered that only the second phases (B versus C) constituted a randomised controlled trial, 
since phases 1 and 3 were unrandomised and allocation in phase 4 was predictable. The outcome 
was the Flexi-level Scale of Shoulder Function (FLEX-SF), which was assessed at baseline and after 
each 3-week phase of the trial. Of relevance here was the measurement at 6 weeks (short term), 
comparing end-range mobilisations and home exercises with MWMs and home exercises.     
 
 
Flexi-level Scale of Shoulder Function (FLEX-SF), short term (6 weeks) 
Result: P = 0.5, MD 1.90 [-3.61, 7.41]. 
Adjusted threshold for MCID (calculated from data in Cook et al 2003): 1.21. 
Interpretation: A mean effect which was clinically important but not statistically significant 
favoured MWMs in the study sample. The 95% CI crossed zero and the adjusted threshold 
for MCID on both sides of zero. Thus it is uncertain in which direction (if any) an effect would 
occur in the population, and whether such an effect would be clinically important. 
2.3.1.5. Adding SWD to outpatient physiotherapy (without passive mobilisations) and home 
exercises for stiffness-predominant contracted (frozen) shoulder   
 
One trial of stiffness-predominant contracted (frozen) shoulder, with 10 patients per subgroup, 
(Leung & Cheing 2008) added shortwave diathermy (SWD) to a combination of outpatient 
physiotherapy (supervised stretching exercises without passive mobilisations) and home stretching 
exercises.  Outcome measures were assessed at 8 weeks (short term) and included the patient-
completed section of the ASES, which is intended to measure pain and functional limitation. (The 
physician-completed section of the ASES was also used. This involves measuring range of 
movement, and data for external rotation were separately reported; but it is unclear whether these 
measurements related to passive or active range.) 
 
 
Patient-completed section of ASES, short term (8 weeks)  
Result: P = 0.03, MD = 17.50 [1.76, 33.24]. 
Adjusted threshold for MCID (calculated from data in Michener, McClure & Sennett 2002): 
2.56. 
Interpretation: A mean effect which was clinically important and statistically significant 
Summary: A clinically significant effect favouring the addition of SWD could be attributed to the 
population with approaching 95% confidence. The trial report did not specify adverse 
effects/events as an outcome. See below for detailed analysis.   
Summary: It is uncertain in which direction (if any) an effect would occur in the population and 
whether such an effect would be clinically important. The trial report did not specify adverse 
effects/events as an outcome. See below for detailed analysis.   
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favoured the addition of SWD in the study sample. The 95% CI lay on the side of zero that 
favoured SWD, so an effect in this direction would be expected in the population. Moreover, 
almost all of the 95% CI exceeded the adjusted threshold for MCID, so a clinically important 
effect favouring SWD might be attributed to the population with approaching 95% 
confidence.  
2.3.1.6. Adding hot packs to outpatient physiotherapy (without passive mobilisations) and home 
exercises for stiffness-predominant contracted (frozen) shoulder     
 
In the same trial, Leung and Cheing (2008) added hot packs to a combination of outpatient 
physiotherapy (supervised stretching exercises without passive mobilisations) and home stretching 
exercises.   
 
 
 
Patient-completed section of ASES, short term (8 weeks)  
Result: P = 0.59, MD = 4.00 [-10.38, 18.38]. 
Adjusted threshold for MCID (calculated from data in Michener, McClure & Sennett 2002): 
2.56. 
Interpretation: A mean effect which was clinically important but not statistically significant 
favoured the addition of hot packs in the study sample. The 95% CI crossed zero and the 
adjusted threshold for MCID on both sides of zero. Thus it is uncertain in which direction (if 
any) an effect would occur in the population, and whether such an effect would be clinically 
important. 
2.3.1.7. Outpatient physiotherapy (SWD and exercises) and home exercises versus outpatient 
physiotherapy (hot pack and exercises) and home exercises for stiffness-predominant contracted 
(frozen) shoulder 
The study considered above (Leung & Cheing 2008) also conducted a head-to-head comparison of 
outpatient physiotherapy (SWD and exercises) and home exercises versus outpatient 
physiotherapy (heat pack and exercises) and home exercises. 
 
 
Patient-completed section of ASES, short term (8 weeks)  
Result: P = 0.09, MD = 13.50 [-2.16, 29.16]. 
Adjusted threshold for MCID (calculated from data in Michener, McClure & Sennett 2002): 
2.56. 
Interpretation: A mean effect which was clinically important but not statistically significant 
Summary: The results indicated unidirectional potential for a clinically important effect in the 
population favouring SWD and exercises over heat pack and exercises. The trial report did not 
specify adverse effects/events as an outcome. See below for detailed analysis.   
Summary: It is uncertain in which direction (if any) an effect would occur in the population, and 
whether such an effect would be clinically important. The trial report did not specify adverse 
effects/events as an outcome. See below for detailed analysis.   
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favoured SWD over hot packs in the study sample. The 95% CI crossed zero, so it is uncertain 
in which direction (if any) an effect would occur in the population, but the only potential for 
a clinically important effect was in the direction favouring SWD.  
2.3.2. Physiotherapy versus other treatments 
2.3.2.1. Intra-articular steroid injections versus outpatient physiotherapy (with mobilisations) for 
both stages of contracted (frozen) shoulder 
 
One primary care-based trial of 109 patients, probably with mixed-stage contracted (frozen) 
shoulder, compared intra-articular steroid injections to outpatient physiotherapy (with 
mobilisations) (van der Windt et al 1998). Outcome measures included the 16-item SDQ; 100-point 
VAS for day and night pain and improvement in passive range of external rotation, with assessment 
time-points including 7 weeks (short term), 6½ months (medium term) and 12 months (long term). 
Adverse effects/events were recorded by the clinician and by patients on their own forms.  
 
 
 
Improvement in 16-item SDQ, short term (7 weeks) 
Result: P = 0.00001, MD = 25.00 [14.81, 35.19]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 5.6. 
Interpretation: A mean effect which was clinically important and highly statistically significant 
favoured intra-articular steroid injections in the study sample. Based on the 95% CI, a 
similarly directional, and clinically important, effect would be anticipated in the population.  
Improvement in 16-item SDQ, medium term (6½ months) 
Result: P = 0.1, MD = 10.00 [-1.88, 21.88]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 5.6. 
Interpretation: A mean effect which was clinically important but not statistically significant 
favoured intra-articular steroid injections in the study sample. The 95% CI crossed zero, so it 
is uncertain in which direction (if any) an effect would occur in the population, but the only 
potential for a clinically important effect was in the direction favouring intra-articular steroid 
injections.  
Summary: For one outcome (16-item SDQ, short term) a clinically important effect favouring 
intra-articular steroid injections could be attributed to the population with 95% confidence. For 
another outcome (passive external rotation, short term) an effect favouring intra-articular steroid 
injections could be attributed to the population with 95% confidence, though the stand-alone 
clinical importance of such an effect (< 21°) is uncertain. For two further short term outcomes 
(100 mm VAS for night pain; 100 mm VAS for day pain) a clinically important effect favouring 
intra-articular steroid injections could be attributed to the population with approaching 95% 
confidence. Additionally, the results of two medium term outcomes (16-item SDQ; passive 
external rotation) indicated unilateral potential for clinically important effects in the population, 
both in the direction favouring intra-articular steroid injections. Adverse effects/events were 
minor and equally distributed across groups.       
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Improvement in 16-item SDQ, long term (12 months) 
Result: P = 0.54, MD = 4.00 [-8.64, 16.64]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 5.6. 
Interpretation: A mean effect which was clinically important but not statistically significant 
favoured intra-articular steroid injections in the study sample. The 95% CI crossed zero and 
the adjusted threshold for MCID on both sides of zero. Thus it is uncertain in which direction 
(if any) an effect would occur in the population, and whether any such an effect would be 
clinically important. 
Night pain (100 mm VAS), short term (7 weeks)  
Result: P = 0.01, MD = 14.00 mm [3.06, 24.94]. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: A mean effect which was clinically important and statistically significant 
favoured intra-articular steroid injections in the study sample. The 95% CI lay on the side of 
zero that favoured intra-articular steroid injections, so an effect in this direction would be 
expected in the population. Moreover, almost all of the 95% CI exceeded the adjusted 
threshold for MCID, so a clinically important effect might be attributed to the population 
with approaching 95% confidence.   
Night pain (100 mm VAS), medium term (6½ months) 
Result: P = 0.89, MD = 1.00 mm [-13.53, 15.53]. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: There was no substantive mean effect in the study sample. The 95% CI 
crossed zero and the adjusted threshold for MCID on both sides of zero. Thus it is uncertain 
in which direction (if any) an effect would occur in the population, and whether such an 
effect would be clinically important. 
Night pain (100 mm VAS), long term (12 months) 
Result: P = 0.77, MD = 2.00 mm [-11.59, 15.59]. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured intra-articular steroid injections in the study sample. The 95% CI crossed 
zero and the adjusted threshold for MCID on both sides of zero. Thus it is uncertain in which 
direction (if any) an effect would occur in the population, and whether such an effect would 
be clinically important. 
Day pain (100 mm VAS), short term (7 weeks)  
Result: P = 0.005, MD = 12.00 mm [3.69, 20.31]. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: A mean effect which was clinically important and highly statistically significant 
favoured intra-articular steroid injections in the study sample. The 95% CI lay on the side of 
zero that favoured intra-articular steroid injections, so an effect in this direction would be 
expected in the population. Moreover, almost all of the 95% CI exceeded the adjusted 
threshold for MCID, so a clinically important effect might be attributed to the population 
with approaching 95% confidence. 
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Day pain (100 mm VAS), medium term (6½ months) 
Result: P = 1.0, MD = 0.00 [-10.00, 10.00]. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: There was no mean difference between groups in the study sample. The 95% 
CI crossed zero and the adjusted threshold for MCID on both sides of zero. Thus it is 
uncertain in which direction (if any) an effect would occur in the population, and whether 
such an effect would be clinically important. 
Day pain (100 mm VAS), long term (12 months) 
Result: P = 0.52, MD = 3.00 mm [-6.24, 12.24]. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm. 
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured intra-articular steroid injections in the study sample. The 95% CI crossed 
zero and the adjusted threshold for MCID on both sides of zero. Thus it is uncertain in which 
direction (if any) an effect would occur in the population, and whether such an effect would 
be clinically important. 
Improvement in passive external rotation (degrees), short term (5 weeks) 
Result: P < 0.00001, MD = 15.00° [9.31, 20.69] 
Adjusted threshold for MCID: MCID not known.  
Interpretation: The mean effect was highly statistically significant and favoured intra-
articular steroid injections in the study sample. Based on the 95% CI, a similarly directional 
effect would be expected in the population. The clinical importance of such an effect (< 21°) 
is uncertain.  
Improvement in passive external rotation (degrees), medium term (6½ months) 
Result: P = 0.02, MD = 9.00° [1.64, 16.36] 
Adjusted threshold for MCID: MCID not known.  
Interpretation: The mean effect was statistically significant and favoured intra-articular 
steroid injections in the study sample. Based on the 95% CI, a similarly directional effect 
would be expected in the population. The clinical importance of such an effect (< 16°) is 
uncertain.  
Adverse events 
Fifty-three percent of the injection group and 56% of the physiotherapy group reported 
adverse effects/events. (Note that, in a deviation from protocol, 5 patients were treated with 
both interventions.) These adverse effects/events were minor, and included: pain lasting a 
day or less after treatment (9 patients in the intra-articular steroid injections group; 17 
patients in the physiotherapy group); pain lasting 2 days or more after treatment (16 
patients in the intra-articular steroid injections group; 13 patients in the physiotherapy 
group); facial flushing (9 patients in the intra-articular steroid injections group; 1 patient in 
the physiotherapy group); irregular menstruation (2 patients in the intra-articular steroid 
injections group); self-diagnosed fever (2 patients in the intra-articular steroid injections 
group;  1 patient in the physiotherapy group); skin irritation (1 patient in the intra-articular 
steroid injections group; 2 patients in the physiotherapy group); and other events, including 
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sweating, fatigue, dry mouth, dizziness and headache (6 patients in the intra-articular steroid 
injections group), and slight swelling, tingling and radiating pain (4 patients in the 
physiotherapy group).   
2.3.2.2. Home muscle function retraining programme versus a subacromial steroid injection for 
both stages of contracted (frozen) shoulder  
 
In a subgroup of 45 patients with mixed-stage contracted (frozen) shoulder in secondary care, Ginn 
and Cohen (2005) compared an individualised programme of home exercises (a ‘muscle function 
retraining programme’) to a subacromial steroid injection. Outcomes were assessed at 5 weeks 
(short term) and included patients’ global perceptions of change: ‘improved’, ‘stable’ or 
‘deteriorated’. No subgroup-specific results were reported for pain, and passive external rotation 
was not among the outcome measures. Adverse effects were reported.   
 
 
 
Patients’ global perception of change, short term (5 weeks) 
We pooled the ‘stable’ and ‘deteriorated’ categories, and compared these to the ‘improved’ 
category for analysis.  
Result: P = 0.79, RR = 0.96 [0.69, 1.33]. 
Adjusted threshold for MCID: MCID not known. 
Interpretation: There was no substantive difference between groups and none would be 
inferred to the population. 
 
Adverse events, short term (5 weeks) 
One patient in the muscle function retraining programme group (1/24 = 4%) and one in the 
subacromial injection group (1/22 = 5%) experienced deterioration. No further details were 
given.  
 
2.3.2.3. Subacromial steroid injection versus outpatient physiotherapy (with passive 
mobilisations) and home exercises versus a for both stages of contracted (frozen) shoulder  
 
Ginn and Cohen (2005) compared a subacromial steroid injection to a combination of outpatient 
physiotherapy (with passive mobilisations) and standard home exercises in a subgroup of 48 
patients with mixed-stage contracted (frozen) shoulder in secondary care. Outcomes were assessed 
at 5 weeks (short term) and included patients’ global perceptions of change: ‘improved’, ‘stable’ or 
‘deteriorated’. No subgroup-specific results were reported for pain, and passive external rotation 
was not among the outcome measures. Adverse effects were reported.   
 
Summary: There was no substantive difference between groups in terms of the proportions 
‘improved’, and none would be inferred to the population. Adverse effects/events were equally 
distributed across groups. See below for detailed analysis.   
  
 
51 
 
 
Patients’ global perception of change, short term (5 weeks) 
We pooled the ‘stable’ and ‘deteriorated’ categories, and compared these to the ‘improved’ 
category for analysis.  
Result: P = 0.52, RR = 0.91 [0.69, 1.21] 
Adjusted threshold for MCID: MCID not known. 
Interpretation: There was no substantive difference between groups, and none would be 
inferred to the population. 
 
Adverse effects/events, short term (5 weeks) 
Result: One patient in the outpatient physiotherapy and home exercises group (1/26 = 4%) 
and one in the subacromial injection group (1/22 = 5%) experienced deterioration. No 
further details were given. 
  
2.3.3.  Physiotherapy versus combinations of physiotherapy and other 
treatments 
 
2.3.3.1. Outpatient physiotherapy (with passive mobilisations) and home exercises versus an 
intra-articular steroid injection and home exercises for both stages of contracted (frozen) 
shoulder 
 
We pooled the results of two trials (Carette et al 2003, Ryans et al 2005), with a combined sample 
size of 88 for the relevant subgroups, which compared outpatient physiotherapy (with passive 
mobilisations) and home exercises to an intra-articular steroid injection and home exercises for 
mixed-stage contracted (frozen) shoulder in primary and secondary care. The combined pain-
function outcome in Carette et al (2003) was the Shoulder Pain and Disability Index (SPADI) and 
that in Ryans et al (2005) was the 22-point Shoulder Disability Questionnaire (SDQ). In addition, 
Carette et al (2003) separately reported the SPADI score for pain (a 100 mm VAS), and Ryans et al 
(2005) scored pain at rest on a 100 mm VAS. Both trials evaluated passive external rotation. 
Neither reported adverse effects/events as an outcome.  
Assessment time points included 6 weeks (short term), 4–6 months (medium term) and, for 
Carette et al (2003) only, 12 months (long term). 
 
 
Summary: For one outcome (combined pain-function, short term) a clinically important effect 
favouring an intra-articular steroid injection could be attributed to the population with 
approaching 95% confidence. For two other outcomes (combined pain-function, medium term; 
pain, short term) the results indicated unidirectional potential for clinically important effects 
favouring an intra-articular steroid injection in the population. The trial reports did not specify 
adverse effects/events as an outcome. See below for detailed analysis.   
Summary: There was no substantive difference between groups in terms of the proportions 
‘improved’, and none would be inferred to the population. Adverse effects/events were equally 
distributed across groups. See below for detailed analysis.   
  
 
52 
Combined pain-function outcome, short term (6 weeks) 
Result: P = 0.02, SMD = 0.52 [0.10, 0.95] and see FIGURE 2.7.  
Result re-expressed as SPADI:  MD = 8.73 [1.68, 15.94]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 3.2.      
Interpretation: A mean effect which was clinically important and statistically significant 
favoured an intra-articular steroid injection in the pooled study sample. The pooled 95% CI 
lay on the side of zero that favoured an intra-articular steroid injection, so an effect in this 
direction would be expected in the population. Moreover, almost all of the 95% CI exceeded 
the adjusted threshold for MCID, so a clinically important effect favouring an intra-articular 
steroid injection might be attributed to the population with approaching 95% confidence. 
 FIGURE 2.7 
 
Combined pain-function outcome, medium term (4–6 months) 
Result: P = 0.13, SMD = 0.34 [-0.11, 0.79].  
Result re-expressed as SPADI: 5.71 [-1.85, 13.26]. 
Adjusted threshold for MCID (calculated from data in Paul et al. 2004): 3.2.      
Interpretation: A mean effect which was clinically important but not statistically significant 
favoured an intra-articular steroid injection in the pooled study sample. The pooled 95% CI 
crossed zero, so it is uncertain in which direction (if any) an effect would occur in the 
population, but the only potential for a clinically important effect was in the direction 
favouring an intra-articular steroid injection.  
 
 FIGURE 2.8 
 
Combined pain-function outcome (SPADI), long term (12 months) 
Result: P = 0.51, MD = 4.60 [-9.13, 18.33]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 3.2.  
Interpretation: A mean effect which was clinically important but not statistically significant 
favoured an intra-articular steroid injection in the study sample. The 95% CI crossed zero and 
the adjusted threshold for MCID on both sides of zero. Thus it is uncertain in which direction 
(if any) an effect would occur in the population, and whether such an effect would be 
clinically important. 
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We pooled the short term and medium term results for the SPADI pain score (a 100 mm VAS) in 
Carette et al (2003) with those for the 100 mm VAS for pain at rest in Ryans et al (2005). No long 
term results were reported by Ryans et al (2005).   
 
Pain (100 mm VAS), short term (6 weeks) 
Result: P =0.17, MD = 8.42 mm [-3.73, 20.57] and see FIGURE 2.9. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm.     
Interpretation: The results were heterogeneous, but a clinical explanation may tentatively be 
offered.9 In the pooled study sample, a mean effect which was clinically important but not 
statistically significant favoured an intra-articular steroid injection.  The pooled 95% CI 
crossed zero, so it is uncertain in which direction (if any) an effect would occur in the 
population, but the only potential for a clinically important effect was in the direction 
favouring an intra-articular steroid injection. 
 
 
FIGURE 2.9 
 
Pain (100 mm VAS), medium term (4–6 months) 
Result: P = 0.83, MD = -3.24 mm [-33.17, 26.68] and see FIGURE 2.10. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm.      
Interpretation: The results were heterogeneous. Although the explanation may be clinical,9 
such an attribution cannot be made with any confidence because of the susceptibility to bias 
of Ryans et al (2005) at this time point. Consequently the quality of the evidence is reduced. 
In the pooled study sample, a very small mean effect which was neither clinically important 
nor statistically significant favoured outpatient physiotherapy. The pooled 95% CI crossed 
zero and the adjusted threshold for MCID on both sides of zero, so it is uncertain in which 
direction (if any) an effect would occur in the population, and whether such an effect would 
be clinically important.   
 
                                                          
9
 The heterogeneity is consistent with differences in injection accuracy—fluoroscopic guidance was used in Carette et al 
(2003), whereas the injections in Ryans et al (2005) were administered blindly—and a dose-response gradient. 
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Chi² = 3.75, df = 1 (P = 0.05); I² = 73%
Test for overall effect: Z = 1.36 (P = 0.17)
Mean
-21.8
-17.6
SD
27.02
39.1
Total
26
20
46
Mean
-39.1
-9.8
SD
26.86
24.7
Total
23
19
42
Weight
64.6%
35.4%
100.0%
IV, Fixed, 95% CI
17.30 [2.19, 32.41]
-7.80 [-28.22, 12.62]
8.42 [-3.73, 20.57]
Physio Steroid injection Mean Difference Mean Difference
IV, Fixed, 95% CI
-20 -10 0 10 20
Favours PT Favours steroid
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FIGURE 2.10 
 
Pain (100 mm VAS), long term (12 months) 
Result: P = 0.40, MD = 6.50 [-8.61, 21.61] 
Adjusted threshold for MCID: (calculated from data in Tashjian et al 2009): 5.5 mm.       
Interpretation: A mean effect which was clinically important but not statistically significant 
favoured an intra-articular steroid injection in the study sample. The 95% CI crossed zero and 
the adjusted MCID on both sides of zero. Thus it is uncertain in which direction (if any) an 
effect would occur in the population, and whether such an effect would be clinically 
important.  
We also pooled the results for improvement in passive external rotation in the short term and 
medium term. No long term results were reported by Ryans et al (2005).  
Passive external rotation (degrees), short term (6 weeks) 
Result: P = 0.35, MD = 3.03° [-3.37, 9.43] and see FIGURE 2.11.  
Adjusted threshold for MCID: MCID not known.     
Interpretation: The results were marginally heterogeneous, but a clinical explanation may 
tentatively be offered.10 In the pooled study sample, a mean effect which was not statistically 
significant favoured an intra-articular steroid injection. The pooled 95% CI crossed zero. Thus 
it is uncertain in which direction (if any) an effect would occur in the population. The clinical 
importance of any such effect (< 10°) is also uncertain.  
 
 
 FIGURE 2.11 
 
  
                                                          
10
 The heterogeneity is consistent with differences in injection accuracy—fluoroscopic guidance was used in Carette et al 
(2003), whereas the injections in Ryans et al (2005) were administered blindly—and a dose-response gradient. 
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Tau² = 379.50; Chi² = 5.28, df = 1 (P = 0.02); I² = 81%
Test for overall effect: Z = 0.21 (P = 0.83)
Mean
-43.8
-29.3
SD
27.02
33.7
Total
26
16
42
Mean
-54.9
-9.8
SD
26.86
24.7
Total
23
13
36
Weight
53.1%
46.9%
100.0%
IV, Random, 95% CI
11.10 [-4.01, 26.21]
-19.50 [-40.78, 1.78]
-3.24 [-33.17, 26.68]
Physio Steroid injection Mean Difference Mean Difference
IV, Random, 95% CI
-50 -25 0 25 50
Favours PT Favours steroid
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Chi² = 2.89, df = 1 (P = 0.09); I² = 65%
Test for overall effect: Z = 0.93 (P = 0.35)
Mean
18.3
14.3
SD
16.31
15.2
Total
23
19
42
Mean
9.6
16.7
SD
16.32
13.2
Total
26
20
46
Weight
48.9%
51.1%
100.0%
IV, Fixed, 95% CI
8.70 [-0.45, 17.85]
-2.40 [-11.35, 6.55]
3.03 [-3.37, 9.43]
Physio Steroid injection Mean Difference Mean Difference
IV, Fixed, 95% CI
-20 -10 0 10 20
Favours PT Favours steroid
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Passive external rotation (degrees), medium term (4–6 months) 
Result: P = 0.22, MD = 4.61 [-2.77, 12.00] and see FIGURE 2.12. 
Adjusted threshold for MCID: MCID not known.       
Interpretation: A mean effect which was not statistically significant favoured an intra-
articular steroid injection in the pooled study sample. The pooled 95% CI crossed zero. Thus 
it is uncertain in which direction (if any) an effect would occur in the population. The clinical 
importance of any such effect (< 12°) is also uncertain.  
 
 
 FIGURE 2.12 
 
Passive external rotation (degrees), long term (12 months) 
Result: P = 0.82, MD = -0.80 [-7.58, 5.98,] 
Adjusted threshold for MCID: MCID not known.       
Interpretation: There was no substantive mean difference between groups in the study 
sample. The 95% CI crossed zero. Thus it is uncertain in which direction (if any) an effect 
would occur in the population. The clinical importance of any such effect (< 8°) is also 
uncertain.   
2.3.4.  Adding physiotherapy to other treatments 
2.3.4.1. Adding outpatient physiotherapy (with mobilisations) and home exercises to distension 
for both stages of contracted (frozen) shoulder 
One trial of 149 patients with mixed-stage contracted (frozen) shoulder in primary and secondary 
care evaluated the effect of adding a package of outpatient physiotherapy (with passive 
mobilisations) and home exercises to arthrographic distension (Buchbinder et al 2007). Outcomes 
included SPADI; pain scores on a 10-point Likert scale, assessed globally, at night, at rest and on 
use; and adverse effects/events by open-ended questions. Assessment points included six weeks 
(short term) and six and a half months (medium term). 
 
 
SPADI, short term (6 weeks) 
Result: P = 0.89, MD = -0.50 [-7.60, 6.60]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 3.2.      
Interpretation: There was no substantive mean difference between groups in the study 
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Chi² = 0.47, df = 1 (P = 0.49); I² = 0%
Test for overall effect: Z = 1.22 (P = 0.22)
Mean
29.5
19.1
SD
16.31
19.2
Total
23
13
36
Mean
23
18
SD
16.32
14
Total
26
16
42
Weight
65.1%
34.9%
100.0%
IV, Fixed, 95% CI
6.50 [-2.65, 15.65]
1.10 [-11.39, 13.59]
4.61 [-2.77, 12.00]
Steroid injection Physio Mean Difference Mean Difference
IV, Fixed, 95% CI
-20 -10 0 10 20
Favours PT Favours steroid
Summary: It is uncertain in which direction (if any) an effect would occur in the population, and 
whether such an effect would be clinically important. The trial report did not specify adverse 
effects/events as an outcome. See below for detailed analysis.    
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sample. The 95% CI crossed zero and the adjusted threshold for MCID on both sides of zero. 
Thus it is uncertain in which direction (if any) an effect would occur in the population, and 
whether such an effect would be clinically important. 
SPADI, medium term (6½ months) 
Result: P = 0.52, MD = -2.40 [-9.69, 4.89] 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 3.2.      
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured the distension-only group in the study sample. The 95% CI crossed zero 
and the adjusted threshold for MCID on both sides of zero. Thus it is uncertain in which 
direction (if any) an effect would occur in the population, and whether such an effect would 
be clinically important. 
Global pain, 10-point Likert scale, short term (6 weeks) 
Result: P = 1.00, MD = 0.00 [-0.69, 0.69] 
Adjusted threshold for MCID: MCID not known.      
Interpretation: There was no mean difference between groups in the study sample. The 95% 
CI crossed zero. Thus it is uncertain in which direction (if any) an effect would occur in the 
population.  
Global pain, 10-point Likert scale, medium term (6½ months) 
Result: P = 0.81, MD = -0.10 [0.93, -0.73]. 
Adjusted threshold for MCID: MCID not known.      
Interpretation: There was no substantive mean difference between groups in the study 
sample. The 95% CI crossed zero. Thus it is uncertain in which direction (if any) an effect 
would occur in the population.  
Pain at night, at rest and on use, short term (6 weeks) and medium term (6½ months) 
As in the preceding pain comparisons, mean differences between groups were either absent 
or trivial and the 95% CIs were equally uninformative.  
 
2.3.4.2. Adding outpatient physiotherapy (with passive mobilisations) to NSAIDs for both stages 
of contracted (frozen) shoulder  
 
One trial of 122 patients with mixed-stage contracted (frozen) shoulder in secondary care 
evaluated the addition of outpatient physiotherapy (with passive mobilisations) to NSAIDs 
(Pajareya et al 2004). Outcomes included the SPADI and range of external rotation (it was unclear 
whether this was passive or active), which were assessed at 3 weeks (short term), and adverse 
effects/events. Regarding the latter, the physiotherapy group were asked (a) whether or not they 
experienced pain for > 2 hours after treatment and (b) whether they had more disability next 
morning; and all patients were asked by a blinded rater ‘Have the trial drugs and/or treatment 
programme upset you in any way?’ and examined for signs of bruises or burns during evaluation of 
movement.  
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SPADI, short term (3 weeks)  
Result: P = 0.002, MD = 8.60 [3.28, 13.92]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 3.2. 
Interpretation: A mean effect which was clinically important and statistically significant 
favoured the addition of physiotherapy in the study sample. Based on the 95% CI, a similarly 
directional, and clinically important, effect would be anticipated in the population.  
 Adverse effects, short term (3 weeks)  
Result: Four patients (6.7%) reported, in total, 10 episodes of pain lasting > 2 hours after 
physiotherapy. Fifteen patients (12.5%) reported gastrointestinal side-effects of NSAIDs. Six 
of these had to stop taking NSAIDs due to severe dyspepsia. Two reported severe oedema 
(site not specified) and one a severe headache which quickly resolved when the drug 
treatment was discontinued.      
2.3.5.  Adding physiotherapy elements to combinations of physiotherapy and 
other treatments 
 
2.3.5.1. Adding outpatient physiotherapy (with mobilisations) to an intra-articular steroid 
injection and home exercises for both stages of contracted (frozen) shoulder  
 
We pooled the results of two trials (Carette et al 2003, Ryans et al 2005), with a combined sample 
size of 83 for the relevant subgroups, which evaluated the effect of adding outpatient 
physiotherapy (with mobilisations) to a package of an intra-articular steroid injection and home 
exercises for mixed-stage contracted (frozen) shoulder in primary and secondary care. The 
combined pain-function outcome in Carette et al (2003) was the Shoulder Pain and Disability Index 
(SPADI) and that in Ryans et al (2005) was the 22-point Shoulder Disability Questionnaire (SDQ). In 
addition, Carette et al (2003) separately reported the SPADI score for pain (a 100 mm VAS), and 
Ryans et al (2005) scored pain at rest on a 100 mm VAS. Both trials evaluated passive external 
rotation. Neither reported adverse effects/events as an outcome.  
Assessment time points included 6 weeks (short term), 4–6 months (medium term) and, for 
Carette et al (2003) only, 12 months (long term). 
 
Summary: For SPADI, short term, a clinically important effect favouring the addition of outpatient 
physiotherapy could be attributed to the population with 95% confidence. Adverse effects/events 
ascribed to NSAIDs were more numerous and serious than those ascribed to physiotherapy. See 
below for detailed analysis.   
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Combined pain-function outcome, short term (6 weeks) 
Result: P = 0.13, SMD = 0.34 [-0.10, 0.77] and see FIGURE 2.13. 
Result re-expressed as SPADI: 5.71 [-1.68, 12.92]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 3.2.      
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured the addition of outpatient physiotherapy in the pooled study sample. 
The pooled 95% CI crossed zero, so it is uncertain in which direction (if any) an effect would 
occur in the population, but the only potential for a clinically important effect was in the 
direction favouring the addition of outpatient physiotherapy.   
 
FIGURE 2.13 
Combined pain-function outcome, medium term (4–6 months) 
Result: P = 0.13, SMD = 0.02 [-0.44, 0.47] and see FIGURE 2.14. 
Result re-expressed as SPADI: 0.34 [-7.38, 7.89]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 3.2.      
Interpretation: The mean effect for the pooled study sample was trivial. The pooled 95% CI 
crossed zero and the adjusted threshold for MCID in either direction. Thus it is uncertain in 
which direction (if any) an effect would occur in the population, and whether such an effect 
would be clinically important. 
 
 
FIGURE 2.14 
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Chi² = 0.07, df = 1 (P = 0.79); I² = 0%
Test for overall effect: Z = 1.53 (P = 0.13)
Mean
-36.7
-6.1
SD
24.46
6.4
Total
23
19
42
Mean
-46.5
-7.8
SD
24.29
5.7
Total
21
20
41
Weight
52.7%
47.3%
100.0%
IV, Fixed, 95% CI
0.39 [-0.20, 0.99]
0.28 [-0.36, 0.91]
0.34 [-0.10, 0.77]
Steroid PT and steroid Std. Mean Difference Std. Mean Difference
IV, Fixed, 95% CI
-1 -0.5 0 0.5 1
Favours steroid Favours PT and steroid
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Chi² = 0.03, df = 1 (P = 0.86); I² = 0%
Test for overall effect: Z = 0.07 (P = 0.95)
Mean
-51.3
-7.8
SD
24.46
5.9
Total
23
13
36
Mean
-52.5
-7.6
SD
24.29
5.8
Total
21
17
38
Weight
59.8%
40.2%
100.0%
IV, Fixed, 95% CI
0.05 [-0.54, 0.64]
-0.03 [-0.76, 0.69]
0.02 [-0.44, 0.47]
Steroid PT and steroid Std. Mean Difference Std. Mean Difference
IV, Fixed, 95% CI
-1 -0.5 0 0.5 1
Favours steroid Favours PT and steroid
Summary: For two short term outcomes (combined pain-function; pain) the results indicated 
unidirectional potential for clinically important effects in the population: in each case the 
potential was in the direction favouring the addition of outpatient physiotherapy. This was 
corroborated by passive external rotation, short term, for which an effect favouring the addition 
of outpatient physiotherapy could be attributed to the population with 95% confidence; though 
the stand-alone clinical importance of this effect (<15°) is uncertain. The trial reports did not 
specify adverse effects/events as an outcome. See below for detailed analysis.   
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Combined pain-function outcome (SPADI), long term (12 months) 
Result: P = 0.81, MD = 1.80 [-12.62, 16.22]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 3.2.      
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured the addition of outpatient physiotherapy in the study sample. The 95% 
CI crossed zero and the adjusted threshold for MCID on both sides of zero. Thus it is 
uncertain in which direction (if any) an effect would occur in the population, and whether 
any such an effect would be clinically important. 
We pooled the short term and medium term results for the SPADI pain score (a 100 mm VAS) in 
Carette et al (2003) with those for the 100 mm VAS for pain at rest in Ryans et al (2005). No long 
term results were reported by Ryans et al (2005).  
Pain, short term (6 weeks) 
Result: P =0.14, MD = 7.93 mm [-2.69, 18.56] and see FIGURE 2.15. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm.     
Interpretation: A mean effect which was clinically important but not statistically significant 
favoured the addition of outpatient physiotherapy in the pooled study sample. The pooled 
95% CI crossed zero, so it is uncertain in which direction (if any) an effect would occur in the 
population, but the only potential for a clinically important effect was in the direction 
favouring the addition of outpatient physiotherapy. 
 
FIGURE 2.15 
Pain (100 mm VAS), medium term (4–6 months) 
Result: P =0.97, MD = 1.65 [-10.21, 13.51] and see FIGURE 2.16. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm.     
Interpretation: A mean effect which was clinically important but not statistically significant 
favoured the addition of outpatient physiotherapy in the pooled study sample. The pooled 
95% CI crossed zero and the adjusted threshold for MCID on both sides of zero. Thus it is 
uncertain in which direction (if any) an effect would occur in the population, and whether 
such an effect would be clinically important. 
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Chi² = 0.08, df = 1 (P = 0.78); I² = 0%
Test for overall effect: Z = 1.46 (P = 0.14)
Mean
-39.1
-9.7
SD
26.86
18.5
Total
23
19
42
Mean
-48.7
-16.3
SD
27.04
26.4
Total
21
20
41
Weight
44.4%
55.6%
100.0%
IV, Fixed, 95% CI
9.60 [-6.35, 25.55]
6.60 [-7.65, 20.85]
7.93 [-2.69, 18.56]
Steroid PT and steroid Mean Difference Mean Difference
IV, Fixed, 95% CI
-20 -10 0 10 20
Favours steroid Favours PT and steroid
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FIGURE 2.16 
Pain (100 mm VAS), long term (12 months) 
Result: P = 0.61, MD = -4.20 mm [-20.15, 11.75] 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm.    
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured the intra-articular steroid injection and home exercises only group in the 
study sample. The 95% CI crossed zero and the 95% confidence interval for the adjusted 
MCID on both sides of zero. Thus it is uncertain in which direction (if any) an effect would 
occur in the population, and whether such an effect would be clinically important.  
We also pooled the results for improvement in passive external rotation in the short and medium 
term. No long term results were reported by Ryans et al (2005).  
Passive external rotation (degrees), short term (6 weeks) 
Result: P = 0.04, MD = 7.47° [0.52, 14.42] and see FIGURE 2.17. 
Adjusted threshold for MCID: MCID not known.    
Interpretation: A mean effect which was statistically significant favoured the addition of 
outpatient physiotherapy in the pooled study sample. Based on the pooled 95% CI, a 
similarly directional effect would be anticipated in the population. The clinical importance of 
such an effect (<15°) is uncertain. 
 
FIGURE 2.17 
Passive external rotation (degrees), medium term (4–6 months) 
Result: P = 0.42, MD = 3.30° [-4.68, 11.29] and see FIGURE 2.18. 
Adjusted threshold for MCID: MCID not known.    
Interpretation: A small mean effect, which was not statistically significant, favoured the 
addition of outpatient physiotherapy in the pooled study sample. The pooled 95% CI crossed 
zero. Thus it is uncertain in which direction (if any) an effect would occur in the population. 
The clinical importance of any such effect (< 12°) is also uncertain.  
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Chi² = 0.48, df = 1 (P = 0.49); I² = 0%
Test for overall effect: Z = 0.27 (P = 0.78)
Mean
-54.9
-9.8
SD
26.86
24.7
Total
23
13
36
Mean
-52.8
-16.1
SD
27.04
24.4
Total
21
17
38
Weight
55.3%
44.7%
100.0%
IV, Fixed, 95% CI
-2.10 [-18.05, 13.85]
6.30 [-11.44, 24.04]
1.65 [-10.21, 13.51]
Steroid PT + steroid Mean Difference Mean Difference
IV, Fixed, 95% CI
-20 -10 0 10 20
Favours steroid Favours PT and steroid
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Chi² = 0.04, df = 1 (P = 0.83); I² = 0%
Test for overall effect: Z = 2.11 (P = 0.04)
Mean
26.5
21
SD
16.5
16.5
Total
21
20
41
Mean
18.3
14.3
SD
16.31
15.2
Total
23
19
42
Weight
51.2%
48.8%
100.0%
IV, Fixed, 95% CI
8.20 [-1.51, 17.91]
6.70 [-3.25, 16.65]
7.47 [0.52, 14.42]
PT and steroid Steroid Mean Difference Mean Difference
IV, Fixed, 95% CI
-10 -5 0 5 10
Favours steroid Favours PT and steroid
  
 
61 
 
FIGURE 2.18 
Passive external rotation (degrees), long term (12 months) 
Result: P = 0.15, MD = 7.20° [-2.51, 16.91]. 
Adjusted threshold for MCID: MCID not known.    
Interpretation: A small mean effect, which was not statistically significant, favoured the 
addition of outpatient physiotherapy in the study sample. The 95% CI crossed zero. Thus it is 
uncertain in which direction (if any) an effect would occur in the population. The clinical 
importance of any such effect (< 17°) is also uncertain. 
2.3.6. Adding other treatments to physiotherapy  
 
2.3.6.1. Adding an intra-articular steroid injection to outpatient physiotherapy (with 
mobilisations) and home exercises for both stages of contracted (frozen) shoulder   
 
We pooled the results of two trials (Carette et al 2003, Ryans et al 2005), with a combined sample 
size of 84 for the relevant subgroups, which evaluated the effect of adding an intra-articular steroid 
injection to a package of outpatient physiotherapy (with passive mobilisations) and home exercises 
for mixed-stage contracted (frozen) shoulder in primary and secondary care. The combined pain-
function outcome in Carette et al (2003) was the Shoulder Pain and Disability Index (SPADI) and 
that in Ryans et al (2005) was the 22-point Shoulder Disability Questionnaire (SDQ). In addition, 
Carette et al (2003) separately reported the SPADI score for pain (a 100 mm VAS), and Ryans et al 
(2005) scored pain at rest on a 100 mm VAS. Both trials evaluated passive external rotation. 
Neither reported adverse effects/events as an outcome.  
Assessment time points included 6 weeks (short term), 4–6 months (medium term) and, for 
Carette et al (2003) only, 12 months (long term). 
 
 
 
Summary: For two short term outcomes (combined pain-function, pain) a clinically important 
effect favouring the addition of an intra-articular steroid injection could be attributed to the 
population with 95% confidence or approaching 95% confidence. This was corroborated by 
passive external rotation, short term and medium term, for each of which an effect favouring the 
addition of an intra-articular steroid injection could be attributed to the population with 95% 
confidence; though the stand-alone clinical importance of these latter effects (<18° and <16° 
respectively) is uncertain. The trial reports did not specify adverse effects/events as an outcome. 
See below for detailed analysis.   
unidirectional potential for clinically important treatment effects in the population: in each case 
the potential was in the direction favouring the addition of outpatient physiotherapy. This was 
corroborated by passive external rotation, short term, for which an effect favouring the addition 
of outpatient physiotherapy could be attributed to the population with 95% confidence; though 
the stand-alone clinical importance of this effect (<14°) is uncertain. The trial reports did not 
specify adverse effects as an outcome. See below for detailed analysis.   
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Combined pain-function outcome, short term (6 weeks) 
Result: P = 0.0001, SMD = 0.89 [0.45, 1.34] and see FIGURE 2.19. 
Result re-expressed as SPADI: 14.93 [7.56, 22.49]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 3.2.      
Interpretation: A mean effect which was clinically important and highly statistically significant 
favoured the addition of an intra-articular steroid injection in the pooled study sample. 
Based on the pooled 95% CI, a similarly directional, and clinically important, effect would be 
anticipated in the population.  
 
FIGURE 2.19 
Combined pain-function outcome, medium term (4–6 months) 
Result: P = 0.11, SMD = 0.36 [-0.08, 0.80] and see FIGURE 2.20. 
Result re-expressed as SPADI: 6.04 [-1.34, 13.42]. 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 3.2.      
Interpretation: A mean effect which was clinically important but not statistically significant 
favoured the addition of an intra-articular steroid injection in the pooled study sample. The 
pooled 95% CI crossed zero, so it is uncertain in which direction (if any) an effect would occur 
in the population, but the only potential for a clinically important effect was in the direction 
favouring the addition of an intra-articular steroid injection.  
 
FIGURE 2.20 
Combined pain-function outcome (SPADI), long term (12 months) 
Result: P = 0.7, MD = 2.80 [-11.22, 16.82] 
Adjusted threshold for MCID (calculated from data in Paul et al 2004): 3.2.      
Interpretation: A mean effect which was neither clinically important nor statistically 
significant favoured the addition of an intra-articular steroid injection in the pooled study 
sample. The 95% CI crossed zero and the adjusted threshold for MCID on both sides of zero. 
Thus it is uncertain in which direction (if any) an effect would occur in the population, and 
whether such an effect would be clinically important. 
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We pooled the short term and medium term results for the SPADI pain score in Carette et al (2003) 
with those for the 100 mm VAS for global pain in Ryans (2005). No long term results were reported 
by Ryans et al (2005). 
Pain (100 mm VAS), short term (6 weeks) 
Result: P =0.008, MD = 16.72 [4.29, 29.14] and see FIGURE 2.21. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm.     
Interpretation: The results were heterogeneous, but a clinical explanation may tentatively be 
offered.11 A mean effect which was clinically important and highly statistically significant 
favoured the addition of an intra-articular steroid injection in the pooled study sample. 
Based on the pooled 95% CI, a similarly directional effect would be anticipated in the 
population. Almost all of the pooled 95% confidence interval exceeded the adjusted MCID in 
the direction favouring the addition of an intra-articular steroid injection, so a clinically 
important effect might be attributed to the population with approaching 95% confidence.  
 
FIGURE 2.21 
Pain (100 mm VAS), medium term (4–6 months) 
Result: P = 0.92, MD = -1.17 mm [-22.85, 20.51] and see FIGURE 2.22. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm.     
Interpretation: The results were marginally heterogeneous. Although the explanation may be 
clinical,11 such an attribution cannot be made with any confidence because of the 
susceptibility to bias of Ryans et al (2005) at this time point. Consequently the quality of the 
evidence is reduced. In the pooled study sample, a mean effect which was neither clinically 
important nor statistically significant favoured outpatient physiotherapy alone. The pooled 
95% CI crossed zero and the adjusted threshold for MCID in either direction. Thus it is 
uncertain in which direction (if any) an effect would occur in the population, and whether 
such an effect would be clinically important.  
  
                                                          
11
 The heterogeneity is consistent with differences in injection accuracy—fluoroscopic guidance was used in Carette et al 
(2003), whereas the injections in Ryans et al (2005) were administered blindly—and a dose-response gradient. 
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Chi² = 4.57, df = 1 (P = 0.03); I² = 78%
Test for overall effect: Z = 2.64 (P = 0.008)
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26.90 [11.36, 42.44]
-1.30 [-21.98, 19.38]
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PT Steroid and PT Mean Difference Mean Difference
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FIGURE 2.22 
Pain (100 mm VAS), long term (12 months) 
Result: P = 0.40, MD = 6.50 [-8.61, 21.61]. 
Adjusted threshold for MCID (calculated from data in Tashjian et al 2009): 5.5 mm.     
Interpretation: A mean effect which was not statistically significant favoured the addition of 
an intra-articular steroid injection in the study sample. The 95% CI crossed zero and the 
adjusted threshold for MCID on both sides of zero. Thus it is uncertain in which direction (if 
any) an effect would occur in the population, and whether such an effect would be clinically 
important.  
We also pooled the results for improvement in passive external rotation in the short and medium 
term. No long term results were reported by Ryans et al (2005).  
Passive external rotation, short term (6 weeks) 
Result: P = 0.002, MD = 10.48 [-3.87, 17.09] and see FIGURE 2.23. 
Adjusted threshold for MCID: MCID not known.    
Interpretation: The results were heterogeneous, but a clinical explanation may tentatively be 
offered.12 A mean effect which was statistically significant favoured the addition of an intra-
articular steroid injection in the pooled study sample. Based on the pooled 95% CI, a similarly 
directional effect would be anticipated in the population. The clinical importance of such an 
effect (< 18°) is uncertain. 
FIGURE 2.23 
Passive external rotation, medium term (4–6 months) 
Result: P = 0.05, MD = 7.40 [0.05, 14.76] and see FIGURE 2.24. 
Adjusted threshold for MCID: MCID not known.    
Interpretation: A mean effect which was statistically significant favoured the addition of an 
intra-articular steroid injection in the pooled study sample. Based on the pooled 95% CI, a 
                                                          
12
 The heterogeneity is consistent with differences in injection accuracy—fluoroscopic guidance was used in Carette et al 
(2003), whereas the injections in Ryans et al (2005) were administered blindly—and a dose-response gradient. 
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Tau² = 162.96; Chi² = 2.95, df = 1 (P = 0.09); I² = 66%
Test for overall effect: Z = 0.11 (P = 0.92)
Mean
-43.8
-29.3
SD
27.02
33.7
Total
26
17
43
Mean
-52.8
-16.1
SD
27.04
24.4
Total
21
16
37
Weight
54.2%
45.8%
100.0%
IV, Random, 95% CI
9.00 [-6.54, 24.54]
-13.20 [-33.19, 6.79]
-1.17 [-22.85, 20.51]
PT Steroid and PT Mean Difference Mean Difference
IV, Random, 95% CI
-20 -10 0 10 20
Favours PT Favours steroid and PT
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Chi² = 3.49, df = 1 (P = 0.06); I² = 71%
Test for overall effect: Z = 3.11 (P = 0.002)
Mean
26.5
21
SD
16.5
16.5
Total
21
20
41
Mean
9.6
16.7
SD
16.32
13.2
Total
26
20
46
Weight
49.0%
51.0%
100.0%
IV, Fixed, 95% CI
16.90 [7.46, 26.34]
4.30 [-4.96, 13.56]
10.48 [3.87, 17.09]
Steroid and PT PT Mean Difference Mean Difference
IV, Fixed, 95% CI
-20 -10 0 10 20
Favours PT Favours steroid and PT
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similarly directional effect would be anticipated in the population. The clinical importance of 
such an effect (< 15°) is uncertain. 
 
FIGURE 2.24 
Passive external rotation (degrees), long term (12 months) 
Result: P = 0.18, MD = 6.40° [-3.04, 15.84]. 
Adjusted threshold for MCID: MCID not known.    
Interpretation: A mean effect which was not statistically significant favoured the addition of 
an intra-articular steroid injection in the pooled study sample. The 95% CI crossed zero. Thus 
it is uncertain in which direction (if any) an effect would occur in the population. The clinical 
importance of such an effect (<16°) is also uncertain. 
2.3.6.2. Adding MUA to home exercises for both stages of contracted (frozen) shoulder 
One trial of 125 patients with mixed-stage contracted (frozen) shoulder in secondary care 
evaluated the addition of MUA to home exercises (Kivimäki et al 2007). Outcomes included a 
modified SDQ (2 questions were omitted from the standard 16-point questionnaire), pain intensity 
on an 11-point scale and passive external rotation. Adverse effects/events in individuals were not 
specified as outcomes. Assessments were undertaken in the short term (6 weeks), medium term (6 
months) and long term (12 months).   
 
Modified SDQ, short term (6 weeks) 
Result (as reported):  MD = 0.30 [-1.7, 2.3]. 
Adjusted threshold for MCID: MCID not known.    
Interpretation: A small mean effect favoured the addition of MUA in the study sample. The 
95% CI crossed zero. Thus it is uncertain in which direction (if any) an effect would occur in 
the population.  
Modified SDQ, medium term (6 months) 
Result (as reported):  MD = -0.30 [-2.69, 2.75]. 
Adjusted threshold for MCID: MCID not known.    
Interpretation: A small mean effect favoured the exercises-only group in the study sample. 
Study or Subgroup
Carette 2003
Ryans 2005
Total (95% CI)
Heterogeneity: Chi² = 1.50, df = 1 (P = 0.22); I² = 33%
Test for overall effect: Z = 1.97 (P = 0.05)
Mean
34.1
19.7
SD
16.5
19.7
Total
21
16
37
Mean
23
18
SD
16.32
14
Total
26
17
43
Weight
60.7%
39.3%
100.0%
IV, Fixed, 95% CI
11.10 [1.66, 20.54]
1.70 [-10.02, 13.42]
7.40 [0.05, 14.76]
Steroid and PT PT Mean Difference Mean Difference
IV, Fixed, 95% CI
-20 -10 0 10 20
Favours PT Favours steroid and PT
Summary: It is uncertain in which direction (if any) a treatment effect would occur in the 
population. For three pain outcomes there was unilateral potential for clinically important 
effects, but this potential was very marginal and inconsistent in direction, favouring exercises 
only in the short term, and the addition of MUA in the medium and long term. The trial report did 
not specify adverse effects/events as an outcome. See below for detailed analysis.   
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The 95% CI crossed zero. Thus it is uncertain in which direction (if any) an effect would occur 
in the population.  
Modified SDQ, medium term (6 months) 
Result (as reported):  MD = -0.30 [-2.75, 2.69]. 
Adjusted threshold for MCID: MCID not known.    
Interpretation: A small mean effect favoured the exercises-only group in the study sample. 
The 95% CI crossed zero. Thus it is uncertain in which direction (if any) an effect would occur 
in the population.  
Pain on 11-point NPRS, short term (6 weeks) 
Result (as reported): MD = 0.20 [-0.64, 1.02].  
Adjusted threshold for MCID (based on data from Salaffi et al 2004): 1. 
Interpretation: There was no substantive mean effect in the study sample. The 95% CI 
crossed zero, so it is uncertain in which direction (if any) an effect would occur in the 
population. The only potential for a clinically important effect (and this was only marginal) 
was in the direction favouring exercises-only. 
Pain on 11-point NPRS, medium term (6 months) 
Results (as reported): MD = 0.80 [-0.20, 1.80].  
Adjusted threshold for MCID (based on data from Salaffi et al 2004): 1. 
Interpretation: There was no substantive mean effect in the study sample. The 95% CI 
crossed zero, so it is uncertain in which direction (if any) an effect would occur in the 
population. The only potential for a clinically important effect (and this was only marginal) 
was in the direction favouring the addition of MUA. 
Pain on 11-point NPRS, long term (12 months) 
Results (as reported): MD = 0.7 [-0.4, 1.80].  
Adjusted threshold for MCID (based on data from Salaffi et al 2004): 1. 
Interpretation: There was no substantive mean effect in the study sample. The 95% CI 
crossed zero, so it is uncertain in which direction (if any) an effect would occur in the 
population. The only potential for a clinically important effect (and this was only marginal) 
was in the direction favouring the addition of MUA. 
Passive external rotation (degrees), short term 
Results (as reported): MD = 5° [-2, 12]. 
Adjusted threshold for MCID: MCID not known. 
Interpretation: A small mean effect, which was probably not clinically important, favoured 
the addition of MUA. The 95% CI was uninformative in respect of inferences to the 
population. 
Passive external rotation (degrees), medium term 
Results (as reported): MD = 6° [-2, 14]. 
Adjusted threshold for MCID: MCID not known. 
Interpretation: A small mean effect, which was probably not clinically important, favoured 
the MUA group. The 95% CI was uninformative in respect of inferences to the population. 
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Passive external rotation (degrees), long term 
Results (as reported): MD = 4° [-4.2, 12.2]. 
Adjusted threshold for MCID: MCID not known. 
Interpretation: A small mean effect, which was probably not clinically important, favoured 
the addition of MUA. The 95% CI was uninformative in respect of inferences to the 
population. 
2.4. Results of questionnaire survey of CSP members  
There were 289 valid responses. A full report is published elsewhere (Hanchard et al 2011).  
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3. Recommendations for management of contracted  
(frozen) shoulder (comparisons involving standard 
physiotherapy) 
 
The justifications take account of the respective trials’ results (see section 3), their risk of bias (we 
have only included RCTs and, moreover, only those RCTs judged to be at low risk of bias) and their 
GRADE quality assessments. Over and above risk of bias, GRADE quality assessments consider the 
following factors: 
 inconsistency (which occurs when trials’ results do not agree); 
 indirectness (which occurs when the trials’ results are inapplicable to the population of 
interest);  
 imprecision (which occurs when the estimates of effect are wide); and 
 publication bias (underestimation or overestimation of effects due to selective publication 
of studies).  
An evidence quality grading (‘high’, ‘moderate’, ‘low’ or ‘very low’) is given accordingly, and 
influences the strength of the recommendation. The GRADE quality assessments are tabulated in 
APPENDIX E (GRADE evidence profile tables). 
 
3.1. Physiotherapy versus other physiotherapy  
3.1.1. In primary and secondary care, should we add outpatient physiotherapy 
(with passive mobilisations) to home exercises for both stages of contracted 
(frozen) shoulder? 
References: Carette et al (2003), Ryans et al (2005). 
Settings: Secondary care in Canada, primary care in Northern Ireland. 
 Our recommendations are summarised in TABLES 3a‒e  
Our recommendations for management of contracted (frozen) shoulder by ‘standard physiotherapy’ 
are set out and justified below. The process has, in some cases, involved comparison with other 
treatments (which will be the focus of future versions).  
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Synthesis: The median quality of the evidence was low for the critical outcomes (combined pain-
function, pain) and moderate for the important but non-critical outcomes (passive external 
rotation). 
In the short term, it was unclear in which direction (if any) an effect on combined pain-
function would occur in the population, and whether any such effect would be clinically important 
(low quality evidence). Pain showed unidirectional potential for a clinically important effect in the 
population, favouring the addition of outpatient physiotherapy (moderate quality evidence). At this 
time point too, passive external rotation favoured the addition of outpatient physiotherapy, 
providing corroboration (moderate quality evidence).  
In the medium and long term, it was unclear in which direction (if any) an effect on 
combined pain-function, pain (low quality evidence) or passive external rotation (moderate quality 
evidence) would occur in the population, and whether any such effect would be clinically 
important.    
Potential harms of mechanical therapy include temporary aggravation of symptoms and 
would be expected to be common to both interventions, but adverse effects/events were neither 
quantified nor described in the trial reports.  
Summary of evidence: In the short term, a combination of outpatient physiotherapy (including 
passive mobilisations, and modified according to the stage of the condition) and home exercises is 
potentially more beneficial for pain than home exercises alone (moderate quality evidence). Also at 
this time point, the results for passive external rotation favour the addition of outpatient 
physiotherapy (moderate quality evidence). Adverse effects/events are neither quantified nor 
described in the trial reports, but would be expected to be temporary, minor and common to both 
groups. 
Recommendation: Probably add outpatient physiotherapy (with passive mobilisations) to home 
exercises for both stages of contracted (frozen) shoulder in primary and secondary care. 
 
3.1.2. In secondary care, which should we use for both stages of contracted 
(frozen) shoulder: a home muscle function retraining programme or 
outpatient physiotherapy (with passive mobilisations) and standard home 
exercises? 
References: Ginn and Cohen (2005). 
Settings: Secondary care in Australia. 
Synthesis: The quality of the evidence was moderate for patients’ global impression of change 
(‘improved’ versus ‘not improved’ or ‘deteriorated’) and adverse effects (‘deteriorated’), both of 
which were critical outcomes and were only reported in the short term. The 95% CI for the 
absolute effect indicated that the home muscle function retraining programme would result in 296 
fewer to 144 more ‘improved’ classifications per 1000 patients.  
Potential harms of mechanical therapy include temporary aggravation of symptoms and 
would be expected to be common to both interventions. Adverse effects/events were not 
described in the trial report, but self-reports of ‘deterioration’ were quantified. The 95% CI for the 
absolute effect indicated that muscle function retraining would result in 36 fewer to 618 more 
‘deteriorated’ classifications per 1000 patients.  
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Summary of evidence: The quality of the evidence is moderate but the estimates of effect relating 
to efficacy are imprecise and only short term outcomes are reported. Adverse effects/events would 
likely be minor, but there is potential for instances of ‘deterioration’ to be more numerous in 
patients treated with muscle function retraining.  
Recommendation: Probably use outpatient physiotherapy (with passive mobilisations) and 
standard home exercises in preference to a home muscle function retraining programme for both 
stages of contracted (frozen) shoulder in secondary care. 
3.1.3. In secondary care, which should we use for stiffness-predominant 
contracted (frozen) shoulder: high grade or low grade mobilisations? 
References: Vermeulen et al (2006). 
Settings: Secondary care in The Netherlands. 
Synthesis: The median quality of the evidence was low for the critical outcomes (SRQ, pain) and 
moderate for the important but non-critical outcomes (passive external rotation).  
Short term, pain at rest showed unidirectional potential for a clinically important effect in 
the population, and was alone in favouring low grade mobilisations (moderate quality evidence). 
For SRQ, night pain, and pain on use it was unclear in which direction (if any) an effect would occur 
in the population, and whether any such effect would be clinically important (low quality evidence); 
likewise for passive external rotation (moderate quality evidence). 
In the medium term, SRQ showed unidirectional potential for a clinically important effect in 
the population, favouring high grade mobilisations (moderate quality evidence), and this was 
corroborated by passive external rotation, for which almost all of the 95% CI lay on the 
corresponding side of zero (moderate quality evidence). For the other outcomes (night pain, pain 
at rest, pain on use) it was unclear in which direction (if any) an effect would occur in the 
population, and whether any such effect would be clinically important (low quality evidence).    
 In the long term, SRQ, night pain and pain on use showed unidirectional potential for a 
clinically important effect in the population, favouring high grade mobilisations (moderate quality 
evidence), and were corroborated by passive external rotation, which showed a directional effect 
(moderate quality evidence). For pain at rest, it was unclear in which direction (if any) an effect 
would occur in the population, and whether any such effect would be clinically important (low 
quality evidence).    
Adverse effects (self-reports of ‘worse’ or ‘much worse’) cannot be quantified, because these 
categories were pooled with ‘no change’ in the trial report.   
Summary of evidence: Short term, low grade mobilisations are potentially more beneficial than 
high grade mobilisations for pain at rest (moderate quality evidence). Conversely, in the medium 
term, high grade mobilisations are potentially more beneficial than low grade mobilisations as 
judged by the SRQ (moderate quality evidence); and in the long term, high grade mobilisations are 
potentially more beneficial than low grade mobilisations as judged by the SRQ, and for night pain 
and pain on use (moderate quality evidence). Also, the results for passive external rotation favour 
high grade mobilisations in the medium term and especially the long term (moderate quality 
evidence). No specific data on adverse effects/events are provided in the trial report, though any 
such effects/events would likely be temporary and minor. On this basis, the potential benefits of 
high grade mobilisations are likely to outweigh the potential harms. 
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Recommendation: Probably use high grade mobilisations (in preference to low grade 
mobilisations) for stiffness-predominant contracted (frozen) shoulder in secondary care.  
 
3.1.4. In secondary care, which should we add to home exercises for both 
stages of contracted (frozen) shoulder: high grade mobilisations or MWMs? 
References: Yang et al (2007). 
Settings: Secondary care in Taiwan. 
Synthesis: The quality of the evidence was low. A single, critical, outcome—the FLEX-SF—was 
reported, and only in the short term. From the results, it was unclear in which direction (if any) an 
effect would occur in the population, and whether any such effect would be clinically important.  
Potential harms of mechanical therapy include temporary aggravation of symptoms and 
would be expected to be common to both interventions. Adverse effects/events were neither 
quantified nor described in the trial report, however.   
Summary of evidence: The quality of the evidence is low, estimates of effect are imprecise and 
only a short term outcome (FLEX-SF) is reported. It is uncertain in which direction (if any) change 
would occur in the population, and whether any such change would be clinically important. 
Adverse effects/events would probably be minor and common to both interventions, although they 
are neither quantified nor described in the trial report; but uncertainty as to the interventions’ 
relative benefits means that no recommendation for practice can be made.   
Recommendation: No recommendation. 
 
3.1.5. In secondary care, should we add SWD to outpatient physiotherapy 
(without passive mobilisations) and home exercises for stiffness-predominant 
contracted (frozen) shoulder?  
References: Leung and Cheing (2008). 
Settings: Secondary care in Hong Kong. 
Synthesis: The quality of the evidence was moderate. A single, critical, outcome—the patient-
completed portion of the ASES—was reported, and only in the short term. From the results, a 
clinically important effect favouring the addition of SWD might cautiously be inferred to the 
population (approaching 95% confidence).  
Potential harms of SWD include burns, but there are well established protocols for 
minimising the risk of these occurring. Adverse effects/events were neither quantified nor 
described in the trial report.   
Summary of evidence: The quality of the evidence is moderate but only a short term outcome is 
reported. The patient-completed section of the ASES is suggestive of a clinically important effect 
favouring SWD in the population. Potential harms of SWD include burns, but there are well 
established protocols for minimising the risk of these occurring. Adverse effects/events are neither 
quantified nor described in the trial report.  
Recommendation: Probably add SWD to outpatient physiotherapy (without passive 
mobilisations) and home exercises for stiffness-predominant contracted (frozen) shoulder in 
secondary care. 
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3.1.6. In secondary care, should we add hot packs to outpatient 
physiotherapy (without passive mobilisations) and home exercises for 
stiffness-predominant contracted (frozen) shoulder?  
References: Leung and Cheing (2008). 
Settings: Secondary care in Hong Kong. 
Synthesis: The quality of the evidence was low. A single, critical, outcome—the patient-completed 
portion of the ASES—was reported, and only in the short term. From the results, it was unclear in 
which direction (if any) an effect would occur in the population, and whether any such effect would 
be clinically important.  
Potential harms of hot packs include burns, but there are well established protocols for 
minimising the risk of these occurring. Adverse effects/events were neither quantified nor 
described in the trial report.   
Summary of evidence: The quality of the evidence is low and only a short term outcome is 
reported. It is uncertain in which direction (if any) an effect would occur in the population, and 
whether any such effect would be clinically important. Potential harms of hot packs include burns, 
but there are well established protocols for minimising the risk of these occurring. Adverse 
effects/events are neither quantified nor described in the trial report.  
Recommendation: Probably don’t add hot packs to outpatient physiotherapy (without passive 
mobilisations) and home exercises for stiffness-predominant contracted (frozen) shoulder in 
secondary care. 
3.1.7. In secondary care, which should we add to outpatient physiotherapy 
(without passive mobilisations) and home exercises for stiffness-predominant 
contracted (frozen) shoulder: SWD or hot packs?  
References: Leung and Cheing (2008). 
Settings: Secondary care in Hong Kong. 
Synthesis: The quality of the evidence was moderate. A single, critical, outcome—the patient-
completed portion of ASES—was reported, and only in the short term. The results showed 
unidirectional potential for a clinically important effect in the population, in the direction favouring 
the addition of SWD.  
Potential harms of SWD and hot packs include burns, but there are well established 
protocols for minimising the risk of these occurring. Adverse effects/events were neither quantified 
nor described in the trial report.   
Summary of evidence: The quality of the evidence is moderate but only a short term outcome is 
reported. Addition of SWD to home exercises is potentially more beneficial as judged by the 
patient-completed portion of ASES than the addition of hot packs. Potential harms of SWD and hot 
packs include burns, but there are well established protocols for minimising the risk of these 
occurring. Adverse effects/events are neither quantified nor described in the trial report.  
Recommendation: Probably add SWD (in preference to hot packs) to outpatient physiotherapy 
(without passive mobilisations) and home exercises for stiffness-predominant contracted 
(frozen) shoulder in secondary care. 
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3.2. Physiotherapy versus other treatments  
3.2.1. In primary care, which should we use for both stages of contracted 
(frozen) shoulder: outpatient physiotherapy (with mobilisations) or intra-
articular steroid injections? 
References: van der Windt et al (1998). 
Settings: Primary care in The Netherlands. 
Synthesis: The median quality of the evidence was moderate for the critical outcomes (SDQ, pain 
and adverse effects/events) and the important but non-critical outcomes (passive external 
rotation).  
In the short term, a clinically important effect favouring intra-articular steroid injections 
could be inferred to the population for the SDQ (moderate quality evidence). A clinically important 
effect favouring intra-articular steroid injections could be cautiously inferred to the population 
(approaching 95% confidence) for two further outcomes: night pain and day pain (moderate quality 
evidence).  
In the medium term, the only potential for a clinically important effect on the SDQ was in the 
direction favouring intra-articular steroid injections (moderate quality evidence). Other outcomes, 
at this time point and in the long term, were equivocal both in terms of the direction of their 
effects and their clinical importance.  
Potential harms of physiotherapy include temporary aggravation of symptoms. Those of 
steroid injections include facial flushing, temporary aggravation of symptoms and, possibly, 
diminished collagen density (Shibata et al 2001). Adverse effects/events were both quantified and 
described in the trial report (moderate quality evidence). Fifty-three percent of the injection group 
and 56% of the physiotherapy group reported adverse effects/events. (Note that, in a deviation 
from protocol, 5 patients were treated with both interventions.) These adverse effects/events were 
minor, and included: pain lasting a day or less after treatment (9 patients in the injection group; 17 
patients in the physiotherapy group); pain lasting 2 days or more after treatment (16 patients in 
the injection group; 13 patients in the physiotherapy group); facial flushing (9 patients in the 
injection group; 1 patient in the physiotherapy group); irregular menstruation (2 patients in the 
injection group); self-diagnosed fever (2 patients in the injection group; 1 patient in the 
physiotherapy group); skin irritation (1 patient in the injection group; 2 patients in the 
physiotherapy group); and other events, including sweating, fatigue, dry mouth, dizziness and 
headache (6 patients in the injection group), and slight swelling, tingling and radiating pain (4 
patients in the physiotherapy group). The 95% CI for absolute effect indicated that 185 fewer to 
174 more patients per 1000 would suffer adverse effects/events with intra-articular steroid 
injections than with physiotherapy.      
Summary of evidence: In the short term, intra-articular steroid injections are more beneficial as 
judged by the SDQ (moderate quality evidence), and probably more beneficial for day pain and 
night pain (moderate quality evidence), than outpatient physiotherapy. In the medium term, intra-
articular steroid injections are potentially more beneficial as judged by the SDQ than outpatient 
physiotherapy (moderate quality evidence). For other efficacy-related outcomes, at this time point 
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and in the long term, the evidence is unclear both in terms of direction of effects and clinical 
importance.  
The adverse effects/events reported were all minor. The 95% CI for relative risk indicate 
that 185 fewer to 174 more patients per 1000 would suffer adverse effects/events with intra-
articular steroid injection than with physiotherapy. The possibility of longer term adverse effects of 
steroid injections (Shibata et al 2001) should be considered, however.    
Recommendation: Probably use intra-articular steroid injections rather than outpatient 
physiotherapy for both stages of contracted (frozen) shoulder in primary care. 
3.2.2. In secondary care, which should we use for both stages of contracted 
(frozen) shoulder: a home muscle function retraining programme or a 
subacromial steroid injection?  
References: Ginn and Cohen (2005). 
Settings: Secondary care in Australia. 
Synthesis: The quality of the evidence was moderate for patients’ global impression of change 
(‘improved’ versus ‘not improved’ or ‘deteriorated’) and adverse effects/events (‘deteriorated’) , 
both of which were critical outcomes and were only reported in the short term. The 95% CI for the 
absolute effect indicated that the home muscle function retraining programme would result in 240 
fewer to 255 more ‘improved’ classifications per 1000 patients.  
Potential harms of mechanical therapy include temporary aggravation of symptoms. Those 
of steroid injections include facial flushing, temporary aggravation of symptoms and, possibly, 
diminished collagen density (Shibata et al 2001). Adverse effects/events were not described in the 
trial report, but self-reports of ‘deterioration’ were quantified. The 95% CI for the absolute effect 
indicated that muscle function retraining would result in 43 fewer to 608 more ‘deteriorated’ 
classifications per 1000 patients.  
Summary of evidence: The quality of the evidence is moderate but only short term outcomes are 
reported. There is no clear differential in terms of benefit. Muscle function retraining shows more 
potential for ‘deterioration’.   
Recommendation: No recommendation for practice.  
3.2.3. In secondary care, which should we use for both stages of contracted 
(frozen) shoulder: outpatient physiotherapy (with passive mobilisations) and 
home exercises or a subacromial steroid injection? 
References: Ginn and Cohen (2005). 
Settings: Secondary care in Australia. 
Synthesis: The quality of the evidence was moderate for patients’ global impression of change 
(‘improved’ versus ‘not improved’ or ‘deteriorated’) and adverse effects/events (‘deteriorated’), 
both of which were critical outcomes and were only reported in the short term. The 95% CI for the 
absolute effect indicated that a subacromial steroid injection would result in 262 fewer to 178 
more ‘improved’ classifications per 1000 patients.  
Potential harms of mechanical therapy include temporary aggravation of symptoms. Those 
of steroid injections include facial flushing, temporary aggravation of symptoms and, possibly, 
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diminished collagen density (Shibata et al 2001). Adverse effects/events were quantified but not 
described in the trial report. The 95% CI for the absolute effect indicated that a subacromial steroid 
injection would result in 35 fewer to 647 more ‘deteriorated’ classifications per 1000 patients.  
Summary of evidence: The quality of the evidence is moderate but only short term outcomes are 
reported. The results show less potential for benefit with a subacromial steroid injection, and more 
potential for ‘deterioration’.  
Recommendation: Probably use outpatient physiotherapy (with passive mobilisations) and home 
exercises in preference to a subacromial steroid injection for both stages of contracted (frozen) 
shoulder in secondary care.  
 
3.3. Physiotherapy versus combinations of physiotherapy  
and other treatments  
3.3.1. In primary and secondary care, which should we add to home exercises 
for both stages of contracted (frozen) shoulder: outpatient physiotherapy 
(with passive mobilisations) or an intra-articular steroid injection?  
References: Carette et al (2003), Ryans et al (2005). 
Settings: Secondary care in Canada, primary care in Northern Ireland. 
Synthesis: The median quality of the evidence was low for the critical outcomes (combined pain-
function, pain) and moderate for the important but non-critical outcomes (passive external 
rotation).  
In the short term, a clinically important effect favouring an intra-articular steroid injection 
could be cautiously inferred to the population (approaching 95% confidence) for combined pain-
function (moderate quality evidence). Pain showed unidirectional potential for a clinically 
important effect in the population, favouring an intra-articular steroid injection (moderate quality 
evidence).  
In the medium term, combined pain-function showed unidirectional potential for a 
clinically important effect in the population, favouring an intra-articular steroid injection (low 
quality evidence). For the remaining outcomes, at this time point and in the long term, it was 
unclear in which direction (if any) an effect would occur in the population, and whether any such 
effect would be clinically important (low quality evidence).  
   Potential harms of mechanical therapy include temporary aggravation of symptoms. Those 
of steroid injections include facial flushing, temporary worsening of symptoms and, possibly, 
diminished collagen density (Shibata et al 2001). Adverse effects/events were not quantified or 
described in the trial reports.  
Summary of evidence: In the short term, addition of an intra-articular steroid injection to home 
exercises is probably more beneficial than addition of outpatient physiotherapy for combined pain-
function, and potentially more beneficial for pain (moderate quality evidence). In the medium 
term, addition of an intra-articular steroid injection to home exercises is potentially more beneficial 
than addition of outpatient physiotherapy for pain (low quality evidence). Adverse effects/events 
are not quantified or described in the trial reports, but the results of another trial (van der Windt 
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1998) suggest that adverse effects/events would be fewer in the intra-articular steroid injection 
group. That trial did not investigate histology, however, and the possibility of adverse effects on 
collagen density should be borne in mind.  
Recommendation: Probably add an intra-articular steroid injection (rather than outpatient 
physiotherapy with passive mobilisations) to home exercises for both stages of contracted 
(frozen) shoulder in primary or secondary care. 
3.4. Adding physiotherapy to other treatments   
3.4.1. In primary and secondary care, should we add outpatient physiotherapy 
(with passive mobilisations) and home exercises to distension for both stages 
of contracted (frozen) shoulder?  
References: Buchbinder et al (2007). 
Settings: Primary and secondary care in Australia. 
Synthesis: The median quality of the evidence was moderate for SPADI, pain and adverse 
effects/events, all of which were critical outcomes and were reported in the short and medium 
term.  
For all outcomes at both time points it was unclear in which direction (if any) an effect 
would occur in the population, and whether any such effect would be clinically important. Adverse 
effects/events were more prevalent in the group that received distension and placebo 
physiotherapy: the 95% CI for the absolute effect was from 14 fewer to 94 more in the short term, 
and from 48 fewer to 118 more in the medium term.     
Summary of evidence: The overall quality of the evidence is moderate. The estimates of relative 
benefits are too imprecise to enable a judgement. There is greater potential for adverse 
effects/events in the distension and placebo physiotherapy and distension group.  
Recommendation: No recommendation for practice. 
3.4.2. In primary and secondary care, should we add outpatient physiotherapy 
(with passive mobilisations) to NSAIDs for both stages of contracted (frozen) 
shoulder?  
References: Pajareya et al (2004). 
Settings: Secondary care in Thailand. 
Synthesis: The quality of the evidence was moderate. A single, critical, outcome—the SPADI—was 
reported, and only in the short term. A clinically important effect favouring the addition of 
outpatient physiotherapy could be inferred to the population (moderate quality evidence).  
Potential harms of physiotherapy include temporary aggravation of symptoms; those of 
NSAIDs primarily gastro-intestinal (GI) disturbances. Adverse effects/events were quantified and 
described in the report of this trial. Four patients reported pain lasting > 2 hours after 
physiotherapy. Fifteen patients in the NSAIDs group reported GI disturbances, and six of these had 
to stop medication due to severe dyspepsia. Two reported severe oedema (the site was 
unspecified) and one a severe headache which resoled on discontinuation of NSAIDs.    
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Summary of evidence: The quality of the evidence was moderate. The results point to a clinically 
important effect favouring the addition of outpatient physiotherapy (with passive mobilisations) in 
the population.  
Recommendation: A combination of outpatient physiotherapy (with passive mobilisations) and 
NSAIDs is more beneficial than NSAIDs alone for both stages of contracted (frozen) shoulder in 
secondary care. (The potential harms of NSAIDs should be carefully considered, although such 
considerations fall outside the non-prescriber’s remit.)  
3.5. Adding physiotherapy elements to combinations  
of physiotherapy and other treatments 
3.5.1. In primary and secondary care, should we add outpatient physiotherapy 
(with passive mobilisations) to an intra-articular steroid injection and home 
exercises for both stages of contracted (frozen) shoulder? 
References: Carette et al (2003), Ryans et al (2005). 
Settings: Secondary care in Canada and primary care in Northern Ireland. 
Synthesis: The median quality of the evidence was low for the critical outcomes (combined pain-
function, pain) and moderate for the important but non-critical outcomes (passive external 
rotation).  
In the short term, combined pain-function and pain showed unidirectional potential for a 
clinically important effect favouring the addition of outpatient physiotherapy in the population 
(moderate quality evidence). This was corroborated by passive external rotation, for which there 
was a directional effect (moderate quality evidence).   
In the medium term, pain-function showed unidirectional potential for a clinically 
important effect favouring the addition of outpatient physiotherapy (very low quality evidence). 
For pain and passive external rotation it was unclear in which direction (if any) an effect would 
occur in the population, and whether any such effect would be clinically important (low quality 
evidence).  
  In the long term, it was unclear for all outcomes in which direction (if any) an effect would 
occur in the population, and whether any such effect would be clinically important (low quality 
evidence). 
Potential harms of mechanical therapy include temporary aggravation of symptoms. Those 
of steroid injections include facial flushing, temporary worsening of symptoms and, possibly, 
diminished collagen density (Shibata et al 2001). Adverse effects/events were not quantified or 
described in the trial reports.  
Summary of evidence: In the short term, addition of outpatient physiotherapy to an intra-articular 
steroid injection and home exercises is potentially more beneficial than an intra-articular steroid 
injection and home exercises alone for pain-function and pain (moderate quality evidence). In the 
medium term, addition of physiotherapy to outpatient physiotherapy and an intra-articular steroid 
injection is potentially more beneficial than outpatient physiotherapy and an intra-articular steroid 
injection alone for pain-function (very low quality evidence). Adverse effects/events were not 
mentioned in the trial reports, but the results of another trial (van der Windt 1998) suggest that 
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adverse effects/events would be fewer in the intra-articular steroid injection group. That trial did 
not investigate histology, however, and the possibility of adverse effects on collagen density should 
be borne in mind. 
Recommendation: Probably add outpatient physiotherapy (with passive mobilisations) to an 
intra-articular steroid injection and home exercises for both stages of contracted (frozen) 
shoulder in primary or secondary care. 
3.6. Adding other treatments to physiotherapy  
3.6.1. In primary and secondary care, should we add an intra-articular steroid 
injection to outpatient physiotherapy (with passive mobilisations) and home 
exercises for both stages of contracted (frozen) shoulder?  
References: Carette et al (2003), Ryans et al (2005). 
Settings: Secondary care in Canada and primary care in Northern Ireland. 
Synthesis: The median quality of the evidence was low for the critical outcomes (combined pain-
function, pain) and moderate for the important but non-critical outcomes (passive external 
rotation).  
In the short term, a clinically important effect favouring the addition of an intra-articular 
steroid injection could be inferred to the population (95% confidence) for pain-function (moderate 
quality evidence). For pain, a clinically important effect favouring the addition of an intra-articular 
steroid injection could be cautiously inferred to the population with approaching 95% confidence 
(moderate quality evidence). Corroboration was provided by passive external rotation, for which 
there was a directional effect (moderate quality evidence). 
In the medium term, combined pain-function showed unidirectional potential for a 
clinically important effect in the population, favouring the addition of an intra-articular steroid 
injection (low quality evidence). This was corroborated by passive external rotation, for which 
there was a directional effect (low quality evidence). For pain, it was unclear in which direction (if 
any) an effect would occur in the population, and whether any such effect would be clinically 
important (very low quality evidence).    
In the long term, it was unclear for all outcomes in which direction (if any) an effect would 
occur in the population, and whether any such effect would be clinically important (low quality 
evidence).     
    Potential harms of mechanical therapy include temporary aggravation of symptoms. Those 
of steroid injections include facial flushing, temporary worsening of symptoms and, possibly, 
diminished collagen density (Shibata et al 2001). Adverse effects/events were not quantified or 
described in the trial reports.  
Summary of evidence: In the short term, addition of an intra-articular steroid injection to 
outpatient physiotherapy and home exercises benefits pain-function (moderate quality evidence) 
and probably benefits pain (moderate quality evidence). Also, the results for passive external 
rotation favour the addition of an intra-articular steroid injection (moderate quality evidence). In 
the medium term, addition of an intra-articular steroid injection to outpatient physiotherapy and 
home exercises potentially benefits combined pain-function (low quality evidence). This too is 
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corroborated by results for passive external rotation (low quality evidence). Adverse effects/events 
were not mentioned in the trial reports, but the results of another trial (van der Windt 1998) 
suggest that adverse effects/events would be fewer in the intra-articular steroid injection group. 
That trial did not investigate histology, however, and the possibility of adverse effects on collagen 
density should be borne in mind. 
Recommendation: Probably add an intra-articular steroid injection to outpatient physiotherapy 
(with passive mobilisations) and home exercises for both stages of contracted (frozen) shoulder 
in primary or secondary care. 
3.6.2. In secondary care, should we add MUA to home exercises for both 
stages of contracted (frozen) shoulder?  
References: Kivimaki et al (2007). 
Settings: Secondary care in Finland. 
Synthesis: The median quality of the evidence was (estimated as) moderate. The critical outcomes 
(a modified SDQ and the NPRS) and the important but non-critical outcomes (passive external 
rotation) were assessed in the short, medium and long term.  
In the short term it was unclear in which direction (if any) effects would occur in the 
population. For the NPRS, the only potential for a clinically important effect (which was marginal) in 
the population was in the direction favouring home exercises only. 
In the medium and long term it was unclear in which direction (if any) effects would occur in 
the population, though for the NPRS at each time point the only potential for a clinically important 
effect on the NPRS in the population was in the direction favouring the addition of MUA.     
Potential harms of MUA include humeral fractures, rotator cuff ruptures, brachial plexus and 
vascular injuries; those of mechanical therapy include temporary aggravation of symptoms. 
Adverse effects/events were neither quantified nor described in the trial report.  
Summary of evidence: The estimates of relative benefits show potential for added MUA to exert a 
clinically important beneficial effect over home exercises alone on pain in the medium and long 
term (quality of evidence not estimable). Adverse effects/events are neither quantified nor 
described in the trial report, but potential harms are known and may be serious. The balance of 
benefits and harms is unclear. 
Recommendation: No recommendation for practice.  
  
 
83 
Physiotherapy versus other physiotherapy  
Question  Recommendation for practice 
3.1.1 In primary and secondary care, should we add outpatient physiotherapy 
(with passive mobilisations) to home exercises for both stages of 
contracted (frozen) shoulder? 
 Probably add outpatient physiotherapy (with passive 
mobilisations) to home exercises. 
3.1.2 In secondary care, which should we use for both stages of contracted 
(frozen) shoulder:  a home muscle function retraining programme or 
outpatient physiotherapy (with passive mobilisations) and standard home 
exercises? 
 Probably use outpatient physiotherapy (with passive 
mobilisations) and standard home exercises in preference to a 
home muscle function retraining programme. 
3.1.3 In secondary care, which should we use for stiffness-predominant 
contracted (frozen) shoulder: high grade or low grade mobilisations? 
 Probably use high grade mobilisations in preference to low 
grade mobilisations. 
3.1.4 In secondary care, which should we add to home exercises for both stages 
of contracted (frozen) shoulder: high grade mobilisations or MWMs? 
 No recommendation for practice. 
TABLE 3a. Clinical questions and recommendations.  The GRADE levels of recommendation are used. ‘Do it’ or ‘don’t 
do it’ indicate a judgement that most well informed people (i.e. patients) would make. ‘“Probably do it” or “probably don’t 
do it” indicate a judgement that majority of well informed people would make but a substantial minority would not’ 
(GRADE Working Group 2004). For further explanation, see pages 6‒7. 
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Physiotherapy versus other physiotherapy (continued) 
Question  Recommendation for practice 
3.1.5 In secondary care, should we add SWD to outpatient physiotherapy 
(without passive mobilisations) and home exercises for stiffness-
predominant contracted (frozen) shoulder? 
 Probably add SWD to outpatient physiotherapy (without 
passive mobilisations) and home exercises. 
3.1.6 In secondary care, should we add hot packs to outpatient physiotherapy 
(without passive mobilisations) and home exercises for stiffness-
predominant contracted (frozen) shoulder? 
 Probably don’t add hot packs to outpatient physiotherapy 
(without passive mobilisations) and home exercises. 
3.1.7 In secondary care, which should we add to outpatient physiotherapy 
(without passive mobilisations) and home exercises for stiffness-
predominant contracted (frozen) shoulder: SWD or hot packs? 
 Probably add SWD (in preference to hot packs) to outpatient 
physiotherapy (without passive mobilisations) and home 
exercises. 
TABLE 3a (continued). Clinical questions and recommendations.  The GRADE levels of recommendation are used. 
‘Do it’ or ‘don’t do it’ indicate a judgement that most well informed people (i.e. patients) would make. ‘“Probably do it” or 
“probably don’t do it” indicate a judgement that majority of well informed people would make but a substantial minority 
would not’ (GRADE Working Group 2004). For further explanation, see pages 6‒7. 
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Physiotherapy versus other treatments 
Question  Recommendation for practice 
3.2.1 In primary care, which should we use for both stages of contracted 
(frozen) shoulder: outpatient physiotherapy (with mobilisations) or  
intra-articular steroid injections? 
 Probably use intra-articular steroid injections in preference to 
outpatient physiotherapy. 
3.2.2 In secondary care, which should we use for both stages of contracted 
(frozen) shoulder: a home muscle function retraining programme or a 
subacromial steroid injection? 
 No recommendation for practice. 
3.2.3 In secondary care, which should we use for both stages of contracted 
(frozen) shoulder: outpatient physiotherapy (with passive mobilisations) 
and home exercises or a subacromial steroid injection? 
 Probably use outpatient physiotherapy (with passive 
mobilisations) and home exercises in preference to a 
subacromial steroid injection. 
TABLE 3b. Clinical questions and recommendations.  The GRADE levels of recommendation are used. ‘Do it’ or 
‘don’t do it’ indicate a judgement that most well informed people (i.e. patients) would make. ‘“Probably do it” or 
“probably don’t do it” indicate a judgement that majority of well informed people would make but a substantial minority 
would not’ (GRADE Working Group 2004). For further explanation, see pages 6‒7. 
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Physiotherapy versus combinations of physiotherapy and other treatments 
Question  Recommendation for practice 
3.3.1 In primary and secondary care, which should we add to home exercises 
for both stages of contracted (frozen) shoulder: outpatient physiotherapy 
(with passive mobilisations) or an intra-articular steroid injection? 
 Probably add an intra-articular steroid injection (rather than 
outpatient physiotherapy with passive mobilisations) to home 
exercises. 
TABLE 3c. Clinical questions and recommendations.  The GRADE levels of recommendation are used. ‘Do it’ or ‘don’t 
do it’ indicate a judgement that most well informed people (i.e. patients) would make. ‘“Probably do it” or “probably don’t 
do it” indicate a judgement that majority of well informed people would make but a substantial minority would not’ 
(GRADE Working Group 2004). For further explanation, see pages 6‒7. 
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Adding physiotherapy to other treatments 
Question  Recommendation for practice 
3.4.1 In primary and secondary care, should we add outpatient physiotherapy 
(with passive mobilisations) and home exercises to distension for both 
stages of contracted (frozen) shoulder? 
 No recommendation for practice. 
3.4.2 In secondary care, should we add outpatient physiotherapy (with passive 
mobilisations) to NSAIDs for both stages of contracted (frozen) shoulder? 
 A combination of outpatient physiotherapy (with passive 
mobilisations) and NSAIDs is preferable to NSAIDs alone. (The 
potential harms of NSAIDs should be carefully considered, 
although such considerations fall outside the non-prescriber’s 
remit.) 
TABLE 3d. Clinical questions and recommendations.  The GRADE levels of recommendation are used. ‘Do it’ or ‘don’t 
do it’ indicate a judgement that most well informed people (i.e. patients) would make. ‘“Probably do it” or “probably don’t 
do it” indicate a judgement that majority of well informed people would make but a substantial minority would not’ 
(GRADE Working Group 2004). For further explanation, see pages 6‒7. 
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Adding physiotherapy elements to combinations of physiotherapy and other treatments 
Question  Recommendation for practice 
3.5.1 In primary and secondary care, should we add outpatient physiotherapy 
(with passive mobilisations) to an intra-articular steroid injection and 
home exercises for both stages of contracted (frozen) shoulder? 
 Probably add outpatient physiotherapy (with passive 
mobilisations) to an intra-articular steroid injection and home 
exercises. 
Adding other treatments to physiotherapy 
Question  Recommendation for practice 
3.6.1 In primary and secondary care, should we add an intra-articular steroid 
injection to outpatient physiotherapy (with passive mobilisations) and 
home exercises for both stages of contracted (frozen) shoulder? 
 Probably add an intra-articular steroid injection to outpatient 
physiotherapy (with passive mobilisations) and home 
exercises. 
3.6.2 In secondary care, should we add MUA to home exercises for both stages 
of contracted (frozen) shoulder? 
 No recommendation for practice. 
TABLE 3e. Clinical questions and recommendations.  The GRADE levels of recommendation are used. ‘Do it’ or ‘don’t 
do it’ indicate a judgement that most well informed people (i.e. patients) would make. ‘“Probably do it” or “probably don’t 
do it” indicate a judgement that majority of well informed people would make but a substantial minority would not’ 
(GRADE Working Group 2004). For further explanation, see pages 6‒7. 
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Facilitators Barriers 
CSP accreditation (assurance of quality) Cost: addition of physiotherapy to home 
exercises has cost implications 
Electronic-only format: easy accessibility for 
those with access to the internet 
Cost: training (e.g. injection therapy, shortwave 
diathermy) 
Cost: the guidelines are free Cost: consumables and equipment  
Advertising (CSP) Availability of resources: e.g. prescriptions for 
injections 
Presentations Electronic-only format: requires internet access 
Workshops Attitudes and beliefs 
Quick reference guide Time 
Patient Information sheet  
Audit tool  
TABLE 3f. Facilitators and barriers to implementation of the guidelines 
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4. Recommendations for research  
 
Approximately half (9/19) of our initially included trials were of low methodological quality and 
carried a moderate-to-high risk of bias. Of these, four were over 20 years old (Bulgen et al 1984, 
Dacre Beeney & Scott 1989; Lee et al 1973), but the remainder were published recently—between 
2004 and 2008—postdating the CONSORT statement for reporting randomised trials (Altman et al 
2001). It is disappointing that the CONSORT recommendations have yet to be generally 
implemented.   
With respect to high quality trials, our survey of CSP members revealed a discrepancy between 
clinicians’ and researchers’ approaches. Clinicians differentiate between stages of contracted 
(frozen) shoulder and use this differentiation to guide their interventions, even though the stages 
have been inconsistently defined. We offered the terms ‘pain-predominant’ and ‘stiffness-
predominant’ contracted (frozen) shoulder, for their clarity and non-ambiguity and, based on these 
terms, our respondents’ choice of clinical interventions was clearly dichotomised. This dichotomy—
or indeed any staged classification—is not usually evident in the research literature. In a number of 
trials in which the stage of the condition appears to have been mixed, and in which interventions, 
comparators or both were physiotherapy, there was no explicit adaptation of treatment according 
to stage. These trials included Ginn and Cohen (2005), among whose physiotherapy treatments 
were a muscle function retraining programme and a package of outpatient physiotherapy with 
passive mobilisations and standard home exercises; Yang et al (2007), who studied high grade 
mobilisations and MWMs; and Pajareya et al (2004), whose trial included physiotherapy with 
passive mobilisations. With all three trials, it is unclear whether the failure to report adaptation of 
treatment by the condition’s stage represents an oversight or a true reflection of the method. In 
either case, the clinical applicability of these trials’ findings is somewhat compromised. It would be 
helpful if, in future, researchers in this area were to report their interventions and comparators in 
sufficient detail to remove ambiguity; and either to focus on a specific stage of contracted (frozen) 
shoulder (we suggest ‘pain-predominant’ or ‘stiffness-predominant’, with pain taking primacy in 
ambiguous cases), or to subgroup their results by the condition’s stage. The last two options might 
reveal therapeutic effects which are too dilute to detect in a generic sample.  
We found a number of trials that used comparators in a way which does not mirror their 
application in practice. This applied particularly to intra-articular steroid injections (Carette et al 
2003, Ryans et al 2005, van der Windt et al 1998), which were employed in studies of apparently 
mixed-stage contracted (frozen) shoulder. It would be interesting to know whether, as theoretical 
principles and clinical usage seem to suggest, such injections would be more efficacious in studies 
(or subgroups) confined to the pain-predominant stage. If so, the relative efficacy of physiotherapy, 
against which the injections were compared, would be reduced.  
For many comparisons, the estimates of effect were too imprecise to allow firm conclusions to be 
drawn: often, the direction of the effect was unclear, as was its clinical importance (see Results). 
For those comparisons considered worth pursuing, the studies require replication with sample sizes 
sufficient to narrow the 95% CIs, render these less ‘fragile’ and facilitate more definitive 
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conclusions. However, implementing this suggestion and some of those made above—i.e. focusing 
on specific stages of contracted (frozen) shoulder or sub-grouping by those stages—would require 
relatively large samples, and we recognise that recruitment to research is problematic. There is a 
strong case for multi-centre trials. 
To a greater or lesser extent, the evidence for the efficacy of interventions may be specific to the 
care settings in which those interventions have been studied. Early on in the guideline 
development, we spent much time arguing about the relative merits of tests and treatments. We 
eventually realised the source of our disagreements: our group had been (deliberately) drawn from 
different care settings, and we were each accustomed to managing different patient populations. It 
is important to bear in mind that, while translating results from one care setting to another will 
often give useful guidance, there is an element of uncertainty inherent in the process. In our 
recommendations for practice we have taken care to clearly state the setting(s) from which the 
evidence was derived. Clearly, many questions remain as to the efficacy of interventions in 
different care settings.  
Lastly, a number of physiotherapy modalities have not been specifically evaluated in relation to 
contracted (frozen) shoulder in any care setting. These include pulsed shortwave diathermy, TENS, 
interferential and ultrasound, although ultrasound has been studied in populations incorporating 
different types of shoulder pain, and consistently found ineffective (Ainsworth et al 2007 and 
review by Hanchard, Cummins & Jeffries 2004). Whether much is to be gained from evaluating the 
remainder in stand-alone fashion is very doubtful, but these interventions may have roles as part of 
therapeutic packages.   
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APPENDIX A: Methods  
i. Types of studies 
We considered for inclusion RCTs and quasi-RCTs, both in the form of full reports only. Abstracts, 
‘letters to the editor’, responses to such letters, commentaries and leaders were not considered.   
ii. Types of participants  
We intended to include in our review a reasonably homogeneous group of patients with contracted 
(frozen) shoulder. To this end we required in each trial report:  
a.  a statement that the sample—or a subgroup with separately reported outcomes—had 
been diagnosed with ‘adhesive capsulitis’, ‘capsulitis’, ‘contracted shoulder’, ‘frozen 
shoulder’ or an equivalent term (but not ‘periarthritis’13). No inclusion criteria were 
required in addition to this statement, but such criteria as were provided had to be 
consistent with a specific diagnosis of contracted (frozen) shoulder: thus inclusion of 
referred pain (from the neck), paraesthesia, painful arc, or pain or weakness on isometric 
actions were not acceptable.  
Alternatively, we required: 
b. that in relation to the sample—or a subgroup with separately reported outcomes—the 
report’s inclusion criteria:  
 should incorporate shoulder stiffness (ideally defining this as present on passive 
movement and affecting external rotation, with or without other movements); but  
 should not incorporate any features of non-capsular causes of shoulder pain (referred 
pain from the neck or paraesthesia, combined neck-shoulder pain, painful arc, or pain 
or weakness on isometric actions).    
iii. Types of interventions 
For the ‘standard physiotherapy’ version of the guidelines, we considered the following 
interventions: 
 advice;  
 exercise therapy; 
 manual therapy; 
                                                          
13
 ‘Periarthritis’ is an ambiguous term, considered by some to be synonymous with contracted (frozen) 
shoulder, but by others to include tendon and bursal disease (see Oxford Concise Colour Medical Dictionary). 
Therefore a diagnosis of ‘periarthritis’ was not an inclusion criterion per se. 
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 electrotherapy;  
 heat or cold treatments; and  
 ultrasound; 
 
regardless of whether these have been used alone, in various combinations, or to supplement 
other interventions (e.g. corticosteroid injection, capsular distension, manipulation under 
anaesthetic).   
iv. Types of comparisons 
We considered comparison with any intervention or combination of interventions, with no 
intervention, or with placebo.    
v. Types of outcome measures  
Patients with frozen shoulder seek help for pain, functional difficulties or both. We therefore 
considered as our primary outcomes:  
1. validated self-report instruments that included questions on shoulder pain and function (e.g. 
DASH, Oxford shoulder score); and 
2. pain scores; whether at rest, at night or during activities; and whether stand-alone (e.g. 100 mm 
VAS, 11-point NPRS) or part of composite shoulder pain and function outcome instruments.  
 
We also considered as primary outcomes:  
 
3. passive or gravity-assisted range of passive external rotation, because restriction of this 
movement is thought to characterise the fact and severity of frozen shoulder more than any 
other single factor; and 
4. adverse effects. 
 
In the absence of 1, above, we considered the following secondary outcomes, in order of 
preference:  
 
5. validated composite subjective/objective outcome measures (e.g. Constant Murley score); 
6. other reportedly ‘primary’ subjective outcome measures  (e.g. patients’ global impression of 
improvement); and 
7. other reportedly ‘primary’ objective outcome measures (e.g. independent assessor’s global 
impression of improvement).  
  
 
99 
vi. Search methods for identification of studies  
We designed our search strategy to cover all interventions that might be undertaken by a 
physiotherapist though, as detailed above, the guidelines will address these in stages, starting with 
‘standard physiotherapy’ in the first version (version 1.X). Our first step was to identify in the 
Cochrane Library (http://www.cochrane.org/) the Cochrane reviews of interest. There were four: 
(1) Buchbinder, Green and Youd (2003) on corticosteroid injections for shoulder pain; (2) 
Buchbinder et al (2008) on arthrographic distension for adhesive capsulitis (frozen shoulder); (3) 
Green, Buchbinder and Hetrick (2003) on physiotherapy interventions for shoulder pain; and (4) 
Green, Buchbinder and Hetrick (2005) on acupuncture for shoulder pain. 
We noted the trials included in these Cochrane reviews, obtained the original reports of these trials 
and, where necessary, filtered out those that were not applicable to the present guidelines. We 
then derived our search strategy from the Cochrane reviews, increasing its specificity to contracted 
(frozen) shoulder as indicated below (see Search strategy), and ran searches on the Ovid MEDLINE, 
AMED, CINAHL and EMBASE databases from 2001 to 09 July 2008, using the OvidSP platform. Thus 
our search period overlapped with that of the earliest of the four Cochrane reviews (Green, 
Buchbinder & Hetrick 2003), whose cut-off for inclusion of trials was June 2002.    
Search strategy  
(The numerals in superscript correspond to the Cochrane reviews listed above, and indicate the 
source of the search terms. Where the original terms were adapted, this is specified.) Note that 
truncation and wildcards were consistent across the OvidSP platform. For database-specific 
comments on the search strategy, see TABLE A1.1. 
  
1. Shoulder Pain/1–4 
2. Shoulder Impingement syndrome/1,3–4 
3. Rotator Cuff/1–4 
4. exp Bursitis/1–4 
5. ((shoulder$ or rotator cuff) adj5 (bursitis or frozen or impinge$ or tendinitis or tendonitis or 
pain$)).mp. 1–4 
6. Rotator cuff.mp. 1–4 
7. adhesive capsulitis.mp. 1–4 
8. or/1–7 
9. exp Rehabilitation/3 
10. exp Physical Therapy Techniques/3 
11. exp Physical Therapy/ 
12. exp Musculoskeletal Manipulations/3 
13. exp Exercise Movement Techniques/3 
14. exp Ultrasonography, Interventional/3 
15. (rehabilitat$ or physiotherap$ or physical therap$ or manual therap$ or exercis$ or ultrasound 
or ultrasonograph$ or TNS or TENS or shockwave or electrotherap$ or mobili$).mp. 3 
16. exp Injections/1 
17. ((an?esthe$ or bupivacaine or corticosteroid$ or hyaluron$ or li?ocaine or ropivacaine or 
steroid$ or sub?acromial) adj5 inject$).mp. 1 (adapted) 
18. exp Acupuncture/4 
19. exp Acupuncture Therapy/4 
20. exp Electroacupuncture/4 
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21. Acupuncture$.mp. 4 (adapted) 
22. Electro?acupuncture$.mp. 4 (adapted) 
23. (Dry adj needl$).mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer name] 
24. Dilatation/2 
25. Arthrography/2 
26. (Arthrographic adj5 distension).mp. 2 
27. Hydrodilat$.mp. 2 
28. or/9–27 
29. Clinical trial.pt.1,3–4 
30. Clinical trial.mp. 
31. random$.mp. 1,3–4 
32. ((single or double) adj (blind$ or mask$)).mp. 1,3–4 
33. placebo$.mp. 1,3–4 
34. or/29–33 
35. 8 and 28 and 34 
36. limit 35 to english language 
37. remove duplicates from 36 
 
 
Line Database 
Ovid MEDLINE AMED CINAHL EMBASE 
9  Term invalid   
10   Term invalid, hence line 11 
inserted 
Term invalid, hence line 11 
inserted 
12   Term invalid  
13   Term invalid  
14   Term invalid Term invalid 
19   Term invalid  
24   Term invalid  
25  Term invalid   
26  Term valid, but test 
returned no results 
  
27  Term valid, but test 
returned no results  
  
29    Term invalid, hence line 30 
inserted 
 
TABLE A1.1. Database-specific comments on the search strategy   
 
After de-duplication, this strategy retrieved 749 citations, most with abstracts. 
Filtering 
Filtering was independently conducted by two reviewers, who resolved any disagreements by 
consensus.  
Preliminary filtering 
In a preliminary filtering process (based on titles and—where these were available—abstracts), we 
included citations which:  
 reported one or more conservative interventions (within the extended scope of physiotherapy 
practice) for intrinsic, musculoskeletal-type shoulder pain unrelated to significant trauma, 
stroke, or systemic inflammatory conditions. 
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We excluded those which:  
 excluded from consideration contracted (frozen) shoulder;  
 focused on peri-operative and post-operative procedures except where these explicitly related 
to the management of contracted (frozen) shoulder e.g. MUA; or 
 were included in any of the four Cochrane reviews underpinning our own.  
 
Secondary filtering 
Secondary filtering was based on titles, abstracts and the full text of reports, as required. We 
included reports on: 
 RCTs and quasi-RCTs. 
 
We excluded reports: 
 
 in which contracted (frozen) shoulder could not be identified as a distinct subgroup;  
 no separate analysis was provided for the contracted (frozen) shoulder subgroup; 
 of trials still in progress; 
 of trials not directly relevant to physiotherapy; or 
 which duplicated other, included, reports.  
vii. Data collection and analysis  
Data extraction was conducted in accordance with an a priori protocol. Data for each included trial 
were extracted on standardised forms by two independent reviewers. The independent reviewers 
also evaluated the risk of bias, using the criteria of Verhagen et al (1998). These Delphi-derived 
criteria are the basis of the PEDro scale (http://www.pedro.fhs.usyd.edu.au/) which is validated for 
RCTs of physiotherapy and was used in the 2003 Cochrane review on physiotherapy interventions 
(Green, Buchbinder & Hetrick 2003). A comparable approach was considered sensible in our own 
review for reasons of consistency. However, Green, Buchbinder and Hetrick (2003) did not present 
summary scores for methodological quality, and neither did we, since numerical methods scores 
have been criticised for their arbitrariness (Cochrane Handbook 2009). 
Where it made sense to do so, we performed meta-analyses. We did not anticipate undertaking 
any sensitivity or subgroup analyses, and did not do so. We did anticipate that the included trials 
would use a range of outcome measures. For dichotomous outcomes (e.g. ‘improved’/‘not 
improved’) we calculated the Relative Risk (RR) and its 95% confidence interval (95% CI). For 
outcomes measured on continuous scales we calculated the Mean Difference (MD) and its 95% CI. 
To pool trials which measured the same outcome but with different tools, e.g. SPADI and SRQ, we 
calculated the Standardised Mean Difference (SMD) and its 95% CI. We then converted the SMD 
and its 95% CIs back into the units of one of the original outcomes, since these are more 
meaningful clinically than the SMD (Cochrane Handbook 2009). To further enhance clinical 
relevance, we reported the Minimal Clinically Important Difference (MCID), if known, for all 
outcomes. We derived within-subject MCIDs from the research literature, but multiplied these by 
0.4. We applied this adjustment because between-groups MCID (i.e. an important difference 
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between groups, as in a controlled trial) is thought to approximate to 40% of that within individuals 
(Finch et al 2002). These processes allowed us to see whether the outcome and its 95% CI (a) 
overlapped zero and (b) overlapped the adjusted threshold for MCID on either side of zero. If the 
95% CI did not overlap zero it could be stated, with 95% confidence, that the intervention had a 
directional effect. Furthermore, a 95% CI that lay entirely beyond the adjusted threshold for a 
MCID could be said, with 95% confidence, to have a clinically important effect favouring that 
intervention. 
If insufficient data were available to calculate these statistics, we reported the fact, but did not 
contact the authors for additional information.  
viii. Questionnaire survey of CSP members 
We conducted a survey of Chartered Society of Physiotherapy (CSP) members in order to: 
 obtain a snapshot of physiotherapists’ approaches to diagnosis and treating contracted 
(frozen) shoulder at the present time, enabling us to:  
o identify the treatment options currently in use and focus on these in our overview 
of interventions (section 1.6);  
o set the overview of interventions in context; 
o establish a baseline against which the guidelines’ impact might be evaluated; and 
 identify discrepancies between practice and research. 
We posted notices on eight special interest networks of the interactive CSP (iCSP) website to whose 
subscribers contracted (frozen) shoulder might be of interest. The notices invited subscribers to 
follow a link to self-administered, on-line questionnaire. The questionnaire required respondents to 
state whether or not they had a ‘special interest’ in contracted (frozen) shoulder, because we were 
interested to see whether this distinction affected the diagnostic and management strategies they 
used; and to differentiate according to whether pain or stiffness was the primary problem.  
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ix. Grading the quality of evidence and strength of 
recommendations from supplementary systematic review of 
interventions 
GRADE system 
Finally, we graded the quality of the evidence and derived our recommendations using the GRADE 
system, which is recommended by the Cochrane Collaboration, transparent, and increasingly in 
standard use. Specifically, we graded the quality of the evidence using GRADEprofiler version 3.2.2 
software, which was developed by the GRADE Working Group 
http://www.gradeworkinggroup.org/index.htm and is available at 
http://www.ims.cochrane.org/revman/gradepro/download. GRADEprofiler facilitates tabulation of 
the results for each outcome, and helps to make judgements on the quality of the available 
evidence transparent. Aspects of quality include: 
 design and limitations (risk of bias); 
  inconsistency (which occurs when trials’ results do not agree); 
 indirectness (which occurs when the trials’ results are inapplicable to the population of 
interest);  
 imprecision (which occurs when the estimates of effect are wide); and  
 publication bias (underestimation or overestimation of effects due to selective publication 
of trials).  
 The resulting tables—GRADE evidence profile tables—are in APPENDIX E.  
Our recommendations for management took the quality of the evidence into account. When 
evidence is graded ‘high’, it means that further research is unlikely to change our confidence in the 
estimated effect; when it is ‘moderate’, further research is likely to influence our confidence in the 
estimated effect, and may change the estimate; when it is ‘low’, further research is very likely to 
seriously influence our confidence in the estimated effect, and is likely to change the estimate; and 
when it is ‘very low’, any estimate of effect is very uncertain. With the quality of the evidence taken 
into account, potential benefits were weighed against potential harms and, if feasible, a 
recommendation for management made. As recommended by the GRADE Working Group, we used 
four classifications of recommendation: ‘do it’, ‘probably do it’, ’probably don’t do it’ and ‘don’t do 
it’. ‘Do it’ or ‘don’t do it’ indicate a judgement that most well informed people (i.e. patients) would 
make. ‘“Probably do it” or “probably don’t do it” indicate a judgement that a majority of well 
informed people would make but a substantial minority would not’ (GRADE Working Group 2004).  
 
‘A recommendation to use or withhold an intervention does not mean that all patients 
should be treated identically. Nor does it mean that clinicians should not involve clinicians in 
the decision, or explain the merits of the alternatives. However, because most well informed 
patients will make the same choice, the explanation of the merits of the alternatives may be 
relatively brief. A recommendation is intended to facilitate an appropriate decision for an 
individual patient or a population. It should therefore reflect what people would likely 
choose, based on the evidence and their own values or preferences in relation to the 
expected outcomes. A recommendation to “probably do something” indicates a need for 
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clinicians to more fully and carefully consider patients’ values and preferences when offering 
them the intervention.’ (GRADE Working Group 2004)  
In instances where the evidence was insufficient to make a recommendation for practice, we 
reserved judgement.  
We have not considered economic data in this iteration of the guidelines. 
x. Ensuring ‘fitness for purpose’ 
 
To ensure the guidelines’ ‘fitness for purpose’ we engaged our diverse target audience to become 
expert panellists in the development process using Delphi methods. Our strategy was as follows. 
 
 The core group wrote the framework of the guidelines.  
 Each of the framework’s three sections was then populated by one subsection: a sample of its 
proposed content.  
 The draft was distributed to the Delphi expert panel, so the panellists could express their 
views (up to six comments each) on the broad structure of the guidelines as well as more 
detailed aspects of their level and style of reporting. 
 The comments were collated and redistributed to the panel, who were asked to indicate 
‘agree’, ‘disagree’ or ‘no opinion’ in relation to each. 
 We proceeded with the guidelines development as directed by the consensus of opinion (the 
majority).      
 
In our opinion, engaging stakeholders in an early, formative role is an improvement on the norm in 
guidelines development.   
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APPENDIX A2: Search and results for diagnostic tests  
Search strategy 
The following search strategy was run across the Medline, CINAHL, AMED and SportDiscus 
databases, from inception to 20 January 2012, in the EBSCO host platform:  
1. TX frozen shoulder 
2. TX adhesive capsulitis 
3. 1 and 2/OR 
4. TX diagnos* 
5. TX test#  
6. 4 and 5/OR 
7. 3 and 6/AND 
(TX = all text) 
Screening criteria 
The screening criteria, based on titles and abstracts in the first instance, were as follows.  
Inclusion criteria 
Category 1 (prospective clinical studies) Reports of prospective, primary, clinical research, available 
in full text, and with explicit reference in the title or abstract to any of the following.  
1.1.  A diagnostic test accuracy study, within the reported study, evaluating physical tests for 
diagnosing contracted (frozen) shoulder against any reference standard (the validity of 
reference standards will be considered on a case-by-case basis).  
1.2.  A diagnostic test accuracy study, within the reported study, evaluating physical tests for 
diagnosing contracted (frozen) shoulder in terms of whether the test outcomes usefully 
inform management. 
1.3.  A primary focus, within the reported study, on describing the baseline presentations of 
specific diagnostic physical tests in a sample of patients with presumptive contracted 
(frozen) shoulder. 
1.4.  A primary focus, within the reported study, on evaluating the reliability of physical tests for 
diagnosing contracted (frozen) shoulder. 
Category 2 (expert opinion based on laboratory studies) 
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2.1.  Expert opinion based on laboratory-based research evaluating physical tests for diagnosing 
contracted (frozen) shoulder. 
Category 3 (expert opinion) 
3.1.  Expert consensus on physical tests for diagnosing contracted (frozen) shoulder. 
3.2.  Individual expert opinion on physical tests for diagnosing contracted (frozen) shoulder.  
Exclusion criteria 
In keeping with the exclusions stated in the guidelines’ protocol (APPENDIX A), we excluded: studies 
whose focus was on shoulder pain associated with stroke, associated with significant trauma 
(fracture or dislocation), secondary to surgery, or associated with systemic inflammatory conditions.   
Also excluded were studies reporting tests which would require specialised equipment for 
replication in the clinical setting, and studies not reported in the English language.  
Search results 
 
Binder et al (1984); Bulgen et al (1984); Carbone et al (2010); Hanchard, Howe and Gilbert (2005); 
Hanchard et al (2011); Kerimoglu et al (2007); Mitsch et al (2004); Mullaney et al (2010); Rundquist 
et al (2003); Rundquist and Ludewig (2004); Tveita et al (2008a); Walmsley, Rivett and Osmotherly 
(2009); Wolf and Cox (2010). 
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APPENDIX B: Table of trials considered for inclusion  
Trial Buchbinder et al (2007) 
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: YES; Groups 
similar at baseline: YES; Blinding of subjects: YES; Blinding of therapists: NO; Blinding of 
assessors: YES; Intention-to-treat: YES; point measures and measures of variability: YES. 
Population 149 patients diagnosed with frozen shoulder: probably a mix of pain-predominant and 
stiffness-predominant. Inclusion criteria: age > 18 years, symptoms of pain and stiffness in 
predominantly 1 shoulder for > 3 months, and restriction of passive motion > 30° in > 2 
planes of movement, measured to onset of pain with a gravity inclinometer. Exclusion 
criteria: pain > 7/10 on VAS at rest; systemic inflammatory joint disease; radiologic evidence 
of shoulder osteoarthritis, fracture, or calcification; reason to suspect a complete rotator cuff 
tear (arm elevation weakness, positive drop arm sign, high-riding humerus on shoulder 
radiograph, or complete rotator cuff tear on ultrasound); contraindications to arthrogram 
and/or distension such as current warfarin therapy; allergy to local anesthetic or iodinated 
contrast; pregnancy; likely not to attend for treatment or comply with follow up; inability to 
partake in moderate exercise; previous post-distension physiotherapy; and lack of written 
informed consent. Mean age ± SD, % female: Physiotherapy group 55 ± 9 years, 68%; 
Placebo group 55 ± 8 years, 58%. Setting Recruitment was from primary care and ‘specialized 
practice’ [secondary or tertiary care]. Trial took place in Victoria, Australia. 
Intervention/ 
Comparison(s) 
Arthrographic joint distension + physiotherapy versus arthrographic joint distension + 
placebo physiotherapy. Arthrographic distension of the glenohumeral joint with steroid and 
normal saline was done under radiologic guidance at one of several community-based 
radiology practices. Patients received physiotherapy or sham physiotherapy from 
experienced physiotherapists, twice weekly for 2 weeks then once weekly for 4 weeks (8 
visits, 30 minutes each). The physiotherapist-patient interaction was standardised. 
Physiotherapy: The goals were to maintain and increase active and passive glenohumeral 
range by stretching soft tissue structures adjacent to the joint; to improve strength, 
particularly within newly gained passive range; and to regain proprioception and normal 
shoulder and trunk biomechanics. Specific interventions included: passive and self-executed 
muscle stretching techniques to stretch muscles passing over the glenohumeral joint, cervical 
and thoracic spine mobilisation, glenohumeral joint passive accessory glides, glenohumeral 
joint passive physiologic mobilisation including rotation, strength and coordination exercises 
for rotator cuff and scapular stabilisers, and proprioceptive challenge. At the end of the 6-
week program, patients were instructed to maintain their 10-minute daily home exercise 
program, recording these sessions in a logbook. Placebo physiotherapy: Patients underwent 
8 sessions of sham ultrasound and application of a non-therapeutic gel. They received no 
instruction in exercise techniques and no manual therapy. This protocol had been used 
previously with successful blinding demonstrated in 81% of placebo-treated participants. 
Accepted 
outcome(s) 
SPADI (a self-administered tool scored out of 100, with higher scores indicating greater pain 
or disability). Overall assessment of pain, pain at night, activity-related pain and pain at rest 
on a 10-point Likert scale. Adverse effects/events by open-ended questions. Timing of 
assessments:  (1) Baseline; (2) End-point: 6 weeks; (3) Follow-up: 12 and 26 weeks.  
Period of data 
collection 
March 2002–April 2005.  
Notes More patients in the placebo group had post-operative capsulitis than those in the active 
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group: 17 (23%) versus 9 (12%). 
Trial Bulgen et al (1984)* 
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: NO; Groups 
similar at baseline: NO; Blinding of subjects: NO; Blinding of therapists: NO; Blinding of 
assessors: YES; Intention-to-treat: NO; point measures and measures of variability: NO. 
Population 42 patients explicitly diagnosed with ‘frozen shoulder’ and apparently at the pain-
predominant stage, since the inclusion criteria stipulate, in addition to restricted active and 
passive movement in all ranges (including > 50% restriction of external rotation), that 
participants be unable to lie on the affected side. Mean age (range), % female: 59 (44–74) 
years, 67%. Setting: Secondary or tertiary care. Trial took place in a Rheumatology Research 
Centre in a UK hospital. 
Intervention/ 
Comparison(s) 
Mobilisation versus ice versus steroid injection versus no treatment. The mobilisation group 
received Maitland’s mobilisations from a research physiotherapist 3 times weekly for 6 
weeks. The steroid injection group received 20 mg methyl prednisolone acetate 20 mg and 
0.5 ml 1% lignocaine hydrochloride injected into the subacromial bursa, and a similar amount 
into the shoulder joint by the anterior route, weekly, for three weeks. The ice group had ice 
packs followed by proprioceptive neuromuscular facilitation (PNF) supervised by the same 
research physiotherapist. All patients were taught pendular exercises and advised to do 
them for 2–3 minutes every hour. Non-salicylate analgesics and diazepam 5 mg at night were 
available as required. 
Accepted 
outcome(s) 
Pain at rest, pain on movement and night pain were initially recorded on a 10 cm VAS and by 
verbal reports: ‘better’, ‘same’, or ‘worse’ (adverse events). The VAS was later abandoned 
but the verbal reports retained. Passive ranges of movement were also measured. Timing of 
assessments: (1) Baseline, (2) In-trial and end-point: weekly for 6 weeks (3) Follow-up: 
monthly for a further 6 months.  
Period of data 
collection 
Unspecified 
Notes Data presentation incompatible with meta-analysis or tabulation, but trial included in review 
by Green, Buchbinder and Hetrick (2003) and the present review for narrative purposes. 
(Bulgen et al. concluded that there was ‘little long term advantage in any of [their] treatment 
regimens over no treatment, but that steroid injections may benefit pain and range of 
movement in the early stages [though not statistically significantly so]. There [appeared] to 
be little place for physiotherapy alone, and, if used, it should not be continued for more than 
four weeks’.) 
Trial Calis et al (2006) 
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: NO; Groups 
similar at baseline: YES; Blinding of subjects: NO; Blinding of therapists: NO; Blinding of 
assessors: NO; Intention-to-treat: YES; point measures and measures of variability: YES. 
Population 95 shoulders diagnosed with adhesive capsulitis in 90 patients. Inclusion criteria: > 1 month’s 
pain; limited active and passive shoulder movement, with decreased range of passive 
movement of > 20% in > 3 ranges; negative Neer’s test. Exclusion criteria: Previous injection 
of involved shoulder; Allergy to local anaesthetics, steroids or sodium hyaluronate; 
coagulation disorders; cervical radiculopathy, fracture dislocation or rotator cuff tears; 
haematological, infectious, neurological, endocrine, cardiovascular, hepatic, renal or 
malignant disease; severe osteoporosis. Mean age ± SD, % female: Group 1 60 ± 10 years, 
58%; Group 2 56 ± 11 years, 64%; Group 3 52 ± 10 years, 62%; Group 4 59 ± 7 years, 70% 
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Setting: Secondary or tertiary care. Trial took place in Erciyes University Medical Faculty, 
Kayseri, Turkey. 
Intervention/ 
Comparison(s) 
Group 1: 30 mg sodium hyaluronate (orthovisc) was injected into the shoulder joint using a 
posterior approach, weekly for 2 weeks. Group 2: 40 Mg triamcinilone acetonide (Kenakort-
A) was injected into the shoulder joint using a posterior approach. Group 3: Physiotherapy 
comprised a 20-minute hot pack, ultrasound at 1.5 W/cm
2
 for 5 minutes, transcutaneous 
electrical nerve stimulation at the patient’s tolerance for 20 minutes and stretching exercises 
daily for 10 days. No other details were given. Group 4: All patients, including control 
patients, were advised on a home exercise programme including stretching and Codman 
(pendular) exercises, and the use of paracetamol if necessary.      
Accepted 
outcome(s) 
Pain severity, measured on a 10 cm VAS; passive external rotation; Constant score. Adverse 
effects/events in individuals were not specified as outcomes. Timing of assessments: (1) 
Baseline: (2) In –trial and end-point: None; (3) Follow-up: 15 days, 3 months.  
Period of data 
collection 
Unspecified 
Notes There were 3 patients with bilateral involvement in Group 1, and 1 in each of Groups 2 and 3.   
Trial Carette et al (2003) 
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: YES; Groups 
similar at baseline: NO*; Blinding of subjects: YES†; Blinding of therapists: YES†; Blinding of 
assessors: YES; Intention-to-treat: YES; point measures and measures of variability: YES.  
 
  *Gender was not evenly distributed between the groups, so analyses were adjusted for this. 
  †In the injection groups.  
  ‡Primary outcome measure, but not secondary outcomes, analysed by intention-to-treat.  
Participants 93 patients aged > 18 and symptomatic < 1 year with adhesive capsulitis. Pain-predominant 
and stiffness-predominant stages were included (but managed differently from the 
physiotherapy perspective – see below). Inclusion criteria: Shoulder pain with limitation of 
both active and passive movements of the glenohumeral joint of > 25% in at least 2 
directions versus the contralateral shoulder or normal values (reference supplied). Patients 
were required to have a total score > 30 on Shoulder Pain And Disability Index (SPADI). 
Exclusion criteria: Capsulitis secondary to another cause including inflammatory, 
degenerative, metabolic or infectious arthritis, CVA or fracture; known blood coagulation 
disorder or allergy to radiologic contrast material. From March 1997, recruitment difficulties 
led to the acceptance of patients with diabetes mellitus. Mean age ± SD, % female:  Group 1 
55 ± 10 years, 65%; Group 2 57 ± 9 years, 61%, Group 3 55 ± 11 years, 67%; Group 4 54 ± 8 
years, 46%. Setting: Secondary care. Trial took place in outpatient rheumatology clinics in 7 
centres across Quebec and Ontario, Canada. 
Intervention/ 
Comparison(s) 
Before randomisation, the physiotherapists responsible for baseline and follow up 
assessments taught all patients a 10-minute home exercise programme to be done twice 
daily for 3 months. This included active and auto-assisted exercises in all ranges. Advice 
about intensity, frequency, progression of the exercises, heat and ice applications, and 
suitable shoulder positions was also given. Compliance was diarised during the first 3 months 
of the trial. Injections were done under fluoroscopic guidance by trained radiologists on the 
day of randomisation and comprised, in Group 1, 40 mg triamcinilone hexacetonide (2 ml) 
or, in Group 2, isotonic saline (2 ml). The syringes were prepared by the hospital pharmacist 
and covered in foil so that neither the injector nor the patient knew what substance was 
injected. Patients randomised to Groups 3 and 4 received injection + physiotherapy, starting 
their physiotherapy programme 1 week after injection (of triamcinilone or saline). This 
comprised 3 x 1-hour sessions given each week for 4 weeks (12 sessions). Physiotherapy 
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differed according to whether the capsulitis was ‘acute’ (meeting > 3 of the following criteria) 
or ‘chronic’: (1) pain at rest > 4 cm on a 10 cm VAS; (2) pain at rest present > 75% of the day; 
(3) pain on active shoulder elevation > 4 cm on a 10 cm VAS; (4) night pain; (5) spasm or 
‘empty’ end-feel in at least 2 directions of passive motion. Patients with acute adhesive 
capsulitis received TENS followed by mobilisation techniques, active ROM exercises and ice 
application. Those with chronic adhesive capsulitis received ultrasound (to heat the deep 
joint structures) prior to mobilisation techniques, active and auto-assisted ROM techniques, 
isometric strengthening exercises and ice application. The 14 physiotherapists who took part 
in the trial (2 per centre) were each experienced in shoulder conditions and mobilisation 
techniques and each attended a 1-day training session before the trial for standardisation. 
Patients and their GPs were asked to limit concurrent interventions: all medications other 
than acetaminophen were stopped. A supply of the latter was given to patients with a form 
to record their use. Information on acetaminophen or other medication use was obtained at 
each follow-up. 
Accepted 
outcomes 
Shoulder Pain And Disability Index (SPADI) with decrease in total score > 10 indicating 
clinically significant improvement in shoulder pain and function; and an increase > 10 
indicating worsening of shoulder pain and function (reference given). Passive external 
rotation measured with a hydrogoniometer. Usually, each patient was measured by the same 
physiotherapist, blind to treatment allocation, through the trial. Adverse effects/events in 
individuals were not specified as outcomes. Timing of assessments: (1) Baseline: SPADI and 
passive external rotation (2) End-point: SPADI at 6 weeks (primary outcome) and passive 
external rotation at 6 weeks (secondary outcome); (3) Follow-up: SPADI and passive external 
rotation at 3, 6 and 12 months (secondary outcomes).   
Period of data 
collection 
November 1996 – June 2000 
Notes  
Trial Cheing, So and Chao (2008) 
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: NO; Groups 
similar at baseline: YES; Blinding of subjects: NO; Blinding of therapists: NO; Blinding of 
assessors: YES; Intention-to-treat: NO; point measures and measures of variability: YES. 
Participants 70 patients diagnosed with idiopathic frozen shoulder by an orthopaedic surgeon. The stage 
appears to have been pain-predominant since the Inclusion criteria state night pain, in 
addition to localised pain over one shoulder and restricted active and passive shoulder ROM. 
Exclusion criteria: History of trauma; fractures; history of shoulder surgery; cervical or 
thoracic pain syndrome; complex regional pain syndrome; malignancy; anticoagulant 
therapy; or acupuncture to the affected shoulder in the past 6 months. Age range, % female: 
33–90 years, 83%. Setting: Secondary or tertiary care. Trial took place in Hong Kong. 
Intervention/ 
Comparison(s) 
Electro-acupuncture: Patients received 10 sessions (2–3 times weekly) from the same 
physiotherapist (accredited to practice acupuncture) over a 4-week period. Following skin 
sterilisation with an isopropyl skin wipe, sterile, stainless steel acupuncture needles (0.30 x 
40 mm) were inserted 15–25 mm intramuscularly into 3 acupoints including one trigger 
point, one local point (LI 15: Jianyu) and one distal point (ST38: Tiaokou). Trigger points were 
identified by areas of greatest tenderness around the painful shoulder. Needles were 
stimulated manually until the patient felt a needling response (de qi) locally. The two needles 
in the shoulder region were connected to an EA device and stimulated with an alternating 
frequency of 2–100 Hz at a pulse duration of 100–400 microseconds for 20 minutes. The 
intensity was adjusted to just below the threshold of pain. The distal needle was retained for 
20 minutes and manually lifted and thrusted every 10 minutes. At the first session patients 
were taught a home exercise programme. This involved following a chart and performing a 
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standard set of shoulder mobilising exercises 5 times daily. The exercises comprised active 
assisted: flexion (using an overhead pulley), external rotation (using a cane), horizontal 
adduction (posterior capsular stretch) and internal rotation (using a towel). Each patient was 
given an exercise registration card to monitor compliance and asked to continue the exercise 
programme until the 6-month review. Interferential electrotherapy (IFE). These patients 
received 10 sessions of IFE over 4 weeks. A Phyaction Guidance E Unit was used to deliver 
current sweeping from 80–120 Hz via 4 suction electrodes in a co-planar arrangement 
around the shoulder region. The intensity was adjusted to just below pain threshold and the 
duration was 20 minutes. The patients were instructed to perform ‘the same set of home 
exercise programmes’ as those in the EA group, and an exercise registration care was also 
given to each subject. Control. These patients received no treatment for 4 weeks, but were 
invited to attend the assessment sessions at baseline and at the end of the fourth week. 
Afterwards, they received regular physiotherapy from other physiotherapists: no further data 
were extracted from them.                   
Accepted 
outcomes 
Constant Murley Assessment Score; VAS for pain ‘at the moment’. Adverse effects/events in 
individuals were not specified as outcomes. Timing of assessments: (1) Baseline; (2) End-
point: 4 weeks; (3) Follow-up (for the electro-acupuncture and IF groups only): 8, 12, and 24 
weeks.  
Period of data 
collection 
Unspecified 
Notes  
Trial Dacre, Beeney and Scott (1989)* 
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: NO; Groups 
similar at baseline: YES; Blinding of subjects: NO; Blinding of therapists: NO; Blinding of 
assessors: YES; Intention-to-treat: NO; point measures and measures of variability: NO. 
Population 62 patients with ‘painful stiff shoulder’ apparently at the pain-predominant stage, since the 
Inclusion criteria state painful stiff shoulder for > 4 weeks, and pain at night causing sleep 
disturbance and inability to lie on the affected side, in addition to inability to use the affected 
arm with restriction of movement and loss of full function. Exclusion criteria: predisposing 
causes such as stroke, generalised arthritis, or cervical spondylosis; or highly localised lesions, 
such as bicipital tendinitis. Mean age, % female: 60 years, 55%. Setting: Secondary or 
tertiary care. Trial took place in London, England.  
Intervention/ 
Comparison(s) 
Physiotherapy alone versus steroid injection alone versus a combination of the two. 
Physiotherapy was performed for 4–6 weeks by one therapist who was free to choose the 
method, though mobilisation was the mainstay. Steroid injections comprised 20 mg 
triamcinolone ‘injected anteriorly around the shoulder joint’ by one physician. 
Accepted 
outcome(s) 
Pain assessed on a 10 cm visual analogue scale, with separate scores for day pain, night pain, 
and pain during active and passive movement. Passive movement of both affected and 
unaffected shoulders measured with a goniometer included glenohumeral external rotation. 
Adverse effects/events in individuals were not specified as outcomes. Timing of assessments: 
(1) Baseline; (2) End-point: 6 weeks; (3) Follow-up: 26 weeks. 
Period of data 
collection 
Unspecified 
Notes Only illustrative examples of results were given, in graphic form, and it was not possible to 
accurately impute quantitative values to these. This data presentation was incompatible with 
meta-analysis or tabulation but trial included in review by Green, Buchbinder and Hetrick 
(2008) and the present review for narrative purposes. The authors concluded: ‘No treatment 
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showed any advantage which was clinically relevant and significant at the 5% level.’ 
Trial Ginn and Cohen (2005)  
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: YES; Groups 
similar at baseline: YES; Blinding of subjects: NO; Blinding of therapists: NO; Blinding of 
assessors: YES; Intention-to-treat: NO; point measures and measures of variability: YES. 
Population 138 volunteers with shoulder pain, of whom 77 had decreased abduction and/or flexion. 
Inclusion criteria: Unilateral pain over the shoulder and/or upper arm > 1 month’s duration 
and aggravated by active shoulder movements; able to understand spoken English. Exclusion 
criteria: Bilateral shoulder pain; shoulder instability; shoulder pain due to inflammatory or 
destructive disease or trauma in the preceding 4 weeks; referred pain from the spine. Mean 
age and range and % female (for whole sample): 55 years (22–90), 41%. Setting: Secondary 
care. Trial took place in a metropolitan public hospital in Sydney, Australia. 
Intervention/ 
Comparison(s) 
Multiple treatment modalities (MTM): Patients attended twice weekly for treatment, 
specifics of which were at the discretion of their treating physiotherapist (n = 6). 
Electrotherapy options were interferential, ultrasound, hot packs and ice packs. Passive 
mobilisation of the shoulder, sternoclavicular and acromioclavicular joints were also 
permissible. Range-of-motion exercises, which could be conducted with or without 
equipment, and which were not required by the protocol to be pain free, focused on 
abduction, flexion, extension, horizontal flexion and hand-behind back, all with excessive 
scapular movement discouraged. Exercises were progressed from active-assisted through 
active to resisted. Patients were also instructed in a daily home exercise programme. Steroid 
injection: A single injection of 40 mg methylprednisolone acetate and lidocaine was given 
subacromially. Afterwards, the patient was asked to use the shoulder normally. Target 
exercise treatment: This was a daily home routine aimed at restoring normal muscle function 
and hence dynamic stability and muscle co-ordination. It involved stretching shortened 
muscles, strengthening weakened muscles, improving co-ordination between muscles, and 
retraining scapulohumeral rhythm. Exercises were required to be pain free. Specific exercises 
in each case were chosen by the treating physiotherapist (n = 2), who reviewed the patient 
weekly for monitoring and progression. 
Accepted 
outcome(s) 
The only outcome reported for the painful stiffness subgroup was perceived change: 
‘improved’, ‘stable’ or ‘deteriorated’. This therefore included adverse events. Timing of 
assessments: (1) Baseline; (2) End-point: 5 weeks; (3) Follow-up: None. 
Period of data 
collection 
46-month period: dates unspecified. 
Notes  
Trial Guler-Uysal and Kozanoglu (2004) 
Methods Eligibility criteria specified: YES; Random allocation: NO; Concealed allocation: YES; Groups 
similar at baseline: YES; Blinding of subjects: NO; Blinding of therapists: NO; Blinding of 
assessors: YES; Intention-to-treat: NO; point measures and measures of variability: YES. 
Population 40 patients (28 female; age range 43–82 years, mean 56 ± 8.6 years) diagnosed with shoulder 
capsulitis, probably a mix of pain-predominant and stiffness-predominant. Inclusion criteria: 
Shoulder pain > 2 months with no major shoulder trauma, marked loss of active and passive 
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shoulder motion, VAS score > 30 mm, normal AP and axillary lateral radiographs of the 
shoulder joint. Exclusion criteria: Polyarthritis, neurological disease or cervical neuropathy, 
medical conditions such as cardiac disease, infections, coagulation disorders, adhesive 
capsulitis secondary to shoulder dislocation, fracture, reflex sympathetic dystrophy or rotator 
cuff tears. Mean age ± SD, % female: 56 ± 9 years, 70%. Setting: Secondary or tertiary care. 
Trial took place in a physical medicine department in Adana, Turkey.     
Intervention/ 
Comparison(s) 
2 groups of 21 each. The Cyriax group received 3, 1-hour sessions weekly, comprising ‘deep 
friction massage and manipulation’ performed by the same experienced physical therapist.  
The physical therapy group were invited to the hospital every weekday for a 1-hour session 
comprising hot packs wrapped in towelling (20 minutes) and continuous SWD (20 minutes). 
Both groups performed active stretching and pendular exercises after each session, and were 
instructed in a standardised home exercise programme comprising passive ROM and 
pendular exercises to be performed daily. Use of NSAIDs or analgesic was not permitted 
throughout the trial. 
Accepted 
outcome(s) 
Physical assessment was repeated by the same blinded observer. ROM was measured using a 
long-arm goniometer, and the patient supine, after every session. (It is unclear who 
performed these measurements). Treatments were stopped when 80% of normal range was 
attained. Attainment of 80% of normal range was therefore the trial’s primary outcome. 
Normal range was taken as 180º for flexion and abduction, 70º for internal- and 90º for 
external rotation (rotations being measured in 90º of shoulder abduction); so that minimum 
ranges of 150º, 150º, 55º and 70º, respectively, were required for a patient to be considered 
‘recovered’. Other accepted outcomes are spontaneous pain, pain on motion, and night pain 
on a 100 mm VAS, and passive range of external rotation (measured at 90º of abduction with 
a long-armed goniometer). Adverse effects/events in individuals were not specified as 
outcomes. Timing of assessments: (1) Baseline, (2) In-trial and end-point: 1 and 2 weeks; (3) 
Follow-up: None.   
Period of data 
collection 
Unspecified 
Notes This is a perplexing study, because deep transverse friction, while originated by Cyriax, was 
not applied by him to contracted (frozen) shoulder. Details of the technique, not provided in 
the report, are therefore not available in the source cited. Moreover the term ‘manipulation’ 
is undefined. 
Study Johnson et al (2007)  
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: YES; Groups 
similar at baseline: YES; Blinding of subjects: NO; Blinding of therapists: NO; Blinding of 
assessors: NO; Intention-to-treat: NO; point measures and measures of variability: YES. 
Population 18 patients diagnosed with adhesive capsulitis or frozen shoulder by any of 4 orthopaedic 
surgeons and referred for outpatient physiotherapy. Probably a mix of pain-predominant and 
stiffness predominant. Inclusion criteria: External rotation restriction that worsened with 
shoulder abduction, idiopathic or primary adhesive capsulitis (i.e. insidious onset with no 
history of major trauma but not excluding minor injuries), unilateral, age 25–80 years, 
normal X-ray within the previous 12 months. Exclusion criteria: External rotation restriction 
that lessened with shoulder abduction, previous shoulder surgeries to the affected shoulder, 
previous manipulations under anesthesia of the affected shoulder, shoulder girdle motor 
control deficits associated with neurological disorders (eg, stroke, or Parkinson’s disease). 
Mean age ± SD, % female: Anterior mobilisation group 55 ± 8 years, 80%; Posterior 
mobilisation group 50 ± 7 years, 75%. Setting: Secondary or tertiary care. Study took place in 
California, USA.   
 
  
 
115 
Intervention/ 
Comparison(s) 
Anterior mobilisation group: 6 therapy sessions (2–3 per week) comprising therapeutic 
ultrasound to the anterior capsule (typically 3 MHz at 1.5 W/cm
2
 continuous for 10 minutes, 
intended to heat the capsule) then anterior mobilisations. During lateral traction, Kaltenborn 
grade III mobilisations were performed at the end-range of available combined abduction 
and external rotation, with non-oscillatory stretches of > 1 minute. Each session included a 
total of 15 minutes’ sustained stretch. This was followed by upper body ergometer exercise 
in pain-free flexion range to reduce post-mobilisation soreness. Posterior mobilisation 
group: as above except that ultrasound (1 MHz) was applied to the posterior capsule, (1 
MHz), the mobilisation was posterior, and the starting position was progressed to maximum 
flexion and external rotation. Both groups: Handout instructions were given on pain free 
activities of daily living on entering the study.   
Accepted 
outcome(s) 
5 items of the 21-item self-assessment function questionnaire developed by L’Insalata et al 
(full reference given). Adverse effects/events in individuals were not specified as outcomes. 
Timing of assessments: (1) Baseline; (2) End-point: 2 or 3 weeks; (3) Follow-up: None.   
Period of data 
collection 
October 2003 – January 2005 
Notes  
Study Khan et al (2005) 
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: NO; Groups 
similar at baseline: YES; Blinding of subjects: NO; Blinding of therapists: NO; Blinding of 
assessors: NO; Intention-to-treat: NO; point measures and measures of variability: NO. 
Population 35 patients attending outpatients of the Departments of Physical Medicine or Department of 
Radiology of a tertiary referral medical college. Probably a mix of pain-predominant and 
stiffness-predominant frozen shoulder, thus: Inclusion criteria: Age 13–69 years, shoulder 
pain > 1 month, restricted movement. Exclusion criteria: Lack of consent, trauma to or 
around the shoulder in the past 2 months, pain and restriction of the shoulder secondary to 
indentified causes (e.g. hemiplegia, cervical radiculopathy, IHD, rheumatological syndromes, 
infective conditions, reflex sympathetic dystrophy, part of a systemic illness), pregnancy and 
lactation. Mean age ± SD, % female: Arthrography group 50 ± 17 years, 50%; Physiotherapy-
only group 50 ± 10 years, 35%. Setting: Tertiary care. Study conducted in Bangladesh, India.  
Intervention/ 
Comparison(s) 
Arthrography group: A posterior approach was made using a 24 G needle: 2 cc  xylocaine, 10 
cc 75% urovideo and 1 cc (40 mg) depot medrol, drawn together in normal saline were 
injected under fluoroscopic guidance. All patients received physiotherapy: comprising 
therapeutic exercises (hold-relax, rotator cuff, pulley, pendular and wall-climbing exercises), 
TENS 3 days a week and infra-red 3 days a week. Length of course of physiotherapy is 
unspecified.     
Accepted 
outcome(s) 
Pain scored on a 0–100 VAS. Adverse events: exacerbations in pain reported on an individual 
basis. Timing of assessments: (1) Baseline; (2) In-trial: Every visit; (3) Follow-up: 8 weeks.   
Period of data 
collection 
December 1996–November 1997 
Notes 
 
Study Kivimäki et al (2007)  
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: YES; Groups 
similar at baseline: YES; Blinding of subjects: NO; Blinding of therapists: NO; Blinding of 
assessors: YES; Intention-to-treat: YES; point measures and measures of variability: YES. 
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Population 125 patients with stiff, painful shoulders recruited from 3 regional hospitals. Probably a mix 
of pain-predominant and stiffness-predominant frozen shoulder. Inclusion criteria: Adult 
patients with gradually increasing shoulder pain and stiffness screened on the basis of X-ray 
and physical examination by physical medicine and rehabilitation specialists; < 140º elevation 
and < 30º passive external rotation. Exclusion criteria: arthritis, traumatic bone or tendon 
changes. Suspected cuff tears were ultrasound scanned and, if confirmed, excluded.  Mean 
age ± SD, % female: Manipulation group 53 ± 8 years, 71%; Control group 53 ± 9 years, 65%. 
Setting: Secondary or tertiary care. Study took place in Southern Finland.  
Intervention/ 
Comparison(s) 
The manipulation group underwent manipulation under anaesthetic within 2 weeks of 
randomisation. With the patient supine, the physician elevated the humerus into scaption 
while supporting the scapula against the patient’s thoracic cage. In the elevated position, the 
humerus was gently rotated internally and externally. Any cracking sound was recorded. 
Normal or near-normal mobility was attained during these procedures. The manipulation 
and control groups received physiotherapy advice in 2 sessions and written instructions for a 
daily training, which included pendular exercises and stretching techniques for the shoulder 
joint.  
Accepted 
outcome(s) 
Modified Shoulder Disability Questionnaire (with 2 questions omitted from the standard 16-
point questionnaire), pain intensity on an 11-point scale, passive external rotation using a 
universal goniometer. Adverse effects/events in individuals were not specified as outcomes. 
Timing of assessments: (1) Baseline; (2) End-point: None; (3) Follow-up: 3, 6 and 12 months.      
Period of data 
collection 
June 1999–September 2002 
Notes 
 
Study Lee et al (1973)* 
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: YES; Groups 
similar at baseline: NO; Blinding of subjects: NO; Blinding of therapists: NO; Blinding of 
assessors: YES; Intention-to-treat: NO; point measures and measures of variability: NO. 
Population 80 outpatients (gender unspecified) with ‘periarthritis’ of the shoulder, defined as pain with 
limitation of passive movement. Probably a mix of pain-predominant and stiffness-
predominant frozen shoulder. Age and % female: not stated in original article, but mean age 
reported as 58 years by Green, Buchbinder and Hetrick (2000), presumably following 
correspondence with authors. Setting: Secondary or tertiary care. Study took place in Leeds, 
England.     
Intervention/ 
Comparison(s) 
4 groups of 20 each. Group 1 received a course of infrared and graduated active exercises 
according to tolerance. Group 2 received an intra-articular injection of 25 mg hydrocortisone 
acetate via the anterior approach below the coracoid process, followed by the same 
graduated exercises. Group 3 received an injection of 25 mg hydrocortisone acetate into the 
biceps tendon sheath, followed by the same graduated exercises. Group 4 was a control and 
received only analgesia. 
Accepted 
outcome(s) 
Movements measured were active external and internal rotation with the arm by the side 
and active and passive abduction; but a single outcome was generated from these 
components. Adverse effects/events in individuals were not specified as outcomes. Timing of 
assessments: (1) Baseline; (2) In-trial and end-point: weekly for 6 weeks (for groups 1–3) and 
6 weeks (for group 4); (3) Follow-up: None.      
Period of data 
collection 
Unspecified 
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Notes Group averages (means?) were presented graphically without error bars. There was no 
statistical analysis. This data presentation was incompatible with meta-analysis or tabulation 
but the trial was included in the review by Green, Buchbinder and Hetrick (2008) and the 
present review for narrative purposes. (The active intervention groups all fared better than 
the control at every time point; among these groups, that receiving intra-articular injection 
plus exercises fared best. Injection of the biceps tendon sheath conferred no benefit over 
heat and exercises alone: in both of these groups benefits reached a plateau at week 3.) 
Study Leung and Cheing (2008) 
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: YES; Groups 
similar at baseline: YES; Blinding of subjects: NO; Blinding of therapists: NO; Blinding of 
assessors: YES; Intention-to-treat: YES; point measures and measures of variability: YES. 
Population 30 patients suffering from ‘stiffness phase’ [stiffness-predominant] idiopathic frozen shoulder 
as diagnosed by an orthopaedic surgeon. Inclusion criteria: Shoulder pain and limited 
movement for at least 8 weeks. Exclusion criteria: History of trauma to the shoulder, acute 
signs of inflammation over the shoulder, intrinsic shoulder pathology, taking analgesic or 
anti-inflammatory drugs, metal implants, impaired sensation of hot and cold, pregnancy or a 
cardiac pacemaker. Mean age ± SD, % female: 60 ± 13 years, 70%. Setting: Secondary or 
tertiary care. Study took place in Hong Kong. 
Intervention/ 
Comparison(s) 
Shortwave diathermy (SWD). SWD was applied by the through-and-through method, with 
subjects seated. Intensity was adjusted until comfortable warmth was perceived, and this 
perception was maintained by further adjustments throughout the treatment if necessary. 20 
minutes treatment was given 3 times a week for 4 weeks. Hot pack. An electrical 35.5 x 68.5 
hot pack was used, with its temperature set at 63º C. Patients were instructed that only 
comfortable warmth should be perceived, and the temperature was adjusted as necessary to 
maintain this perception throughout the treatment. 20 minutes treatment was given 3 times 
a week for 4 weeks. Immediately after either heat treatment, patients were asked to perform 
4 stretching exercises in a fixed sequence: external rotation; flexion; hand behind the back; 
and horizontal adduction (posterior capsular stretch). Each stretch was sustained for 30 sec, 
followed by 10 sec rest, and repeated 4 times. Patients were asked to repeat the stretches at 
home every day. A therapist checked for compliance with the exercise regime. In the 
stretching exercises only group, the procedure was identical.    
Accepted 
outcome(s) 
Measures included the American Shoulder and Elbow Surgeons Assessment form (ASES). This 
has a patient self-completed section designed to measure pain and functional limitation, 
(reference given). A further section of the ASES was physician-completed, and involved 
measurement of ROM. Data for external rotation were separately reported, but unclear was 
whether this was passive or active range. All assessments were performed by the same 
physiotherapist who was blinded to subject and intervention order throughout. Adverse 
effects/events in individuals were not specified as outcomes. Timing of assessments: (1) 
Baseline; (2) In-trial and end-point: Week 2 and 4; (3) Follow-up: Week 8.        
Period of data 
collection 
Unspecified 
Notes  
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Study Nicholson (1985)* 
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: NO; Groups 
similar at baseline: YES; Blinding of subjects: NO; Blinding of therapists: NO; Blinding of 
assessors: YES; Intention-to-treat: NO; point measures and measures of variability: YES. 
Population 20 patients explicitly diagnosed with ‘adhesive capsulitis’ as indicated by the presence of 
shoulder pain and limited passive movement at the glenohumeral joint. Probably a mix of 
pain-predominant and stiffness-predominant stages. Mean age (range), % female: 53 (20–
77 years), 50%. Setting: Care setting unclear. Study took place in Alabama, USA. 
Intervention/ 
Comparison(s) 
A 4-week course of mobilisation plus active exercises versus active exercises alone. Choice of 
mobilisation techniques was based on assessment of accessory movements on a patient-by-
patient basis. 
Accepted 
outcome(s) 
Measurements included: completion of a pain questionnaire, of which no further details are 
given; active internal and external rotation and abduction; and passive abduction. Adverse 
effects/events were not specified as outcomes. Timing of assessments: (1) Baseline; (2) In-
trial and end-point: Weekly for 4 weeks; (3) Follow-up: None.         
Period of data 
collection 
Unspecified 
Notes Included in review by Green, Buchbinder and Hetrick (2003). 
Study Pajareya et al (2004) 
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: YES; Groups 
similar at baseline: YES; Blinding of subjects: NO; Blinding of therapists: NO; Blinding of 
assessors: YES; Intention-to-treat: YES; point measures and measures of variability: YES. 
Population 122 patients attending an orthopaedic and rehabilitation clinic. Inclusion criteria: Shoulder 
pain and limitation of passive shoulder ROM in all directions that interfered with ADL. 
Attending the orthopaedic and rehabilitation clinic. Exclusion criteria: Secondary adhesive 
capsulitis; ‘intrinsic’ causes of shoulder problems such as history of fracture or dislocation, or 
‘extrinsic’ causes such as neuromuscular disorders, generalised arthritis, bilateral 
involvement, contraindications to NSAIDs or susceptibility to bleeding. Mean age ± SD, % 
female: Control group 58 ± 10 years, 76%; Physiotherapy group: 56 ± 11 years, 60%. Setting: 
Secondary or tertiary care. Study took place in Siriraj Hospital, Thailand.  
Intervention/ 
Comparison(s) 
Control group received ibuprofen 400 mg 3x daily for 3 weeks and an information sheet. This 
gave advice on protecting the shoulder from vigorous activities such as pushing or pulling. 
They were advised to use their arms normally for reaching and other ADL. They were asked 
to have no adjuvant therapy for the duration of the study except oral acetaminophen (up to 
6g/day). They were asked to record if they received additional treatment [additional to 
acetaminophen?] and to keep a home exercise diary. Physiotherapy group: in addition to the 
above received a hospital-based physiotherapy programme, 3 x weekly by one of 3 research 
physiotherapists using standardised technique. Each session comprised: 20 minutes’ 
shortwave diathermy (no further details given) then mobilisation and passive stretching to 
tolerance. If pain occurred before end-range, exercise (see below) was considered 
contraindicated, but the subsequent management of any such patients is unspecified.  On 
non-physiotherapy days members of the physiotherapy group were advised to apply a hot 
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pack for 20 minutes, then, after 5 minutes’ interval, to do active assisted pulley exercises for 
5 min, and active exercises using a towel and wall.   
Accepted 
outcome(s) 
SPADI. (External rotation was measured, but unclear was whether this was passive or active 
range.) Adverse events: The physiotherapy group were asked (a) whether or not they 
experienced pain for > 2 hours after treatment and (b) whether they had more disability next 
morning; All patients were asked by a blinded rater ‘Have the trial drugs and/or treatment 
programme upset you in any way?’ and examined for signs of bruises or burns during 
evaluation of movement. Timing of assessments: (1) Baseline; (2) End-point: 3 weeks; (3) 
Follow-up: 6, 12 and 24 weeks, though an undefined outcome – ‘successful treatment’ – was 
used, and any treatment was allowed after week 3.           
Period of data 
collection 
January–September 2001 
Notes  
Study Ryans et al (2005) 
Methods 
Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: YES; Groups 
similar at baseline: YES; Blinding of subjects: NO; Blinding of therapists: YES; Blinding of 
assessors: YES; Intention-to-treat: NO; point measures and measures of variability: YES. 
Population 80 adults recruited from 20 local general practices. Probably a mix of pain-predominant and 
stiffness-predominant frozen shoulder, thus: Inclusion criteria: > 18 years, painful shoulder in 
C5 distribution, > 4 weeks’ but < 6 months’ duration, limitation of active and passive ROM > 
25% in both abduction and external rotation compared with the other shoulder. Exclusion 
criteria: Previous intra-articular injection or physiotherapy for this episode, evidence of 
glenohumeral arthritis on plain X-ray, clinical evidence of a complete cuff tear or significant 
cervical spine disease, history of significant trauma to the shoulder, inflammatory joint 
disease or a CVA affecting the shoulder, bilateral adhesive capsulitis. Mean age ± SD, % 
female: Group A 56 ± 6 years, 45%; Group B 52 ± 9 years, 68%; Group C 53 ± 8 years, 70%; 
Group D 55 ± 9 years, 53%. Setting: Primary care. Study took place in Belfast, Northern 
Ireland. 
 
Intervention/ 
Comparison(s) 
Injection group. 3 ml comprising 1 ml triamcinilone (20 mg) and 2 ml normal saline was 
injected, half by an anterior approach (anterior glenohumeral) and half by a lateral approach 
(lateral subacromial), without guidance, by a single clinician. Physiotherapy group. 8 
standardised sessions were given over 4 weeks by a single therapist or a nominated deputy. 
The sessions included PNF, Maitland mobilisations –which were progressed as the condition 
improved – standardised interferential and active exercise therapy using gym equipment. For 
patients receiving injection and physiotherapy, the interval between the two is unspecified. 
General. Patients who were not already taking analgesics were advised to take 1 or 2 500 mg 
paracetamol tablets 4–6 hourly as required, up to a maximum of 8 tablets a day. Analgesics 
and NSAIDs taken were recorded in a medication diary. Patients were taught a home exercise 
programme using a video and instruction sheet. They were asked to make a record, in their 
medication diary, of when they did the programme.     
Accepted 
outcome(s) 
22-point Shoulder Disability Questionnaire (SDQ), 100 mm VAS for daytime pain at rest, 
passive external rotation (to nearest 2º) using a Myrin™ OB goniometer. Adverse 
effects/events in individuals were not specified as outcomes. Timing of assessments: (1) 
Baseline; (2) End-point: None; (3) Follow-up: 6, 16 and 24 weeks (but results not presented 
for 24 weeks).         
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Period of data 
collection 
October 1998–April 2002 
Notes  
Study Van der Windt et al (1998)* 
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: YES; Groups 
similar at baseline: YES; Blinding of subjects: NO; Blinding of therapists: NO; Blinding of 
assessors: YES; Intention-to-treat: YES; point measures and measures of variability: YES. 
Population 108 patients visiting one of 60 participating GPs. Probably a mix of pain-predominant and 
stiffness-predominant frozen shoulder, thus: Inclusion criteria: Painful, limited passive 
glenohumeral mobility, with external rotation relatively more restricted than abduction and 
internal rotation. Exclusion criteria: Indications that any condition other than ‘capsular 
syndrome’ was contributory to symptoms were regarded as an exclusion criterion. Other 
exclusions were bilateral symptoms; a steroid injection or physiotherapy in the preceding 6 
months; contraindications to treatment; surgery, dislocation, or fractures in the shoulder 
region; insulin dependent diabetes; systemic disorders of the musculoskeletal system; 
neurological disorders. Mean age ± SD, % female: Injection group 58 ± 10 years, 47%; 
Physiotherapy group 60 ± 11 years, 59%. Setting: Primary care. Study took place in the 
Netherlands. 
Intervention/ 
Comparison(s) 
Up to 3 intra-articular injections of 40 mg triamcinilone acetonide, by the posterior route, 
over 6 weeks versus 12, 30-minute physiotherapy sessions over 4 weeks comprising passive 
joint mobilisations and exercises and, optionally, ice, hot packs, or electrotherapy. 
Acupuncture, high-velocity thrusts and ultrasound were not permitted. Patients were 
allowed to continue taking drugs for pain if they had started before enrolment, and drugs 
could also be prescribed for severe pain. 
Accepted 
outcome(s) 
Measures included: 16-item Shoulder Disability Questionnaire (SDQ); 100-point VAS for day 
and night pain and improvement in passive range of external rotation. Adverse 
effects/events were recorded by the clinician and by patients on their own forms. Timing of 
assessments: (1) Baseline; (2) In-trial and end-point: 3 weeks; (3) Follow-up: 7, 13, 26 and 52 
weeks. 
Period of data 
collection 
Unspecified 
Notes Included in review by Green, Buchbinder and Hetrick (2008). 
Study Vermeulen et al (2006) 
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: YES; Groups 
similar at baseline: YES; Blinding of subjects: YES; Blinding of therapists: NO; Blinding of 
assessors: YES; Intention-to-treat: YES; point measures and measures of variability: YES. 
Population 100 patients with stiffness-predominant frozen shoulder (‘shoulder pain is apparent mainly in 
the end-range of ROM’) recruited by one orthopaedic consultant from 6 hospitals. Inclusion 
criteria: > 50% loss of passive movement of the shoulder joint relative to the non-affected 
side in > 1 of flexion, abduction and external rotation, duration of > 3 months, ability to 
complete questionnaire in Dutch. Exclusion criteria: previous manipulation under anaesthetic 
of the affected shoulder; other conditions affecting the shoulder (e.g. rheumatoid arthritis, 
osteoarthritis, chondral damage, Hill-Sachs lesions, osteoporosis or malignancies); 
neurological deficits; pain or disorders of neck,  elbow, wrist or hand; steroid injection in the 
preceding 4 weeks. Diabetes was not an exclusion criterion. Mean age ± SD, % female: 
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Group 1 52 ± 8 years, 65%; Group 2 52 ± 9 years, 67%. Setting: Secondary or tertiary care. 
Study took place in Leiden, the Netherlands.  
Intervention/ 
Comparison(s) 
Both groups: Mobilisations: with both hands close to the humeral head, the therapist applied 
inferior, posterolateral, anteromedial and oscillatory glides, and oscillatory distraction. If 
range of movement increased during treatment, the techniques were performed in greater 
elevation and abduction. In the last 3 minutes of the treatment session, passive PNF patterns 
were performed in the pain-free range, followed by pendular exercises in prone. Concurrent 
interventions apart from self- or physician-prescribed pain medications were disallowed in 
the first 3 months of the study. Group 1: High grade mobilisations (Maitland’s grade III–IV) 
with standard precautions. The duration of time on stretch depended on the individual 
patients’ responses. Group 2: Low grade mobilisations (Maitland’s grade I–II), again, with 
standard precautions. Both groups: Treatments were twice weekly for 12 weeks. Thereupon 
further management was decided by the orthopaedic consultant and patient. For continued 
physiotherapy, if required, patients were referred to private practice.  
Accepted 
outcome(s) 
Shoulder rating score; pain during movement, at rest, and at night using a VAS; passive 
external rotation measured using a goniometer. Adverse events: Participants’ opinions on 
their shoulder function (global change) relative to baseline were sought, but ‘much worse’, 
‘worse’ and ‘no change’ categories were combined in the Results.  Follow up was at 3, 6 and 
12 months. Timing of assessments: (1) Baseline; (2) End-point: 3 months; (3) Follow-up: 6 
and 12 months. 
Period of data 
collection 
August 1999–March 2002 
Notes The therapists administering the high grade mobilisation were trained, whereas those 
administering the low grade mobilisations were not. There was no non-intervention group, so 
it is unclear whether either intervention is better than doing nothing.  
Study Yang et al (2007) 
Methods Eligibility criteria specified: YES; Random allocation: YES; Concealed allocation: YES; Groups 
similar at baseline: YES; Blinding of subjects: NO; Blinding of therapists: NO; Blinding of 
assessors: YES; Intention-to-treat: YES; point mea sures and measures of variability: YES. 
Population 28 patients with painful, stiff shoulder recruited from a Department of Physical Medicine and 
Rehabilitation. Probably a mix of pain-predominant and stiffness-predominant frozen 
shoulder, thus: Inclusion criteria: Painful, stiff shoulder for > 3 months, limited range of 
movement (> 25% versus the contralateral shoulder in at least 2 of flexion, abduction or 
internal and external rotation) and consent of patient and physician. Exclusion criteria: 
Diabetes, history of surgery on affected shoulder, rheumatoid arthritis, history of severe 
trauma, fracture in the shoulder region, rotator cuff rupture, tendon calcification. Mean age 
± SD, % female: Group A-B-A-C 53 ± 7 years, 93%; Group A-C-A-B 58 ± 10 years, 79%.  
Setting: Secondary or tertiary care. Study was conducted at the National Taiwan University 
Hospital. 
Intervention/ 
Comparison(s) 
A: 10-15 repetitions of mid-range mobilisation as described by Maitland and Kaltenborn, 
with the supine patient’s shoulder abducted 40º. B: End-range mobilisation as described by 
Vermeulen et al. and Maitland; 10–15 repetitions of ‘intensive mobilising techniques’ were 
applied with the humerus at end-range in different directions. C: Mobilisations with 
movement (MWMs) as described by Mulligan. A belt was placed round the seated patient’s 
proximal humerus to glide the humeral head appropriately. One of the therapist’s hands was 
used over the appropriate aspect of the head of humerus, while the other applied counter 
pressure to the scapula. ‘The glide was sustained during slow active shoulder movements to 
the end of the pain-free range and released after return to the starting position.’ The 
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technique was repeated in 3 sets of 10, with 1 minute rest between sets. All groups: No 
instruction in home exercises was given, and the patients were frequently asked not to do 
exercises. The Sequence of interventions was A-B-A-C and A-C-A-B with each component 
being 3 weeks: hence a total of 12 weeks. 
Accepted 
outcome(s) 
A self-administered scale, the Flexi-level scale of Shoulder Function (FLEX-SF). Adverse 
effects/events in individuals were not specified as an outcome. Timing of assessments: (1) 
Baseline; (2) In-trial and end-point: 3, 6, 9 and 12 weeks; (3) Follow-up: None. 
Period of data 
collection 
Unspecified 
Notes  
 
Trials marked ‘*’ were included in the review by Green, Buchbinder and Hetrick (2003)   
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APPENDIX C: Table of excluded studies   
1st Author Year  Target condition Intervention Reason(s) for exclusion 
Ahn 2008 Frozen shoulder Adhesiolysis Not an RCT; not directly relevant to physiotherapy 
Ainsworth 2007 Shoulder pain Ultrasound No separate analysis for capsular pattern subgroup 
Ainsworth 2008 Shoulder pain Ultrasound Not an RCT (reply to a comment) 
Amir-Us-
Saqin 
2007 Frozen shoulder MUA plus steroid injection with and 
without immobilisation  
Not directly relevant to physiotherapy 
Amoretti 2006 Frozen shoulder Capsular distension Not an RCT (cohort study) 
Bang 2000 Shoulder 
impingement 
syndrome 
Exercise and physiotherapy Not frozen shoulder 
Bergman 2004 Shoulder dysfunction 
and pain 
Manipulative therapy in addition to 
usual medical care 
Patients with Frozen shoulder cannot be identified as a subgroup  
Berry* 1980 Painful-stiff shoulder Acupuncture, steroid injection, 
physiotherapy 
Not frozen shoulder 
Binder* 1984 Rotator cuff 
tendinitis  
Pulsed electromagnetic fields Not frozen shoulder 
Bingöl 2005 Shoulder pain Low-power laser Patients with frozen shoulder cannot be identified as a subgroup 
Boylan 2005 Shoulder pain Soft-tissue massage Not primary research: summary of article by van den Dolder 2003 
Bron 2007 Common shoulder 
disorders 
Trigger point physiotherapy RCT in progress 
Brox* 1993/7 Rotator cuff disease Exercise, arthroscopic surgery Not frozen shoulder 
Brox 2003 Shoulder pain Overview including steroid 
injections and physiotherapy 
Not an RCT (descriptive review/monograph) 
Buchbinder 2003 Frozen shoulder Oral steroids Not directly relevant to physiotherapy 
Buchbinder  2006 Frozen shoulder Oral steroids Not an RCT (systematic review); not directly relevant to physiotherapy  
Cleland 2002 Frozen shoulder Physiotherapy Not an RCT (systematic review) 
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1st Author Year  Target condition Intervention Reason(s) for exclusion 
Conroy* 1998 Shoulder 
impingement 
syndrome 
Physiotherapy Not frozen shoulder 
Dal Conte* 1990 Calcific tendinitis Pulsed electromagnetic fields Not frozen shoulder 
De Bruijn 2005, 
2007 
Shoulder complaints Education and activation 
programme 
Patients with frozen shoulder cannot be identified as a subgroup 
Diercks 2004 Frozen shoulder Supervised neglect v. intensive 
physiotherapy 
Not an RCT (control and intervention groups were not contemporary) 
Downing* 1986 Subacromial bursitis Ultrasound Not frozen shoulder 
Ebenbichler* 1999 Calcific tendinitis Ultrasound Not frozen shoulder 
England* 1989 Suprasinatus and 
biceps tendinitis 
Laser Not frozen shoulder 
Garaets  2005 Shoulder pain 
(chronic) 
Graded exercise programme v. usual 
care 
Patients with frozen shoulder cannot be identified as a subgroup 
Garaets 2006 Shoulder pain 
(chronic) 
Graded exercise programme v. usual 
care 
Duplication of 2005 report 
Ginn*  1997 Shoulder pain Physiotherapy Patients with frozen shoulder cannot be identified as a subgroup 
Ginn 2004 Shoulder pain with 
capsulitis subgroup 
Various combinations of 
physiotherapy interventions and 
steroid injections 
Not an RCT (cohort study) 
Green 2003 Frozen shoulder Steroid injections and 
physiotherapy, separately and in 
combination 
Not an RCT (commentary on Carette 2003) 
Gulik  2007 Frozen shoulder Analgesic nerve block Not an RCT (case study); not directly relevant to physiotherapy 
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1st Author Year  Target condition Intervention Reason(s) for exclusion 
Gursel 2004 ‘pain and limitation 
of [shoulder] 
motion’, but unclear 
is whether this 
limitation pertained 
to active or passive 
range 
Physiotherapy with and without 
ultrasound 
Reported baseline ranges of motion not commensurate with frozen 
shoulder 
Halverson  2002 Frozen shoulder Capsular distension Not an RCT (case series) 
Hamdan 2003 Frozen shoulder Manipulation under anaesthesia, 
injection and physiotherapy 
Not an RCT  
Hay 2003 Shoulder pain Steroid injection v. physiotherapy The subgroup with frozen shoulder was not separately analysed 
Herrera-
Lasso* 
1993 Bicipital or 
supraspinatus 
tendinitis, subdeltoid 
bursitis or 
periarthritis 
Ultrasound, TENS The subgroup with frozen shoulder was not separately analysed 
James 2005 Shoulder pain Steroid injection v. physiotherapy Patients with frozen shoulder cannot be identified as a subgroup 
Karatas 2002 Frozen shoulder Comparison of two types of 
suprascapular nerve block  
Not directly relevant to physiotherapy 
Koel  2008 Shoulder pain Ultrasound Not an RCT (comment) 
Leclaire* 1991 Shoulder periarthritis Magnetotherapy Ambiguity of trial inclusion criteria 
Loew 2004 Frozen shoulder Inspection for iatrogenic damage 
post MUA 
Not an RCT (observational study) 
Nykanen* 1995 Rotator cuff disease Ultrasound Not frozen shoulder 
Perron* 1997 Calcific tendinitis Iontophoresis, ultrasound Not frozen shoulder 
Piotte 2004 Frozen shoulder Distension therapy plus 
physiotherapy 
Not an RCT  
Pirotta 2007 General Acupuncture Not an RCT (descriptive review) 
Polimeni 2006 Shoulder pain Ultrasound and (non-standard) 
physiotherapy 
Not an RCT (cohort study); no frozen shoulder subgroup identifiable 
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1st Author Year  Target condition Intervention Reason(s) for exclusion 
Reid* 1996 Anterior instability Exercise, EMG biofeedback Not frozen shoulder 
Rendeiro  2006 Frozen shoulder Added effect of manipulation after 
interscalene block to a course of 
physiotherapy 
Not an RCT (non-randomised controlled trial); not a full report 
(conference abstract) 
Roy 2007 Frozen shoulder Overview Not an RCT (descriptive review) 
Saunders* 1995 Supraspinatus 
tendinitis 
Laser Not frozen shoulder 
Saadat Niaki 2005 Frozen shoulder Comparison of sites for blocks using 
steroid with local anaesthetic  
Not an RCT  
Shah 2007 Frozen shoulder Multiple steroid injections Not an RCT (systematic review) 
Shehab* 2000 Peri-articular 
shoulder pain 
TENS, ultrasound, ice, stretches No frozen shoulder subgroup identifiable 
Smidt 2003 Shoulder pain Discussion on importance of 
diagnosis 
Not an RCT (commentary) 
Speed 2002 Shoulder pain Overview Not an RCT (review) 
Taverna* 1990 Shoulder peri-
arthritis 
Laser Not in English language (Italian) 
Teys 2008 ‘inability to elevate 
the arm greater than 
100º in the plane of 
the scapula because 
of the presence of 
[anterior shoulder] 
pain’ 
Mulligan’s mobilisations-with-
movement  
The inclusion criterion is not specific to frozen shoulder 
Thomas 2005 Shoulder pain Injection v. physiotherapy Not an RCT (review) 
Van den 
Dolder  
2003 Shoulder pain Soft-tissue massage No frozen shoulder subgroup identifiable 
van den Hout 2005 Frozen shoulder High-grade v. low-grade 
mobilisation techniques 
Not an RCT (economic evaluation conducted alongside Vermeulen 
2006) 
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1st Author Year  Target condition Intervention Reason(s) for exclusion 
Van der 
Heijden 
1999 Shoulder pain Interferential, ultrasound, exercises No frozen shoulder subgroup identifiable 
van der 
Windt 
2003 Shoulder pain Steroid injections and physiotherapy  Not an RCT (leader) 
Vecchio* 1993 Rotator cuff 
tendinitis 
Laser Not frozen shoulder 
Wang 2006 Shoulder pain  Customised v. standard exercises No frozen shoulder subgroup identifiable 
Watson 2007 Frozen shoulder Capsular distension Not an RCT (cohort study) 
Whitman  2003 Frozen shoulder Manipulation under local 
anaesthetic block v. mobilisation 
Not an RCT (case report); no full report  
1st Author Year  Target condition Intervention Reason(s) for exclusion 
Winters* 1997/9 Shoulder pain Steroid injection, manipulation, 
physiotherapy 
No frozen shoulder subgroup identifiable 
Asterisked studies were included in the Cochrane review by Green, Buchbinder and Hetrick (2003) 
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APPENDIX D: References to excluded studies  
This reference list is limited to articles identified in the supplementary search but excluded from 
analysis (see APPENDIX A: Methods, and APPENDIX C: Table of excluded studies).  
Ahn K, Lee YJ, Kim EH, Yang SM, Lim TK, Kim YS, Jhun HJ (2008). Interventional microadhesiolysis: A 
new nonsurgical release technique for adhesive capsulitis of the shoulder, BMC 
Musculoskeletal Disorders, 9, 12.  
Ainsworth R, Dziedzic K, Hiller L, Daniels J, Bruton A, Broadfield J (2007). A prospective double blind 
placebo-controlled randomized trial of ultrasound in the physiotherapy treatment of shoulder 
pain,  Rheumatology, 46, 5, 815–820.  
Ainsworth R, Dziedzic K, Hiller L, Daniels J, Bruton A, Broadfield J (2008). Comment on: A prospective 
double blind placebo-controlled randomized trial of ultrasound in the physiotherapy 
treatment of shoulder pain: Reply [10]. Rheumatology, 47, 2, 230–231.  
Amir-Us-Saqlain H, Zubairi A, Taufiq I (2007). Functional outcome of frozen shoulder after 
manipulation under anaesthesia, JPMA - Journal of the Pakistan Medical Association, 57, 4, 
181–185.  
Amoretti N, Grimaud A, Brocq O, Roux C, Dausse F, Fournol M, Chevallier P, Bruneton JN (2006). 
Shoulder distension arthrography in adhesive capsulitis, Clinical Imaging, 30, 4, 254–256.  
Bang MD, Deyle GD (2000). Comparison of supervised exercise with and without manual physical 
therapy for patients with shoulder impingement syndrome. Journal of Orthopaedic & Sports 
Physical Therapy, 30, 3, 126–137.  
Bergman GJ, Winters JC, Groenier KH, Pool JJ, Meyboom-de Jong B, Postema K, van der Heijden GJ 
(2004). Manipulative therapy in addition to usual medical care for patients with shoulder 
dysfunction and pain: A randomized, controlled trial. See comment. Annals of Internal 
Medicine, 141, 6, 432–439.  
Bingol U, Altan L, Yurtkuran M (2005). Low-power laser treatment for shoulder pain, Photomedicine 
& Laser Surgery, 23 , 5, 459–464.  
Boylan M (2005). Soft tissue massage improves range of motion, function and pain in shoulder pain,  
Journal of the Australian Traditional-Medicine Society, 11, 4, 177–178.  
Bron C, Wensing M, Franssen JL, Oostendorp RA (2007). Treatment of myofascial trigger points in 
common shoulder disorders by physical therapy: A randomized controlled trial 
[ISRCTN75722066], BMC Musculoskeletal Disorders, 8, 107.  
Brox JI (2003). Shoulder pain, Best Practice & Research in Clinical Rheumatology, 17, 1, 33–56.  
Buchbinder R, Green S, Youd JM, Johnston RV (2006). Oral steroids for adhesive capsulitis, Cochrane 
Database of Systematic Reviews (4).  
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Cleland J, Durall CJ (2002). Physical therapy for adhesive capsulitis: Systematic review, 
Physiotherapy, 88, 8, 450–457.  
De Bruijn C, Goossens M, De Bie R, Ament A, Geraets J, Dinant G (2007). Cost-effectiveness of an 
education and activation program for patients with acute and subacute shoulder complaints 
compared to usual care, International Journal of Technology Assessment in Health Care, 23, 1, 
80–88.  
Diercks RL, Stevens M (2004). Gentle thawing of the frozen shoulder: A prospective study of 
supervised neglect versus intensive physical therapy in seventy-seven patients with frozen 
shoulder syndrome followed up for two years, Journal of Shoulder & Elbow Surgery, 13, 5, 
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APPENDIX E: GRADE evidence profile tables  
i. Physiotherapy versus other physiotherapy 
 
Author(s)  Carette et al (2003), Ryans et al (2005) 
Question i.i  Should we add outpatient physiotherapy to home exercises for both stages of contracted (frozen) shoulder? 
Settings   Primary care, Canada; secondary care, Northern Ireland. 
 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
Outpatient physiotherapy 
and home exercises  
Home 
exercises 
alone 
Relative 
(95% 
CI) 
Absolute 
Improvement in combined pain-function outcome (6 weeks) 
2 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious1 
none 
46 42 - 
SMD 0.11 higher (0.3 
lower to 0.53 higher) 
 
LOW 
CRITICAL 
Improvement in combined pain-function outcome (4-6 months) 
2 randomised 
trials 
serious2 no serious 
inconsistency 
no serious 
indirectness 
very 
serious1 
none 
42 35 - 
SMD 0.06 higher (0.39 
lower to 0.51 higher) 
 
VERY LOW 
CRITICAL 
Improvement in combined pain-function outcome: SPADI (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious1 
none 
26 23 - 
MD 1.7 higher (12.78 
lower to 16.18 higher) 
 
LOW 
CRITICAL 
Improvement in pain, 100 mm VAS (6 weeks) 
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2 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious3 none 
46 42 - 
MD 7.09 higher (5.22 
lower to 19.4 higher) 
 
MODERATE 
CRITICAL 
Improvement in pain, 100 mm VAS (4-6 months) 
2 randomised 
trials 
serious2 no serious 
inconsistency 
no serious 
indirectness 
very 
serious1 
none 
42 35 - 
MD 6.72 higher (6.27 
lower to 19.71 higher) 
 
VERY LOW 
CRITICAL 
Improvement in pain, 100 mm VAS (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious1 
none 
26 23 - 
MD 0.1 higher (15.01 
lower to 15.21 higher) 
 
LOW 
CRITICAL 
Improvement in passive external rotation, degrees (6 weeks) 
2 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious4 none 
46 42 - 
MD 6.68 higher (0.53 to 
12.82 higher) 
 
MODERATE 
IMPORTANT5 
Improvement in passive external rotation, degrees (4-6 months) 
2 randomised 
trials 
serious2 no serious 
inconsistency 
no serious 
indirectness 
serious6 none 
37 35 - 
MD 1.44 higher (6.59 
lower to 9.48 higher) 
 
LOW 
IMPORTANT5 
Improvement in passive external rotation, degrees (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious6 none 
26 23 - 
MD 1.2 higher (7.95 
lower to 10.35 higher) 
 
MODERATE 
IMPORTANT5 
 
1
 95% CI crossed zero and adjusted threshold for MCID on both sides of zero.  
2
 Unclear risk of bias. 
3
 95% CI crossed zero and adjusted threshold for MCID favouring addition of outpatient physiotherapy. 
4
 95% CI did not cross zero but potentially ‘fragile’ as total population small.  
5
 Probably not critical from patients' perspective. 
6
 95% CI crossed zero. Threshold for MCID not known, but unlikely to lie inside 95% CI on either side of zero. 95% CI potentially 'fragile' however, as total population small. 
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Author(s)  Ginn and Cohen (2005) 
Question i.ii  Should we use a home muscle function retraining programme or outpatient physiotherapy (with passive mobilisations) and home exercises for both stages of contracted (frozen) 
shoulder? 
Settings   Secondary care, Australia. 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
Muscle function 
retraining 
programme 
Outpatient 
physiotherapy and home 
exercises 
Relative 
(95% CI) 
Absolute 
Patients' global impression of change (5 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
17/23 (73.9%) 
22/26 (84.6%) RR 0.87 
(0.65 to 
1.17) 
110 fewer per 1000 
(from 296 fewer to 144 
more)  
MODERATE 
CRITICAL2 
84.6% 
110 fewer per 1000 
(from 296 fewer to 144 
more) 
 
1
 See 95% confidence limits for absolute effect. 
2
 Outcome critical but unvalidated. 
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Author(s)  Ginn and Cohen (2005) 
Question i.ii-A  Should we use a home muscle function retraining programme or outpatient physiotherapy (with passive mobilisations) and home exercises for both stages of contracted (frozen) 
shoulder? (Adverse events.) 
Settings   Secondary care, Australia. 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
Muscle function 
retraining 
programme 
Outpatient 
physiotherapy and home 
exercises 
Relative 
(95% CI) 
Absolute 
Adverse effects/events (5 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
1/23 (4.3%) 
1/26 (3.8%) 
RR 1.13 (0.07 
to 17.07) 
5 more per 1000 
(from 36 fewer to 618 
more)  
MODERATE 
CRITICAL 
3.8% 
5 more per 1000 
(from 35 fewer to 611 
more) 
 
1 
See 95% confidence limits for absolute effect. 
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Author(s)  Vermeulen et al (2006) 
Question i.iii  Which should we use for stiffness-predominant contracted (frozen) shoulder: high-grade mobilisations or low-grade mobilisations? 
Settings   Secondary care, Leiden, The Netherlands.  
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
High-grade 
mobilisations 
Low-grade 
mobilisations 
Relative 
(95% 
CI) 
Absolute 
Improvement in SRQ (3 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious1 
none 
47 49 - 
MD 2.00 higher (10.07 
lower to 14.07 higher) 
 
LOW 
CRITICAL 
Improvement in SRQ (6 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious2 none 
47 49 - 
MD 4.5 higher (2.4 lower 
to 11.4 higher) 
 
MODERATE 
CRITICAL 
Improvement in SRQ (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious2 none 
47 49 - 
MD 6.6 higher (0.61 lower 
to 13.81 higher) 
 
MODERATE 
CRITICAL 
Improvement in night pain, 100 mm VAS (3 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious1 
none 
47 49 - 
MD 3.8 higher (9.75 lower 
to 17.35 higher) 
 
LOW 
CRITICAL 
Improvement in night pain, 100 mm VAS (6 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious1 
none 
47 49 - 
MD 7.1 higher (7.1 lower 
to 21.3 higher) 
 
LOW 
CRITICAL 
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Improvement in night pain, 100 mm VAS (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious2 none 
47 49 - 
MD 7.8 higher (4.91 lower 
to 21.3 higher) 
 
MODERATE 
CRITICAL 
Improvement pain at rest, 100 mm VAS (3 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious3 none 
47 49 - 
MD 7.1 lower (17.9 lower 
to 3.7 higher) 
 
MODERATE 
CRITICAL 
Improvement in pain at rest, 100 mm VAS (6 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious1 
none 
47 49 - 
MD 2 lower (13.74 lower 
to 9.74 higher) 
 
LOW 
CRITICAL 
Improvement in pain at rest, 100 mm VAS (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious1 
none 
47 49 - 
MD 0.9 lower (9.88 lower 
to 11.68 higher) 
 
LOW 
CRITICAL 
Improvement in pain on use, 100 mm VAS (3 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious1 
none 
47 49 - 
MD 2.6 higher (8.46 lower 
to 13.66 higher) 
 
LOW 
CRITICAL 
Improvement in pain on use, 100 mm VAS (6 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious1 
none 
47 49 - 
MD 0.5 higher (10.19 lower 
to 11.19 higher) 
 
LOW 
CRITICAL 
Improvement in pain on use, 100 mm VAS (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious2 none 
47 49 - 
MD 6.6 higher (4.99 lower 
to 18.19 higher) 
 
MODERATE 
CRITICAL 
Improvement in passive external rotation, degrees (3 months) 
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1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious4 none 
47 51 - 
MD 1.4 higher (3.5 lower 
to 6.3 higher) 
 
MODERATE 
IMPORTANT5 
Improvement in passive external rotation, degrees (6 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious4 none 
47 49 - 
MD 4.1 higher (1.03 lower 
to 9.23 higher) 
 
MODERATE 
IMPORTANT5 
Improvement in passive external rotation, degrees (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious6 none 
47 49 - 
MD 6.5 higher (0.27 to 
12.73 higher) 
 
MODERATE 
IMPORTANT5 
 
1
 95% CI crossed zero and adjusted threshold for MCID on both sides of zero. 
2
 95% CI crossed zero and adjusted threshold for MCID favouring high-grade mobilisations. 
3
 95% CI crossed zero and adjusted threshold for MCID favouring low-grade mobilisations.  
4
 95% CI crossed zero. Threshold for MCID not known, but unlikely to lie within 95% CI on either side of zero. 95% CI potentially 'fragile', however, as total population small.  
5
 Probably not critical from patients' perspective. 
6
 95% CI did not cross zero. Threshold for MCID not known, but unlikely to lie inside 95% CI. 95% CI potentially 'fragile', however, as total population small. 
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Author(s)  Vermeulen et al (2006) 
Question i.iii-A  Which should we use for stiffness-predominant contracted (frozen) shoulder: high-grade mobilisations or low-grade mobilisations? (Adverse events.) 
Settings   Secondary care, Leiden, The Netherlands. 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
High-grade 
mobilisations 
Low-grade 
mobilisations  
Relative 
(95% CI) 
Absolute 
Adverse effects/events (short term) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
serious1 very 
serious2 
none 
6/46 (13%) 
6/49 (12.2%) 
RR 1.07 (0.37 
to 3.07) 
9 more per 1000 (from 77 
fewer to 253 more) 
 
VERY 
LOW 
CRITICAL3 
12.2% 
9 more per 1000 (from 77 
fewer to 253 more) 
Adverse effects/events (medium term) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
serious1 very 
serious2 
none 
6/46 (13%) 
5/48 (10.4%) 
RR 1.25 (0.41 
to 3.82) 
26 more per 1000 (from 61 
fewer to 294 more) 
 
VERY 
LOW 
CRITICAL3 
10.4% 
26 more per 1000 (from 61 
fewer to 293 more) 
Adverse effects/events (long term) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
serious1 very 
serious2 
none 
4/47 (8.5%) 
9/49 (18.4%) 
RR 0.46 (0.15 
to 1.4) 
99 fewer per 1000 (from 156 
fewer to 73 more) 
 
VERY 
LOW 
CRITICAL3 
18.4% 
99 fewer per 1000 (from 156 
fewer to 74 more) 
 
1
 'Adverse events' and 'No change' categories were pooled. 
2
 See 95% confidence limits for absolute effect. 
3
 Outcome critical but unvalidated. 
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Author(s)  Yang et al (2007)  
Question i.iv  Which should we add to home exercises for both stages of contracted (frozen) shoulder: high-grade mobilisations or mobilisations with movement (MWMs)? 
Settings   Secondary care, Taiwan. 
 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
MWMs and home 
exercises 
High-grade mobilisations 
and home exercises 
Relative 
(95% 
CI) 
Absolute 
Improvement in FLEX-SF (6 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious1 
none 
13 14 - 
MD 1.9 higher (3.61 
lower to 7.41 higher) 
 
LOW 
CRITICAL 
 
1
 95% CI crossed zero and adjusted threshold for MCID on both sides of zero. 
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Author(s)  Leung and Cheing (2008) 
Question i.v  Should we add shortwave diathermy (SWD) to outpatient physiotherapy (without passive mobilisations) and home exercises for stiffness-predominant contracted (frozen) 
shoulder? 
Settings  Secondary care, Hong Kong. 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
SWD, outpatient 
physiotherapy and home 
exercises 
Outpatient physiotherapy 
and home exercises 
Relative 
(95% 
CI) 
Absolute 
Improvement in ASES (8 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
10 10 - 
MD 17.50 higher 
(1.76 to 33.24 
higher) 
 
MODERATE 
CRITICAL 
 
1
 95% CI did not cross zero and mostly exceeded adjusted threshold for MCID favouring SWD, but potentially 'fragile', as total population small. 
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Author(s)  Leung and Cheing (2008) 
Question i.vi  Should we add hot packs to outpatient physiotherapy (without passive mobilisations) and home exercises for stiffness-predominant contracted (frozen) shoulder? 
Settings   Secondary care, Hong Kong. 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
Hot packs, outpatient 
physiotherapy and home 
exercises 
Outpatient physiotherapy 
and home exercises 
Relative 
(95% 
CI) 
Absolute 
Improvement in ASES (8 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious1 
none 
10 10 - 
MD 4 higher (10.38 
lower to 18.38 
higher) 
 
LOW 
CRITICAL 
 
1
 95% CI crossed zero and adjusted threshold for MCID on both sides of zero. 
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Author(s):  Leung and Cheing 
Question i.vii  Should we add shortwave diathermy (SWD) or hot packs to outpatient physiotherapy (without passive mobilisations) and exercises for stiffness-predominant contracted (frozen) 
shoulder? 
Settings  Secondary care, Hong Kong 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
SWD, outpatient 
physiotherapy and 
exercises 
Hot packs, outpatient 
physiotherapy and 
exercises 
Relative 
(95% 
CI) 
Absolute 
Improvement in ASES (8 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
10 10 - 
MD 13.5 higher (2.16 
lower to 29.16 
higher) 
 
MODERATE 
CRITICAL 
 
1
 95% CI crossed zero and adjusted threshold for MCID favouring SWD. 
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ii. Physiotherapy versus other treatments 
Author(s)  van der Windt et al (1998) 
Question ii.i  Which should we use for both stages of contracted (frozen) shoulder: outpatient physiotherapy (with passive mobilisations) or intra-articular steroid injections? 
Settings   Primary care, The Netherlands. 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
Steroid 
injections 
Outpatient 
physiotherapy 
Relative 
(95% 
CI) 
Absolute 
Improvement in SDQ (7 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
52 56 - 
MD 25 higher (14.81 to 
35.19 higher) 
 
MODERATE 
CRITICAL 
Improvement in SDQ (6.5 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious2 none 
52 56 - 
MD 10 higher (1.88 lower 
to 21.88 higher) 
 
MODERATE 
CRITICAL 
Improvement in SDQ (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious3 
none 
52 56 - 
MD 4 higher (8.64 lower to 
16.64 higher) 
 
LOW 
CRITICAL 
Improvement in night pain, 100 mm VAS (7 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious4 none 
52 56 - 
MD 14 higher (3.06 to 
24.94 higher) 
 
MODERATE 
CRITICAL 
Improvement in night pain, 100 mm VAS (6.5 months) 
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1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious3 
none 
52 56 - 
MD 1 higher (13.53 lower 
to 15.53 higher) 
 
LOW 
CRITICAL 
Improvement in night pain, 100 mm VAS (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious3 
none 
52 56 - 
MD 2 higher (11.59 lower 
to 15.59 higher) 
 
LOW 
CRITICAL 
Improvement in day pain, 100 mm VAS (7 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious4 none 
52 56 - 
MD 12 higher (3.69 to 
20.31 higher) 
 
MODERATE 
CRITICAL 
Improvement in day pain, 100 mm VAS (6.5 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious3 
none 
52 56 - 
MD 0 higher (10 lower to 
10 higher) 
 
LOW 
CRITICAL 
Improvement in day pain, 100 mm VAS (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious3 
none 
52 56 - 
MD 3 higher (6.24 lower to 
12.24 higher) 
 
LOW 
CRITICAL 
Improvement in passive external rotation, degrees (7 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious5 none 
52 56 - 
MD 15 higher (9.31 to 
20.69 higher) 
 
MODERATE 
IMPORTANT6 
Improvement in passive external rotation, degrees (6.5 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious5 none 
52 56 - 
MD 9 higher (1.64 to 16.36 
higher) 
 
MODERATE 
IMPORTANT6 
 
1
 95% CI did not cross zero and substantially exceeded adjusted threshold for MCID favouring intra-articular steroid injections, but potentially 'fragile', as total population small.  
2
 95% CI crossed zero and adjusted threshold for MCID favouring intra-articular steroid injections. 
3
 95% CI crossed zero and adjusted threshold for MCID on both sides of zero. 
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4
 95% CI did not cross zero and mostly exceeded adjusted threshold for MCID favouring intra-articular steroid injections, but potentially 'fragile', as total population small.  
5
 95% CI did not cross zero. MCID not known, but probably crossed by 95% CI on the side favouring intra-articular steroid injections. 95% CI potentially 'fragile', however, as total population small.  
6
 Probably not critical from patients' perspective. 
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Author(s)  van der Windt et al (1998) 
Question ii.i-A  Which should we use for both stages of contracted (frozen) shoulder: outpatient physiotherapy (with passive mobilisations) or intra-articular steroid injections? (Adverse events.) 
Settings   Primary care, The Netherlands. 
 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
Intra-articular 
steroid injections 
Outpatient 
physiotherapy 
Relative 
(95% CI) 
Absolute 
Adverse events 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
30/57 (52.6%) 
32/57 (56.1%) 
RR 0.94 (0.67 
to 1.31) 
34 fewer per 1000 (from 
185 fewer to 174 more)  
MODERATE 
CRITICAL 
56.1% 
34 fewer per 1000 (from 
185 fewer to 174 more) 
 
1
 See 95% confidence limits for absolute effect.  
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Author(s)  Ginn and Cohen (2005) 
Question ii.ii  Which should we use for both stages of contracted (frozen) shoulder: a home muscle function retraining programme or a subacromial steroid injection? 
Settings   Secondary care, Sydney, Australia 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
Muscle function 
retraining  
programme 
Subacromial 
steroid injection 
Relative 
(95% CI) 
Absolute 
Patients' global impression of change (5 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
17/23 (73.9%) 
17/22 (77.3%) 
RR 0.96 (0.69 
to 1.33) 
31 fewer per 1000 (from 
240 fewer to 255 more)  
MODERATE 
CRITICAL2 
77.3% 
31 fewer per 1000 (from 
240 fewer to 255 more) 
 
1
 See confidence limits for absolute effect. 
2
 Outcome critical but unvalidated. 
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Author(s)  Ginn and Cohen (2005) 
Question ii.ii-A  Which should we use for both stages of contracted (frozen) shoulder: a home muscle function retraining programme or a subacromial steroid injection? (‘Deteriorated’ 
classifications.)  
Settings:  Secondary care, Sydney, Australia. 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
Muscle function 
retraining  
programme 
Subacromial  
steroid 
injection 
Relative 
(95% CI) 
Absolute 
‘Deteriorated’ classifications 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
1/23 (4.3%) 
1/22 (4.5%) 
RR 0.96 (0.06 
to 14.37) 
2 fewer per 1000 (from 43 
fewer to 608 more)  
MODERATE 
CRITICAL 
4.5% 
2 fewer per 1000 (from 42 
fewer to 602 more) 
 
1
 See 95% confidence limits for absolute effect. 
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Author(s)  Ginn and Cohen (2005) 
Question ii.iii  Which should we use for both stages of contracted (frozen) shoulder: outpatient physiotherapy (with passive mobilisations) and home exercises or a subacromial steroid 
injection? 
Settings  Secondary care, Sydney, Australia. 
 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
Subacromial 
steroid injection 
Outpatient physiotherapy 
(with passive mobilisations)  
and home exercises  
Relative 
(95% CI) 
Absolute 
Patients' global impression of change (5 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
17/22 (77.3%) 
22/26 (84.6%) 
RR 0.91 
(0.69 to 
1.21) 
76 fewer per 1000 
(from 262 fewer to 
178 more)  
MODERATE 
CRITICAL2 
84.6% 
76 fewer per 1000 
(from 262 fewer to 178 
more) 
 
1
 See 95% confidence limits for absolute effect. 
2
 Outcome critical but unvalidated. 
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Author(s)  Ginn and Cohen (2005) 
Question ii.iii-A  Which should we use for both stages of contracted (frozen) shoulder: outpatient physiotherapy (with passive mobilisations) and home exercises or a subacromial steroid 
injection? (‘Deteriorated’ classifications.) 
Settings  Secondary care, Sydney, Australia. 
 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
Subacromial 
steroid injection 
Outpatient physiotherapy 
(with passive mobilisations)  
and home exercises  
Relative 
(95% CI) 
Absolute 
‘Deteriorated’ classifications (5 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
1/22 (4.5%) 
1/26 (3.8%) 
RR 1.18 (0.08 
to 17.82) 
7 more per 1000 
(from 35 fewer to 647 
more)  
MODERATE 
CRITICAL 
3.8% 
7 more per 1000 
(from 35 fewer to 639 
more) 
 
1
 See 95% confidence limits for absolute effect. 
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iii. Physiotherapy versus combinations of physiotherapy and other treatments 
Author(s)  Carette et al (2003), Ryans et al (2005)  
Question iii.i  Which should we add to home exercises for both stages of contracted (frozen) shoulder: outpatient physiotherapy (with passive mobilisations) or an intra-articular steroid 
injection? 
Settings  Secondary care, Canada; primary care, Northern Ireland. 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
Steroid injection 
and home 
exercises 
Outpatient physiotherapy 
(with passive mobilisations)  
and home exercises 
Relative 
(95% 
CI) 
Absolute 
Improvement in combined pain-function outcome (6 weeks) 
2 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
46 42 - 
SMD 0.52 higher (0.1 
to 0.95 higher) 
 
MODERATE 
CRITICAL 
Improvement in combined pain-function outcome (4-6 months) 
2 randomised 
trials 
serious2 no serious 
inconsistency 
no serious 
indirectness 
serious3 none 
39 39 - 
SMD 0.34 higher (0.11 
lower to 0.79 higher) 
 
LOW 
CRITICAL 
Improvement in combined pain-function outcome: SPADI (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious4 
none 
26 23 - 
MD 4.6 higher (9.13 
lower to 18.33 higher) 
 
LOW 
CRITICAL 
Improvement in pain, 100 mm VAS (6 weeks) 
2 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency5 
no serious 
indirectness 
serious3 none 
46 42 - 
MD 8.42 higher (3.73 
lower to 20.57 higher) 
 
MODERATE 
CRITICAL 
Improvement in pain, 100 mm VAS (4-6 months) 
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2 randomised 
trials 
serious2 serious6 no serious 
indirectness 
very 
serious4 
none 
42 36 - 
MD 3.24 lower (33.17 
lower to 26.68 higher) 
 
VERY LOW 
CRITICAL 
Improvement in pain, 100 mm VAS (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious4 
none 
26 23 - 
MD 6.5 higher (8.61 
lower to 21.61 higher) 
 
LOW 
CRITICAL 
Improvement in passive external rotation, degrees (6 weeks) 
2 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency5 
no serious 
indirectness 
serious7 none 
46 42 - 
MD 3.03 higher (3.37 
lower to 9.43 higher) 
 
MODERATE 
IMPORTANT8 
Improvement in passive external rotation, degrees (4-6 months) 
2 randomised 
trials 
serious2 no serious 
inconsistency 
no serious 
indirectness 
serious7 none 
42 36 - 
MD 4.61 higher (2.77 
lower to 12 higher) 
 
LOW 
IMPORTANT8 
Improvement in passive external rotation, degrees (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious7 none 
26 23 - 
MD 0.8 lower (7.58 
lower to 5.98 higher) 
 
MODERATE 
IMPORTANT8 
 
1
 95% CI did not cross zero and mostly exceeded adjusted threshold for MCID favouring an intra-articular steroid injection, but potentially 'fragile', as total population small.  
2
 Unclear risk of bias. 
3
 95% CI crossed zero and adjusted threshold for MCID favouring an intra-articular steroid injection. 
4
 95% CI crossed zero and adjusted threshold for MCID on both sides of zero. 
5
 Heterogeneity plausibly explicable by clinical factors. See section 2.3.3.1.  
6
 Heterogeneity may reflect bias in Ryans (2005) at this time point. See section 2.3.3.1.  
7
 95% CI crossed zero. Threshold for MCID not known, but unlikely to lie inside 95% CI on either side of zero. 95% CI potentially 'fragile', however, as total population small.  
8
 Probably not critical from patients' perspective. 
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iv. Adding physiotherapy to other treatments 
Author(s)  Buchbinder et al (2007) 
Question iv.i  Should we add outpatient physiotherapy (with passive mobilisations) and home exercises to distension for both stages of contracted (frozen) shoulder? 
Settings   Primary and secondary care, Australia. 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
Distension, outpatient physiotherapy 
(with mobilisations) and home 
exercises  
Distension 
alone 
Relative 
(95% 
CI) 
Absolute 
Improvement in SPADI (6 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious1 
none 
75 73 - 
MD 0.5 lower (7.6 
lower to 6.6 higher) 
 
LOW 
CRITICAL 
Improvement in SPADI (6.5 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious1 
none 
74 70 - 
MD 2.4 lower (9.69 
lower to 4.89 higher) 
 
LOW 
CRITICAL 
Improvement in global pain (6 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious2 none 
75 73 - 
MD 0 higher (0.69 
lower to 0.69 higher) 
 
MODERATE 
CRITICAL 
Improvement in global pain (6.5 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious2 none 
74 70 - 
MD 0.1 lower (0.93 
lower to 0.73 higher) 
 
MODERATE 
CRITICAL 
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1
 95% CI crossed zero and adjusted threshold for the MCID on both sides of zero. 
2
 95% CI crossed zero. Threshold for MCID not known, but unlikely to lie inside 95% CI on either side of zero. 95% CI potentially 'fragile', however, as total population small. 
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Author(s)  Buchbinder et al (2007) 
Question iv.i-A  Should we add outpatient physiotherapy (with passive mobilisations) and home exercises to distension for both stages of contracted (frozen) shoulder? (Adverse events.) 
Settings   Primary and secondary care, Australia. 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
Distension and  
outpatient 
physiotherapy  
Distension  
Relative 
(95% CI) 
Absolute 
Adverse effects/events (6 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
0/75 (0%) 
1/73 
(1.4%) RR 0.32 (0.01 
to 7.84) 
9 fewer per 1000 (from 14 
fewer to 94 more)  
MODERATE 
CRITICAL 
1.4% 
10 fewer per 1000 (from 14 
fewer to 96 more) 
Adverse effects/events (6.5 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
3/74 (4.1%) 
4/70 
(5.7%) RR 0.71 (0.16 
to 3.06) 
17 fewer per 1000 (from 48 
fewer to 118 more)  
MODERATE 
CRITICAL 
5.7% 
17 fewer per 1000 (from 48 
fewer to 117 more) 
 
1
 See 95% confidence limits for absolute effect. 
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Author(s)  Pajareya et al (2004) 
Question iv.ii  Should we add outpatient physiotherapy (with passive mobilisations) to non-steroidal anti-inflammatory drugs (NSAIDs) for both stages of contracted (frozen) shoulder? 
Settings   Secondary care, Thailand. 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
Outpatient physiotherapy 
and NSAIDs 
NSAIDs  
Relative 
(95% 
CI) 
Absolute 
Improvement in SPADI (3 weeks) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
60 59 - 
MD 8.6 higher (3.28 to 
13.92 higher) 
 
MODERATE 
CRITICAL 
 
1
 95% CI did not cross zero and exceeded adjusted threshold for MCID favouring addition of physiotherapy, but potentially 'fragile', as total population small. 
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v. Adding physiotherapy elements to combinations of physiotherapy and other treatments 
Author(s) Carette et al (2003), Ryans et al (2005)  
Question v.i  Should we add outpatient physiotherapy (with passive mobilisations mobilisations) to an intra-articular steroid injection and home exercises for both stages of contracted (frozen) 
shoulder? 
Settings  Secondary care, Canada; primary care, Northern Ireland. 
 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
Outpatient physiotherapy (with 
mobilisations), intra-articular steroid 
injection and home exercises 
Intra-articular 
steroid injection 
and home exercises 
Relative 
(95% 
CI) 
Absolute 
Improvement in combined pain-function outcome (6 weeks) 
2 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
41 42 - 
SMD 0.34 higher 
(0.1 lower to 0.77 
higher) 
 
MODERATE 
CRITICAL 
Improvement in combined pain-function outcome (4-6 months) 
2 randomised 
trials 
serious2 no serious 
inconsistency 
no serious 
indirectness 
very 
serious3 
none 
38 36 - 
SMD 0.02 higher 
(0.44 lower to 
0.47 higher) 
 
VERY LOW 
CRITICAL 
Improvement in combined pain-function outcome: SPADI (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious4 
none 
21 23 - 
MD 1.8 higher 
(12.62 lower to 
16.22 higher) 
 
LOW 
CRITICAL 
Improvement in pain, 100 mm VAS (6 weeks) 
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2 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
41 42 - 
MD 7.93 higher 
(2.69 lower to 
18.56 higher) 
 
MODERATE 
CRITICAL 
Improvement in pain, 100 mm VAS (4-6 months) 
2 randomised 
trials 
serious2 no serious 
inconsistency 
no serious 
indirectness 
very 
serious4 
none 
38 36 - 
MD 1.65 higher 
(10.21 lower to 
13.51 higher) 
 
VERY LOW 
CRITICAL 
Improvement in pain, 100 mm VAS (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious4 
none 
21 23 - 
MD 4.2 lower 
(20.15 lower to 
11.75 higher) 
 
LOW 
CRITICAL 
Improvement in passive ER, degrees (6 weeks) 
2 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious5 none 
41 42 - 
MD 7.47 higher 
(0.52 to 14.42 
higher) 
 
MODERATE 
IMPORTANT6 
Improvement in passive ER, degrees (4-6 months) 
2 randomised 
trials 
serious2 no serious 
inconsistency 
no serious 
indirectness 
serious7 none 
38 36 - 
MD 3.3 higher 
(4.68 lower to 
11.29 higher) 
 
LOW 
IMPORTANT6 
Improvement in passive ER, degrees (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious3 none 
21 23 - 
MD 7.2 higher 
(2.51 lower to 
16.91 higher) 
 
MODERATE 
IMPORTANT6 
 
1
 95% CI crossed zero and adjusted threshold for MCID favouring addition of steroid injection. 
2
 Unclear risk of bias. 
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3
 95% CI crossed zero. MCID not known, but threshold may lie inside the 95% CI on the side favouring addition of outpatient physiotherapy. 
4
 95% CI crossed zero and adjusted threshold for MCID on both sides of zero.  
5
 95% CI did not cross zero. Threshold for MCID not known, but may lie within 95% CI on the side favouring addition of outpatient physiotherapy. 95% CI potentially 'fragile', however, as total 
population small.  
6
 Probably not critical from patients' perspective. 
7
 95% CI crossed zero. Threshold for MCID not known, but unlikely to lie within 95% CI on either side of zero. 95% CI potentially 'fragile', however, as total population small. 
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vi. Adding other treatments to physiotherapy 
Author(s)  Carette et al (2003), Ryans et al (2005) 
Question vi.i Should we add steroid injection to outpatient physiotherapy (with passive mobilisations) and home exercises for both stages of contracted (frozen) shoulder? 
Settings   Secondary care, Canada; primary care, Northern Ireland. 
Quality assessment 
Summary of findings 
Importance 
No of patients Effect 
Quality 
No of 
studies 
Design Limitations Inconsistency Indirectness Imprecision 
Other 
considerations 
Intra-articular steroid injection 
with outpatient physiotherapy 
(with passive mobilisations) and 
home exercises 
Outpatient physiotherapy 
(with passive 
mobilisations) and home 
exercises 
Relative 
(95% 
CI) 
Absolute 
Improvement in combined pain-function outcome (6 weeks) 
2 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
serious1 none 
41 46 - 
SMD 0.89 higher 
(0.45 to 1.34 
higher) 
 
MODERATE 
CRITICAL 
Improvement in combined pain-function outcome (4-6 months)  
2 randomised 
trials 
serious2 no serious 
inconsistency 
no serious 
indirectness 
serious3 none 
38 41 - 
SMD 0.36 higher 
(0.08 lower to 
0.8 higher) 
 
LOW 
CRITICAL 
Improvement in combined pain-function outcome: SPADI (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious4 
none 
21 26 - 
MD 2.8 higher 
(11.22 lower to 
16.82 higher) 
 
LOW 
CRITICAL 
Improvement in pain, 100 mm VAS (6 weeks)  
2 randomised no serious no serious no serious serious6 none 41 46 - MD 16.72 higher 
(4.29 to 29.14 
 
CRITICAL 
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trials limitations inconsistency5 indirectness higher) MODERATE 
Improvement in pain, 100 mm VAS (4-6 months) 
2 randomised 
trials 
serious2 Serious no serious 
indirectness 
very 
serious4 
none 
37 43 - 
MD 1.17 lower 
(22.85 lower to 
20.51 higher) 
 
VERY LOW 
CRITICAL 
Pain, 100 mm VAS (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
very 
serious4 
none 
21 26 - 
MD 6.5 higher 
(8.61 lower to 
21.61 higher) 
 
LOW 
CRITICAL 
Passive ER, degrees (6 weeks) 
2 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency5 
no serious 
indirectness 
serious7 none 
41 46 - 
MD 10.48 higher 
(3.87 to 17.09 
higher) 
 
MODERATE 
IMPORTANT8 
Passive ER, degrees (4-6 months) 
2 randomised 
trials 
serious2 no serious 
inconsistency 
no serious 
indirectness 
serious7 none 
37 43 - 
MD 7.4 higher 
(0.05 to 14.76 
higher) 
 
LOW 
IMPORTANT8 
Passive ER, degrees (12 months) 
1 randomised 
trials 
no serious 
limitations 
no serious 
inconsistency 
no serious 
indirectness 
Serious7 none 
21 26 - 
MD 6.4 higher 
(3.04 to 15.84 
higher) 
 
MODERATE 
IMPORTANT8 
 
1
 95% CI did not cross zero and substantially exceeded adjusted threshold for MCID favouring injection, but potentially 'fragile', as total population small.  
2
 Unclear risk of bias. 
3
 95% CI crossed zero and threshold for adjusted MCID favouring injection. 
4
 95% CI crossed zero and threshold for adjusted MCID on both sides of zero. 
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5
 Heterogeneity plausibly explicable by clinical factors. See section 2.3.6.1.  
6
 95% CI did not cross zero and mostly exceeded adjusted threshold for MCID favouring injection, but potentially 'fragile', as total population small.  
7
 95% CI did not cross zero. Threshold for MCID not known, but may lie within 95% CI on the side favouring injection. 95% CI potentially 'fragile', however, as total population small.  
8
 Probably not critical from patients' perspective. 
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Author(s)  Kivimäki et al (2007) 
Question vi.ii  Should we add MUA to home exercises for both stages of contracted (frozen) shoulder? 
Settings   Secondary care, Finland. 
Data not reported in GRADE-usable format.
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APPENDIX F: Delphi panellists  
Our invited Delphi panel included patients and targeted physiotherapists (shoulder experts and 
musculoskeletal generalists from primary and secondary care settings), managers and specialist 
shoulder surgeons. With a view to optimising the guidelines’ usefulness across the range of intended 
users, the aim was to reach agreement—at an early stage in the guidelines’ development—on 
factors such as layout, and depth and style of reporting. It was expressly not our intention that 
achieving a consensus on ‘best practice’ would fall within panel’s remit, nor that the panel would 
evaluate the final product14. Instead, its role was formative.   
 
Specifically, we chose our Delphi expert panel to represent the following groups: 
  
 patients receiving physiotherapy for frozen (contracted) shoulder;  
 other members of the public;  
 targeted shoulder specialist physiotherapists; 
 a sample of musculoskeletal generalist physiotherapists; and  
 targeted managers and specialist shoulder surgeons.    
The individual Delphi panellists were: 
 Mrs Christine Baldwin (service user/member of the public) 
 Mr David Burton, Consultant Orthopaedic Surgeon, Darlington Memorial Hospital, 
Darlington 
 Professor Andrew Carr, Nuffield Professor of Orthopaedic Surgery, Nuffield Orthopaedic 
Hospital, Oxford 
 Mr Drew Coverdale, private physiotherapy practitioner and Lecturer, MACP 
 Dr John Fordham, Consultant Rheumatologist, James Cook University Hospital, 
Middlesbrough 
 Mr Garry Goodchild (service user/member of the public) 
 Mrs Anne Hardy, Extended Scope Practitioner in Physiotherapy, Middlesbrough and Redcar 
& Cleveland Community Services 
 Mrs Denise Jones, Lecturer in Physiotherapy, Teesside University, and private practitioner 
 Dr Jeremy Lewis, Consultant Physiotherapist, St. Georges Hospital London and Research 
Lead, Therapy Department, Chelsea and Westminster Hospital, London 
 Ms Jane Moser, Specialist Physiotherapist, Nuffield Orthopaedic Hospital, Oxford 
 Mrs Janice Murphy (service user/member of the public) 
 Professor Amar Rangan, Consultant Orthopaedic Surgeon, James Cook University Hospital, 
Middlesbrough and visiting professor, Teesside University 
 Dr Jim Robertson, General Practitioner with Special Interest in Musculoskeletal, 
Middlesbrough and Redcar & Cleveland Community Services  
 Mr Paul Thurland, Assistant Director, Specialist Services, Middlesbrough and Redcar & 
Cleveland Community Services. 
                                                          
14
 This role fell to the CSP’s Good Practice Panel (methods) and external reviewers (specialist subject content)  
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APPENDIX G: Delphi survey and Guidelines Development 
Group’s responses 
Comments/suggestion 
 
Consensus Action 
1 The draft is well-written and clear Agreed Not required 
2 There is too much detail in section 1.2 Disagreed Not required 
3 There is too much detail in section 1.3 Disagreed Not required 
4 There is too much detail in section 1.4 Disagreed Not required 
5 Section 1.2 is very good Agreed Not required 
6 Section 1.3 is very good Agreed Not required 
7 The explanation of types of studies (section 
vi) is clear and easy to understand 
Agreed Not required 
8 The clinical diagnosis section (1.3.) is very 
good 
Agreed Not required 
9 Overall very useful Agreed Not required 
10 Good format Agreed Not required 
11 Logical Agreed Not required 
12 Would benefit from a bullet-point summary 
of recommendations after each section 
Agreed Change implemented  
13 Would benefit from a final overall bullet-
point summary of recommendations 
Agreed Change implemented 
14 Would benefit from findings of survey of 
physiotherapists being summarized 
separately from the published evidence, in 
bullet-points 
Disagreed Not required 
15 The change of terminology from ‘frozen 
shoulder’ to ‘contracted shoulder’ is not 
justified 
Disagreed Not required 
16 Use of both of the terms ‘frozen shoulder’ 
and ‘contracted shoulder’ is confusing  
Disagreed Not required 
17 The guidelines are attempting to reach too 
wide a readership 
Agreed Decision was made to 
develop a separate patient 
information leaflet 
18 The pain management service should be 
involved in the management of frozen 
shoulder 
Disagreed Not required 
19 Parts of the non-technical sections might be 
heavy going for lay readers 
Agreed Not required 
20 Very thorough literature search – gives 
credence to the guidelines 
Agreed Not required 
21 Clear definition of terms including the 
genesis of the term ‘contracted shoulder’ 
rather than the term ‘frozen shoulder’ 
Agreed Not required 
22 Great introduction – up to date theory 
underpinning current understanding of 
pathology 
Agreed Not required 
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Comments/suggestion 
 
Consensus Action 
23 The use of your symbols is confusing and not 
intuitive. Consider open book for everyone 
and microscope for the more technical 
understanding 
Agreed Change implemented  
24 The entire guidelines are heavily influenced 
by the Cyriax model and I question if this 
introduces bias 
No opinion Not required 
25 Section on errors in measurement of ROM 
useful, pertinent and relevant 
Agreed Not required 
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APPENDIX H:  Deviations from protocol 
We deviated from our pre-defined protocol in four instances, as set out below. 
Our aims originally included, ‘to standardise physiotherapists’ diagnosis, assessment and 
management of contracted (frozen) shoulder’ and to ‘standardise a care pathway for 
patients/service users utilising best practice in the diagnosis, assessment and physiotherapy 
management of contracted (frozen) shoulder’. We abandoned both because we felt they were 
excessively prescriptive.  
Our objectives included ‘to identify and systematically appraise the best available evidence relating 
to the physiotherapy management of contracted (frozen) shoulder’. We modified this to ‘to 
systematically review the best available evidence relating to the physiotherapy management of 
contracted (frozen) shoulder’. This more precisely reflected our intended and actual conduct of the 
review.  
Finally, we did not anticipate that our systematic review of physiotherapy management for 
contracted (frozen) shoulder would identify so many comparisons, nor that so many would be in 
trials with a moderate-to-high risk of bias. Our response to this contingency was to restrict further 
analysis to trials which we judged, by transparent processes, to have a low risk of bias. We took this 
course with the users of the guidelines in mind, in the interests of conciseness and clarity.  
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APPENDIX I: Guidelines Development Group profiles  
Co-leads 
Nigel Hanchard PhD, MSc, MCSP, HPC, FCO (Fellow of the Cyriax Organisation), PGD (tertiary level 
teaching), PGD (injection therapy) is an experienced clinician and teacher at pre- and post-
registration levels, and formerly led the pre-registration MSc in Physiotherapy at Teesside University. 
He is a faculty member of the M-level module, ‘diagnosis and treatment of shoulder conditions’ at 
Teesside University. He has conducted research into the diagnosis and treatment of shoulder pain, 
and is a recipient of the CSP’s Robert Williams award for work in this area. His publications include 
first authorship of the CSP shoulder impingement guidelines and review and primary research 
articles. He is a member of the international Cochrane workgroup developing systematic diagnostic 
reviews, a Cochrane author and an editor of the Cochrane Bone, Joint and Muscle Injuries Group; 
and a co-applicant on and member of the Advisory Group for a major HTA-funded investigation into 
contracted (frozen) shoulder. His other memberships include the British Elbow and Shoulder Society 
and the CSP’s Dynamic Ultrasound Group.  
Lorna Goodchild MSc, MCSP, HPC, MMACP, PGC (Sports Injury Management), PGD (injection 
therapy) is an Extended Scope Physiotherapist based at James Cook University Hospital, 
Middlesbrough. She has six years’ experience as an upper limb specialist working in collaboration 
with a consultant shoulder surgeon.  Responsibilities of her post include conducting new patient 
assessment clinics where patients presenting with complex shoulder problems are triaged. She 
orders investigations and lists patients for surgical procedures. She also conducts clinics for 
preoperative assessment and postoperative review. She is a faculty member of the M-level module, 
‘diagnosis and treatment of shoulder conditions’, a guest lecturer of the M-level ‘sports injury 
management’ module and examiner for the MSc ‘Management of patients with neuro-
musculoskeletal dysfunction’ at Teesside University. She is a published researcher, and her co-
authorships include a Cochrane review. She is a member of the Trial steering committee for the HTA 
funded ProFHER Trial (Proximal Fractures of the Humerus Evaluation by Randomisation); as well as a 
co-applicant on and member of the Advisory Group for a major HTA-funded investigation into 
contracted (frozen) shoulder. Her society memberships include the British Elbow and Shoulder 
Society.  
Members 
Dot Davison BSc, MCSP, HPC is a community-based clinical specialist physiotherapist in general 
musculoskeletal management, with experience in guidelines development. 
Sibongile Mtopo MSc, BSc (Hons), MCSP, HPC, MBAHT is a specialist physiotherapist (upper limb and 
hand). Her current role involves dealing with complex hand and shoulder disorders. She has a keen 
interest in research and evidence-based practice.  
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Tracey O’Brien MCSP, HPC, PGD (Manipulative Therapy), MSOM, PGD (Injection Therapy) is an 
experienced clinician in musculoskeletal medicine who has a special interest in shoulders.  She has 
six years’ experience working as an extended scope practitioner for Middlesbrough, Redcar and 
Cleveland Community Services as part of the Musculoskeletal Service. Her role includes triaging 
orthopaedic referrals and providing upper and lower limb clinical assessment clinics in the 
community. This includes ordering investigations and direct referral into the orthopaedic and 
rheumatology directorates. She has been involved as an investigator and facilitator in several clinical 
trials. 
Christine Richardson MCSP, HPC, PG Dip (injection therapy) is a community-based clinical specialist 
physiotherapist in musculoskeletal, with a special interest in shoulder disorders.   
Martin Scott MSc, BSc, MCSP, HPC is a clinical specialist physiotherapist (shoulders). He is a founder 
member of the International Board of Shoulder & Elbow Therapists and a winner of the British Elbow 
& Shoulder Society AHP Fellowship (2005). He has presented scientific papers and posters of original 
research at national and international conferences of shoulder surgery & physiotherapy since 2001, 
and lectures internationally on the shoulder and physiotherapy. 
Jackie Thompson MCSP, HPC, PGD (mobilisation/manipulative therapy), PGD (injection therapy). 
Jackie Thompson is an Extended Scope Physiotherapist with a special interest in the shoulder. She 
works alongside the upper limb consultant surgeons in joint clinics and triages the referrals into the 
orthopaedic directorate. 
Mary Wragg MCSP, HPC, MSOM, MMACP (assoc), PGD (injection therapy) is an ESP shoulder 
specialist who works in collaboration with a consultant shoulder surgeon. She independently 
conducts clinics where she diagnoses and triages shoulder conditions, ordering special investigations 
at her discretion, and is authorised to list patients for surgical procedures such as decompression, 
stabilization and arthroplasty. She also reviews patients post-operatively at her ESP-led shoulder 
clinic.    
Helen Watson BSc, MCSP, HPC, PGD (injection therapy) has been a clinical specialist and Extended 
Scope Physiotherapist in shoulders at the Freeman Royal Hospital since 2001. Her research 
experience includes running clinical trials and interpreting clinical data. She has co-authored primary 
research articles in peer-reviewed journals and presented research papers nationally and 
internationally.  
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APPENDIX J: Revisions history  
Version 1.2 (minor revision) contained changes to the front cover and amended citation information. 
 
Version 1.3 (minor revision) contained a corrected title to Table 3d and removal of redundant rows 
in Tables 3c and 3d (the authors thank Corinne Birch MCSP for bringing these items to their 
attention). The recommendation to use the terminology ‘pain-predominant’ and ‘stiffness-
predominant’ was made explicit in Summary Table 1.6. 
 
Version 1.4 (minor revision) contained a correction to Tables 2.2 and 2.3 and accompanying text, 
other minor corrections and reformatting.    
 
Version 1.5 (minor revision) contained clarification of the search results and filtering process with 
inclusion of a new table (2.2), addition of summary outcome statements for each comparison in 
section 2, and minor corrections and reformatting. 
 
Version 1.6 (minor revision) expanded the section on diagnosis. The forest plots were edited so that 
the control (or less comprehensive or less invasive intervention) was always to the left. The GRADE 
evidence profiles were streamlined. Corrections were made to pain outcomes in Figures 2.3-4, 2.9-
10 and 2.15-16 and related text, and heterogeneity was re-evaluated statistically. Minor corrections 
were implemented. 
Version 1.7 (minor revision) expands slightly on the intention-to-treat principle.    
 
